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The adult onset familial spinocerebellar ataxias are an 
uncommon group of genetic disorders which have been well 
characterised in North America and Europe. Information 
concerning these conditions in Africa and other parts is 
scant. In order to address this problem, a large scale survey 
has been undertaken in the Western Cape region of South 
Africa. In this investigation more than 300 persons in 18 
affected families have been appraised and investigated and the 
phenotypic features have been analysed in detail. In 10 of 
these families, the phenotype was similar and the remaining 8 
had clinically distinct phenotypes. The morphological changes 
of the nervous system, present at different stages of the 
disorder, were shown on the MRI scans. Electrophysiologic 
studies demonstrated that a motor polyneuropathy was a 
variable, and usually late manifestation in persons with adult 
onset ataxia. 
A minimum prevalence for the late onset hereditary ataxias was 
24.68 per million for the population of the Western Cape at 
the end of December 1993. 
Six South African families with the same phenotype were 
studied for linkage between SCA and the HLA locus. This 
analysis revealed linkage in one family only (lod score= 4.13 
at 9 = 0.05). 
Five of the largest South African families were then 
investigated for linkage to the highly informative PCR based 
dinucleotide repeat markers at the D6S89 and D6S260 loci on 
the short arm of chromosome 6. Allele frequencies for the 2 
markers were established in the mixed ancestry population 
group and linkage was demonstrated in the 2 largest families. 
In family A, the maximum lod score for the D6S89 marker= 7.43 
at 9 = 0.0 and the maximum lod score for the D6S260 marker= 
6.11 at 0 = 0.0. In family B, the maximum lod score for the 
D6S89 marker= 3.8 ate= 0.0 and the maximum lod score for 
the D6S260 marker= 4.1 at 9 = 0.0. In the 3 smaller families 
the maximum lod scores ate= 0.0 were suggestive of linkage 
to the disorder. Results with the 2 microsatellite markers 
(D6S89 and D6S260) indicate that 2 different disease-
associated haplotypes occur in the 5 families of mixed 
ancestry suggesting independent origins of the disorder. 
Eleven South African families (8 families with the same 
phenotype and 3 with distinct phenotypes) were screened by PCR 
analysis for the presence of the expanded CAG repeat at the 
SCA! locus. Definite cosegregation of the disorder with the 
CAG trinucleotide expansion at SCA! occurred in 5 families all 
of whom had the same phenotype. The size of the repeats 
correlate inversely to the age of onset. In 6 of the 11 
families, the disorder was not associated with the CAG 
expansion at SCAl. The disorder in 3 of the 6 kindred was 
clinically indistinguishable from that in the families found 
to have the trinucleotide expansion. The relatively simple 
resolution of the CAG repeats associated with the disorder 
provides an accurate tool for predictive testing. 
X 
The data obtained from the questionnaire survey indicates the 
profound psychological impact of the disorder on unaffected 
family members. The majority of the family members surveyed 
had a very poor understanding of the genetic nature of the 
disorder and 80% of the unaffected persons had incorrect 
perceptions of personal risk status. The survey revealed that 
the disorder had little impact on the attitudes of both 
affected and unaffected persons concerning reproduction. Many 
factors influence the responses of those persons at risk. The 
psychological survey has identified several issues which will 
be addressed prior to the introduction of a predictive testing 
service for the familial ataxias in South Africa. 
The results of this study have provided data on the clinical 
spectrum and natural history of the late onset familial 
ataxias in the Western Cape region of South Africa. This has 
facilitated improved genetic counselling of both affected and 
unaffected persons at the recently established Groote Schuur 
Hospital Neurogenetics Clinic. 
XI 
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LAYOUT OF THESIS 
The layout of this thesis has been planned to facilitate ease 
of reading and to avoid unnecessary duplication of data. For 
this reason, the Tables and Figures pertinent to each chapter 
are interspersed with the text and there is extensive cross-
referencing between chapters. 
The thesis is divided into seven sections. Section I is a 
review of the subject and the aims of the present study. A 
retrospective pilot study of individuals with familial ataxia 
who were assessed at Groote Schuur Hospital over a 10 year 
period is presented in Section II. The prospective clinical 
survey of the late onset familial ataxias is presented in 
Section III, followed by the special investigations 
(diagnostic imaging and neurophysiological tests) of affected 
persons in Section IV. Section Vis a molecular linkage study 
in 5 families with hereditary ataxia. The psychological survey 
of a group of unaffected and affected persons with ataxia is 
in Section VI. Section VII is concerned with the conclusions, 
practical applications and recommendations of the study. 
BIBLIOGRAPHY: 
In the bibliography the references are listed alphabetically 
by first author. Standard abbreviations are used for journal 
names in accordance with current convention. Where the number 
of authors exceed S, the names of the first 4 authors are 
cited, followed by et al. In the text, if multiple authors 
XXIII 
are responsible for an article, then the first author is cited 
followed by "et al". 
Appendix: 
The pedigrees of all the families described in this project 
are illustrated in the appendix. Protocols of investigation, 
and a list of previously published manuscripts and papers 
presented at scientific meetings relating to this study appear 
in the appendix. 
This investigation was undertaken with the approval of the 
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REVIEW OF SPINOCEREBELLAR ATAXIA 
1.1 CLINICAL DEFINITION AND SYMPTOMATOLOGY 
The hereditary late onset spinocerebellar ataxias are a 
heterogeneous group of progressive neurologic disorders in 
which cerebellar ataxia is the predominant manifestation. 
Affected individuals suffer from progressive gait and limb 
ataxia and dysarthria. Many different phenotypes have been 
identified. The cerebellar signs may be accompanied by a wide 
variety of other symptoms and signs, depending on the 
particular phenotype, the extent of the pathology and the 
duration of the disorder. These include pyramidal and 
extrapyramidal signs, ophthalmoplegia, optic atrophy, 
dementia, peripheral neuropathy, amyotrophy, lateral and 
dorsal column involvement and deafness (Schut, 1954; Currier 
et al., 1972; Nino et al., 1980; Berciano, 1982a; Zoghbi et 
al., 1988). 
1.2 PHENOTYPIC VARIETY 
The age of onset, clinical features and rate of progression 
may vary from family to family. Even within a given family 
there may be considerable variation in phenotypic expressivity 
with regard to the onset of the disorder, extent of the 
3 
clinical and pathological manifestations as well as the course 
and prognosis (Diaz et al., 1990). Infrequently there is a 
characteristic clinical syndrome in the majority of the 
affected family members and a different phenotype in one or 
several other members (Rosenberg, 1990). Currier et al.(1972) 
described clinical features in members of a kindred who became 
affected at a younger age which differed from those persons 
who were older when they developed signs of the disease. 
1.3 COURSE AND PROGNOSIS 
In the late onset autosomal dominant variety of spino-
cerbellar ataxia the onset of the disorder is usually in the 
3rd or 4th decade but may be as early as 15 years of age 
(Haines et al., 1984; Nino et al., 1980; Currier et al.,1972). 
Most patients present with progressive ataxia of gait and this 
is invariably associated with dysarthria. The majority of 
persons are unable to walk unaided within 15 years of onset. 
In the well-studied Schut-Swier kindred patients were confined 
to a wheelchair within 10 to 15 years of onset. Speech becomes 
unintelligible and the upper limbs useless because of marked 
incoordination. Ultimately aspiration of food leads to 
frequent bouts of pneumonia and choking is likely. Life 
expectancy is shortened; Harding (1984a) has recorded a mean 
age of death at 57.43 years+/- 13.19 years. In other 
families a younger average age of death (viz. 39years) was 
documented (Haines et al.,1984). In certain kindreds the 
evidence suggests that the rate of progression of the disease 
is more rapid the younger the age of onset (Zoghbi et al., 
4 
1988; Diaz et al., 1990). Death usually results from pneumonia 
(Haines et al., 1984). 
1.4 MODE OF INHERITANCE 
Recognizable modes of inheritance in the hereditary 
spinocerebellar ataxias are autosomal dominant, autosomal 
recessive and rarely, X-linked recessive (Lutz et al., 1989; 
Apak et al., 1989). The nosology of the spinocerebellar 
ataxias is complex and this issue is addressed at length in 
chapter 3. For the sake of clarity a simplified list of the 
different forms of this condition are given in table 1.1. 
TABLE 1.1 TYPES OF HEREDITARY ATAXIA 
1. Hereditary congenital nonprogressive ataxias 
2. Friedreich's Ataxia 
3. Childhood onset recessive ataxias 
(non-Friedreich's) 
4. Adult onset recessive or sporadic ataxias 
5. Adult onset dominant ataxia - common type 
6. Adult onset dominant ataxias - other types 
Friedreichs ataxia, an early onset cerebellar ataxia, is an 
autosomal recessive disease. The majority of the familial 
late onset (usually after the age of 20 years) cerebellar 
ataxias show an autosomal dominant inheritance pattern. 
Sporadic examples of late onset cerebellar ataxia are common. 
This situation poses considerable difficulty for the genetic 
counselling of these individuals and their families. 
5 
In those families with an autosomal dominant inheritance, 
clinical examination of the asymptomatic members at risk is 
generally unhelpful in predicting whether or not they will 
develop the disorder in the future. 
1.5 PATHOGENESIS 
The aetiology of this group of conditions remains undetermined 
and at present the putative genes and their products have not 
been identified. In the autosomal dominant group of late 
onset cerebellar ataxias there has been much speculation 
whether the phenotypic variability can be explained by a 
single gene mutation in which many host factors modify the 
expression and penetrance of the mutant gene or whether the 
phenotypic variation between different families can be 
attributed to different mutations. 
The advent of recombinant DNA technology has made the 
investigation of the aetiology of the genetically determined 
neurodegenerative disorders a realistic proposition. This 
rapidly advancing technology has lead to the cloning of the 
disease genes in a number of these conditions, notably, 
Huntington disease. Similar genetic localization studies are 
presently being undertaken for the familial ataxias. 
Various biochemical and other parameters implicated in the 
pathogenesis have also been studied in different kindreds. 
Examples of these studies include: the rate of cerebellar 
glucose metabolism utilizing labelled glucose and positron 
emission tomography (Gilman et al., 1988); the activity and 
6 
concentration of certain enzymes, amino acids, and 
neurotransmitter substances in post mortem brain samples (Kish 
et al., 1987, 1988, 1991; Perry, 1984); glutamate 
dehydrogenase activity in peripheral leukocytes and 
fibroblasts as well as brain homogenates (Plaitakis et al., 
1980, 1984; Duvoisin et al., 1983; Maruyama and Yamaguchi, 
1984; Finocchiaro et al., 1986; Grossman et al.,1987; 
Rosenberg and Banner, 1989); abnormalities of urinary 
glycolipid content (Berenberg et al., 1984); and the density 
of different cerebellar receptors (Whitehouse et al., 1986; 
Makowiec et al., 1990). Although these findings are of value 
in understanding aspects of the pathogenesis, they have not 
aided the delineation of the molecular genetics (Rosenberg, 
1990) in that these receptor or biochemical alterations may 
represent a genetic epiphenomenon. Even in diseases in which 
the specific biochemical defect is known (eg. abetalipo-
proteinaemia), the relationship between the clinical and 
pathologic features and the biochemical defect is not fully 
understood (Berenberg et al., 1984). Biochemical 
abnormalities, however, provide clues to the pathogenesis of 
the disease process and may serve as markers for the 
underlying genetic defect. 
1.6 NEUROPATHOLOGY 
The neuropathology in this group of diseases is characterized 
by a loss of neurones in the cerebellar cortex, basis pontis 
and inferior olivary nuclei. Some neuronal loss may also 
occur in the spinal cord, cerebral cortex and basal ganglia. 
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The outstanding feature on microscopy is the loss of Purkinje 
cells in the cerebellum which may be so extensive that none 
can be found (Koeppen and Barron, 1984; Koeppen and Turok, 
1992). Pathogenesis is a dynamic process that is inadequately 
explored by the gross and microscopic study of tissues. 
Individuals who die from hereditary ataxia generally reveal 
the morphologic end-stage of their illness, though early death 
by suicide or intercurrent illness has come to attention from 
time to time (Koeppen and Turok, 1992). Subramony et al.(1986) 
have reported a case of an 18 year old man who died from a 
self inflicted gunshot wound to the chest. While not ataxic 
prior to death, he was thought to be at high risk for dominant 
ataxia due to his HLA genotype. The cerebellar cortex revealed 
considerable Purkinje cell loss, suggesting that neuronal 
atrophy antedates the onset of ataxia and that a certain 
degree of neuronal depletion must be reached for first 
symptoms to be become manifest. 
The morphology and pathology of the various subgroups of 
familial ataxia has been extensively discussed in the 
literature since the late 19th century. 
Menzel described the pathology of a case of hereditary ataxia 
in 1891 and Dejerine and Thomas reported a similar sporadic 
case in 1900 and first used the term "atrophie olivo-ponto-
cerebelleuse". In both familial and sporadic cases there was 
symmetrical atrophy of the cerebellum affecting the 
hemispheres more than the vermis with severe atrophy of the 
middle cerebellar peduncle, basis pontis and inferior olive 
and partial atrophy of the restiform body. A stream of similar 
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reports followed. These reports have differed in the extent of 
the atrophic process and the clinical manifestations. 
Olivopontocerebellar atrophy is a label which has remained 
firmly entrenched in the literature, although it is now 
recognized as not being a unitary morbid entity (Duvoisin, 
1987). The olivopontocerebellar atrophies comprise a 
heterogeneous group of familial and sporadic disorders sharing 
major clinical and morphologic features (see chapter 3.2 ). 
A fundamental problem with the label "olivopontocerebellar 
atrophy" has been the enormous variation in the pathologic 
changes, even within the same kindred. 
The earlier classifications were based on the pathological 
studies and the monumental works by Greenfield (1954) and 
Koningsmark and Weiner (1970) are two often quoted examples 
(see chapter 3.3). Harding reviewed the wide spectrum of 
pathological changes reported in the different kindreds with 
late onset autosomal dominant cerebellar ataxia (1984a). The 
neuropathology of the olivopontocerebellar atrophies has also 
been reviewed in detail by Koeppen and Barron (1984) and 
includes a discussion of the gross and microscopic pathology 
and electron microscopy findings. Despite the known 
heterogeneity of the morphological alterations in hereditary 
ataxia, certain trends can be recognized: The autosomal 
dominant forms, perhaps with the exception of "spastic 
ataxia", tend to have severe lesions of cerebellar cortex, 
while the dentate nucleus is usually unaffected. In contrast, 
the cerebellar cortex is variably involved in Friedreich's 
ataxia or is entirely normal but the dentate nucleus may be 
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quite seriously affected. Machado-Joseph disease is an 
autosomal dominant form of ataxia in which the dentate nucleus 
is more severely affected than the cerebellar cortex (Koeppen 
and Turok, 1992). In this disorder, there is also neuronal 
loss and gliosis in the substantia nigra, motor cranial 
nuclei, and neostriatum (Rosenberg, 1992). 
As this topic has been extensively reviewed in the literature 
and as the scope of this thesis does not include a pathologic 
study, the author has omitted any additional review of the 
wide spectrum of neuropathology observed in this group of 
disorders. 
1.8 PSYCHOSOCIAL IMPLICATIONS 
There are enormous psychosocial implications for members of 
families with familial adult onset cerebellar ataxia. By the 
time the patients develop symptoms of the disease they have 
often procreated. Their children become aware of the threat of 
potential calamity as they are faced with observing their 
affected parent's gradual decline and know that they too may 
succumb to a similar fate. Clinicians who have worked with 
such families are well acquainted with the feelings of guilt, 
anxiety and depression that are generated in members of such a 
kindred. In unsophisticated communities family members 
frequently do not seek genetic counselling. Individuals at 
risk are often unaware or uninformed of their relative risk 
for developing the disorder. These issues are addressed in 
greater detail in chapter 12. 
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Clinical examination of asymptomatic individuals at risk does 
not reliably predict whether they will develop the disorder. 
Some studies have reported the presence of subtle clinical or 
physiologic "markers" (eg.:abnormal ocular motility, defective 
optokinetic nystagmus and absent or abnormal oculo-vestibular 
reflexes) to predict the development of the disorder in 
presymptomatic young adults in different kindred (Philcox et 
al., 1975; Hotson et al., 1987; Hutton et al., 1987). The 
presence of such abnormalities in asymptomatic individuals may 
well have ominous significance, but it is uncertain whether 
these findings constitute a consistent presymptomatic feature 
in this heterogeneous group. Furthermore, it is unclear for 
what duration of time these clinical "markers" are present 
prior to the individual becoming symptomatic. 
Providing optimal genetic information to individuals at risk 
remains a primary goal to all those dealings with such 
patients and their kindred. As with other neurodegenerative 
disorders for which no cause or treatment is known the advent 
of a suitable genetic marker for prenatal and presymptomatic 
diagnosis would be invaluable. 
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CHAPTER 2 
THE AIMS OF THE STUDY 
The inherited cerebellar ataxias are an uncommon group of 
disorders which have been well characterized in North America 
and Europe (see chapter 4). Prior to this study, however, 
there has been no collective information concerning the 
clinical diversity, natural history, prognosis and genetic 
pattern of this disease in the population of South Africa (see 
4.2). The author became interested in this group of conditions 
after observing that a significant number of patients with 
familial ataxia were attending the Groote Schuur Hospital 
neurology outpatient service. Although a tertiary referral 
centre will tend to accumulate unusual disorders, the author 
wondered whether there was not a pocket of families with 
ataxia within the local population of the Western Cape region, 
as the other neurologists at the clinic reported similar 
experience. 
The aims of this investigation were as follows: 
1. To survey the familial late onset cerebellar ataxias and 
clinically appraise and investigate all affected individuals 
and their kindred. In this way the different phenotypes within 
the population of the Western Cape could be documented. 
2. To establish the mode of genetic transmission in the 
affected families. 
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3. To document the natural history and prognosis of the 
various subgroups. 
4. To perform appropriate electrophysiological evaluation (EMG 
and nerve conduction velocities) in order to further delineate 
the phenotype. 
5. To document the neuroradiologic findings in affected 
patients with particular reference to MRI imaging. 
6. To determine the prevalence of the various forms of the 
condition in the Western Cape of South Africa. 
7. To study the families by conventional and molecular linkage 
in the evaluation of heterogeneity in the disorder. 
8. To identify reliable genetic markers which could be used 
for presymptomatic and prenatal diagnosis. 
9. To establish a community record of all identified kindreds 
and to inform affected individuals and their families of the 
medical and genetic implications of the disorder. 
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CHAPTER 3: HISTORICAL BACKGROUND AND NOSOLOGY 
"It is a conunonplace that no differential diagnosis is 
possible during life between the different forms of cerebellar 
and spinocerebellar disease." (Greenfield, 1954). 
"It is no exaggeration to state that there are as many 
classifications as there are authors on the subject. (Refsum 
and Skre, 1978)." 
"These problems (of classification) have been magnified by the 
large numbers of descriptions of patients with a bewildering 
variety of hereditary ataxias." (Harding, 1982). 
"This chapter ("classification of ataxia") is printed with 
apologies to Barbeau, Bell and Carmichael, Brouwer and Bemed, 
Eadie, Greenfield, Harding, Holmes, Koningsmark and Weiner, 
Netsky, Plaitakis, Schut, Sjogren, Sobue, Zulch and others who 














HISTORICAL BACKGROUND AND NOSOLOGY 
3.1 HISTORY 
The early descriptions of the ataxias have their roots in the 
19th century European schools of Neurology of France and 
Germany. Nicolaus Friedreich (1825-1882), Professor of 
Medicine at Heidelberg, was the first to describe an inherited 
ataxia in 1863. The autosomal recessive disorder which to 
this day bears his name was at first disputed by his European 
colleagues (Friedreich made a distinction between his cases 
and those with "locomotor ataxie"). The great French 
neurologist Charcot (1825-1893) finally conceded the existence 
of Friedreich's ataxia as a separate entity in 1884. In 1893 
Charcot's pupil and subsequent successor to the Chair of 
Neurology at the Salpetriere, Pierre Marie (1853-1940) drew 
attention to a heterogeneous group of previously reported 
patients with manifestations clinically and pathologically 
distinct from Friedreich's ataxia. The onset of the symptoms 
was later in the 3rd decade and the disorder was usually 
inherited as an autosomal dominant trait. Although these 
cases represented a heterogeneous group the concept of Marie's 
ataxia is still used by some authors to this day. 
Sir Gordon Holmes (1876-1966), a leader of modern English 
Neurology and physician at the National Hospital for Nervous 
Diseases for more than 40 years, wrote extensively on 
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cerebellar disease and the localization of function in the 
cerebellum. Holmes identified an autosomal recessive form of 
hereditary ataxia which was associated with hypogonadism, and 
he also proposed a classification for cerebellar disorders 
(Holmes, 1907). Many other attempts at classifications of the 
hereditary ataxias have followed and this topic remains a 
.contentious and problematic issue to this day (see 3.3). 
3.2 NOSOLOGY 
In his monograph, Greenfield (1954) used the term 
spinocerebellar degeneration to include the group of familial 
and sporadic "progressive diseases characterized clinically by 
disturbances of the co-ordination of movement, or ataxia, and 
pathologically by degeneration of those afferent and efferent 
neuronal systems on which the smooth and efficient regulation 
depends". This label is still used by the National Library of 
Medicine, Washington as a subject heading in Index Medicus. 
The early descriptions of the inherited ataxias have been 
followed by a vast number of descriptions with many different 
phenotypes appearing in the literature. As Harding has 
pointedly noted, many of these cases appeared to be the same 
syndrome but have been given different labels by different 
authors. This has even happened to members of the same 
families. 
The nosologic label, olivopontocerebellar atrophy appears 
frequently in reports. Debate about the ongoing use of this 
label has enlivened the literature. Duvoisin (1987) has argued 
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that the diversity of the morbid entities to which the term is 
applied calls for an attempt to define the syndrome in 
clinical terms. He suggested that the essential feature 
required is cerebellar involvement, either reflected 
clinically or demonstrated on CT or MRI scan, showing atrophy 
of the cerebellum and pons. High resolution CT and MRI are 
able to demonstrate the gross anatomic pathology which first 
defined this syndrome. In addition to the cerebellar signs, 
affected persons should show involvement of the extrapyramidal 
system which manifests usually as bradykinesia and rigidity 
and occasionally chorea or even dystonia. Additional systems 
involved include, the pyramidal, autonomic and peripheral 
nervous systems. Dementia, myoclonus, palatal myoclonus and 
amyotrophy may also occur but are less distinctive 
manifestations. Duvoisin (1987) concedes that the extra-
pyramidal features may be lacking or masked by prominent 
cerebellar signs, and that the sequence with which different 
systems are affected in the course of the disease may vary 
giving rise to difficulties with the clinical diagnosis of 
this entity. 
Harding (1987) has argued strongly against the application of 
pathological labels to living people since the pathology is no 
more specific than the clinical features in reflecting the 
basic disease defect and varies both within and between 
kindred. The term olivopontocerebellar atrophy is incomplete 
in describing the pathological features to which it has been 
applied as there may be associated degenerative changes in the 
basal ganglia, dentate nucleus, cerebral cortex, spinal cord 
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or peripheral nerves which are the rule rather than the 
exception (Koeppen and Barron, 1987). This situation is 
complicated by the lack of agreement in the interpretation of 
autopsy findings amongst several authors (Koeppen, 1984). 
Pathologically olivopontocerebellar atrophy can be found in a 
number of aetiologically distinct degenerative ataxic 
disorders (van Rossum et al., 1981; Harding, 1982) as well as 
in cases of progressive autonomic failure and striatonigral 
degeneration. Harding has suggested that inappropriate 
nosologic labels which stand the test of time and are easily 
understood by all who use them are acceptable and useful, 
provided they are mishandled consistently. She does not 
believe that this holds true for the term 
"olivopontocerebellar atrophy" as clinicians' views of what 
constitutes olivopontocerebellar atrophy are often defined by 
whatever clinical signs are observed in the particular group 
of patients they are likely to see with this type of disorder. 
Duvoisin's requirement for extrapyramidal involvement, for 
example, is not borne out by other reviews of the clinical 
features of the syndrome (Berciano, 1982). 
3.3 CLASSIFICATION 
The issue of the classification of the hereditary ataxias has 
been passionately debated for many years. Attempts at this 
task have resulted in more than 16 classifications. None are 
entirely satisfactory. A variety of parameters have been used 
to categorize different subgroups resulting in scholarly but 
diverse approaches (see table 3.1). 
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TABLE 3.1 
SUMMARY OF VARIABLES USED IN ATAXIA CLASSIFICATIONS 
Common vs. rare 
Stationary vs. progressive 
Hereditary vs. non-hereditary 
Inheritance type 
Gene locus 




Early classifications based primarily on pathology have been 
followed by attempts at a more broadly based classification 
incorporating clinical, genetic and biochemical data 
(Greenfield, 1954; Koningsmark and Weiner, 1970; Harding,1983; 
Barbeau, 1982; Currier 1984). The limitations of current 
classifications and their need for a working system has been 
debated and discussed at length in the literature. 
Harding (1984) presents a strong argument against the 
continued use of a pathological classification for the late 
onset autosomal dominant cerebellar ataxias. As previously 
mentioned, pathological labels are invariably incomplete in 
describing the extent of the pathological features, and she 
questions the accuracy and wisdom of applying pathological 
labels to living patients. It is well known that there is 
considerable variability in the pathological findings even 
within a given family, and there has also been considerable 
disagreement with the interpretation of the neuropathology. 
Harding has utilized a combination of clinical and genetic 
parameters in her approach to classification which is 
presented in table 3.2. Autosomal recessive late onset 
cerebellar ataxias are thought to be exceptionally rare. The 
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clustering of clinical features was used to create the 
different subgroups for patients with a progressive 
unremitting cerebellar ataxia, autosomal dominant inheritance, 
and an onset after the age of 20. 
Ataxic disorders in Harding's classification which are due to 
known metabolic defects have been omitted from table 3.2 as 
these disorders are not pertinent to this thesis. In 
particular, they usually present in the first or second decade 
and have characteristic clinical, radiological or biochemical 
features which identify them. 
TABLE 3.2 CLASSIFICATION OF THE HEREDITARY ATAXIAS 
(Harding 1982) 
ATAXIC DISORDERS OF UNKNOWN AETIOLOGY 











Early onset cerebellar ataxia with retained tendon 
reflexes 
With hypogonadism +/- deafness and/or dementia 
With myoclonus (Ramsay Hunt syndrome, Baltic 
myoclonus) 
With pigmentary retinal degeneration+/- mental 
retardation and/or deafness 
With optic atrophy+/- mental retardation 
With cataracts and mental retardation (Marinesco-
Sjogren syndrome) 
With childhood onset deafness and mental 
retardation 
ix. With congenital deafness 
x With extrapyramidal features 
xi. X-linked recessive spinocerebellar ataxia 
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B. Late onset cerebellar ataxia (onset usually after 20 years) 
i. Autosomal dominant cerebellar ataxia with optic 
atrophy /ophthalmoplegia /dementia/ 
extrapyramidal features/ amyotrophy (probably 
includes Azorean ataxia) (ADCA type 1) 





retinal degeneration+/- ophthalmoplegia and/ or 
extrapyramidal features (ADCA type II) 
'Pure' autosomal dominant cerebellar ataxia of 
later onset (over 50 years) (ADCA type III) 
Autosomal dominant cerebellar ataxia with myoclonus 
and deafness (ADCA type IV) 
Autosomal dominant cerebellar ataxia with essential 
tremor 
vi. Periodic autosomal dominant ataxia 
This classification, which has departed from the traditional 
eponymous and pathological labels, has been criticized for the 
inequality in the numbers of kindred within each subgroup. 
The majority of kindred would be classified as having 
autosomal dominant cerebellar ataxia type 1 with only a few 
kindred falling into the remaining 5 categories. The 
inclusion of Machado-Joseph disease into subgroup autosomal 
dominant type I has also been controversial as this group has 
a high incidence of dystonia and amyotrophy (Nakano et al., 
1972; Coutino and Andrade, 1978; Rosenberg 1976,1978,1991). 
Harding has pointed out that these features are not confined 
to patients from the Azores. Nevertheless, she has 
reiterated that her classification is provisional and awaits 
the identification of special genetic markers for these 
conditions, and that it may well be wise to regard each family 
as having its own specific mutation until there is evidence to 
the contrary. 
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Subramony and Currier (1991) have reviewed the different 
variables which have been used for the arrangement of 
categories and have proposed a classification incorporating 
proposals from the World Federation of Neurology (1985 
meeting) and the World Health organization (1989 see table 
3.3). They sought to adhere to the format of the new 
International Classification of Diseases (ICD-10) and have 
attempted to achieve a more balanced number of persons within 
each category. There is general agreement for the need of a 
classification which is clinically useful so that the 
physician can easily and correctly categorize affected persons 
with familial ataxia. Many of the previous classifications 
were large, complex and therefore somewhat imperfect in this 
regard. Currier's proposals were discussed at length at a 
meeting of the Heredoataxia Research Group of the WFN in 
Vancouver in September 1993. Following this discussion a new 
classification based on frequency, age of onset, gene loci and 
heredity was approved (see Table 3.4). It allows for expansion 
so that newly described syndromes can be added to the 
different rubrics and its use was recommended on a trial basis 
with the intent of eventual incorporation into the 
International Classification of Diseases. 
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TABLE 3.3 









Hereditary ataxias and paraplegia 
Excludes:hereditary and idiopathic neuropathy (G60.-) 
Congenital nonprogressive ataxia 
Excludes: infantile cerebral palsy (GBO.-) 
Early-onset cerebellar ataxia 
Note:onset usually before 20 years 
Early-onset cerebellar ataxia with retained tendon 
reflexes 
Friedreich's ataxia (autosomal recessive) 
With: 
essential tremor 
myoclonus (Hunt's ataxia) 
X-linked recessive spinocerebellar ataxia 
Late-onset cerebellar ataxia 
Note: onset usually after 20 years 
Cerebellar ataxia with defective DNA repair 
Ataxia telangiectasia (Louis-Bar syndrome) 
Hereditary spastic paraplegia 
Other hereditary ataxias 
Hereditary ataxia, unspecified 
TABLE 3.4 
CLASSIFICATION OF HEREDITARY ATAXIAS AND FAMILIAL SPASTIC 
PARAPLEGIAS 
WFN: HEREDOATAXIA RESEARCH GROUP 1993 
G.11.0 Hereditary congenital nonprogressive ataxias 
Chromosomal loci to be determined 
Gll.1 Recessive Friedreich's phenotype 
.10 9th chromosome typical Friedreich's, onset 
before age 20 
.11 9th chromosome Friedreich's,onset after age 20 
.12 8th chromosome vitamin E deficiency, Friedreich's 
phenotype 
.13 et seq. Other types and loci 
Gll.2 Childhood onset recessive ataxias, non-Friedreich's 
.20 ataxia telangiectasia, 11th chromosome 
.201 other gene locus ataxia telangiectasia 









Saguenay (9th chromosome excluded) 
.22 Other childhood onset recessive with retained 
reflexes 
.23 et seq. Other types and loci 
Adult onset recessive or sporadic ataxias 
non-Friedreich's 
.30 Adult onset recessive ataxia with retained 
reflexes 
.31 Multiple system atrophy (sporadic) 
.32 Sporadic adult onset ataxia - non multiple system 
atrophy 
.33 et seq. Other types and loci 
Adult onset dominant ataxia (onset usually after 
age 20) 
with retained reflexes and without early slow eye 
movement or early basal ganglia signs . 
. 40 6th chromosome (SCAl) 
.41 Other locus 
.42 locus not known 
.43 et seq. Other types and loci 
Adult onset dominant ataxia with early development 
of slow eye movements 
.50 12th chromosome (SCA 2) 
.51 Other locus 
.52 Locus not known 
.53 et seq. Other types and loci 
Adult onset dominant Machado-Joseph ataxia. May 
demonstrate early rigidity, amyotrophy and facial 
fasciculations 
.60 14th chromosome 
.61 Other locus 
.62 Locus not known 
.63 et seq. Other types and loci 
Other adult onset dominant ataxias 
.70 Late onset (usually after age 50) dominant ataxia 
with retained reflexes 
.71 Adult onset dominant ataxia with retinal or optic 
nerve involvement 
.72 Adult onset dominant ataxia with dementia 
.73 Adult onset dominant ataxia with periodicity 
.74 Et seq. Other adult onset dominant ataxias not 
identified elsewhere 
Familial spastic paraplegia 
.80 Typical familial spastic paraplegia 
.81 Atypical familial spastic paraplegia 
.83 Et seq. Other types and loci 
Ataxia unspecified 
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In reviewing the issue of classification, Rosenberg (1990) 
argues that the various subtypes of autosomal dominant OPCA 
may be examples of a single genetic disease in which the 
phenotype variability can be attributed to genetic epistasis 
whereby many other host genes modify the expression and 
penetrance of the mutant gene. Alternatively each phenotypic 
variation that may be seen in separate families could be 
attributed to different mutations. At present there are no 
known storage products or any primary metabolic clues to 
indicate a potential molecular basis for the disorder. In the 
future the discovery of the genotypes will finally settle the 
issue of classification. Considering these limitations, which 
are inherent in any existing classification at present, the 
author has elected to utilize the classification presented in 
table 3.4 as the framework within which to group the various 
South African phenotypes. Where appropriate, reference to 
other classifications outlined in this chapter is also made in 
the chapters concerning the South African phenotypes. 
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CHAPTER 4 
DEMOGRAPHY 
4.1 EPIDEMIOLOGY OF SPINOCEREBELLAR ATAXIA 
This group of disorders is distributed widely in the world. 
Since the late 19th century different kindreds have been 
described, in amongst other places, North and South America, 
the United Kingdom, Europe and Scandinavia as well as India 
and Japan. They have also been described in islands such as 
the Azores and Cuba. Nevertheless large scale personal surveys 
of patients with hereditary ataxias in any one country have 
been very scarce. The familial ataxias present problems and 
challenges for any epidemiologic survey. The condition is 
relatively uncommon and therefore requires surveillance of a 
large population over many years to accumulate sufficiently 
large numbers of patients for adequate study. Furthermore case 
ascertainment in most studies is defined by the clinical 
assessment of the in~estigator without reference to diagnostic 
criteria, which have not been formalized. Such criteria exist 
for Friedreich's Ataxia but minimal criteria are not agreed 
upon for the majority of the hereditary ataxias. These 
difficulties are compounded by the considerable overlap in 
clinical patterns between the hereditary ataxias and certain 
other neurologic disorders. 
Difficulties with the classification (see 3.3), phenotypic 
variation, insidious onset and progression (which may require 
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prolonged follow-up to be certain of diagnosis), are factors 
which are pertinent to the recording of accurate incidence 
data. Schoenberg (1978) has reviewed these epidemiological 
problems and previous prevalence studies. Despite difficulties 
inherent in comparing one study with another, he argues that 
most descriptive investigations provide prevalence estimates 
_of less than 6 cases per 100,000 population. This estimate 
includes early and late onset hereditary ataxias. Higher 
prevalence figures have been noted in certain communities 
which are somewhat isolated. Examples of such areas include 
regions of West Norway, the Azores (Rosenberg, 1978; Coutinho 
and Andrade, 1978) and Cuba. A prevalence as high as 41 cases 
per 100,000 population of autosomal dominant ataxia has been 
recorded in the province of Holguin in Cuba (Orozco et al., 
1989). This figure is much higher than in other parts of that 
country. 
4.2 PREVALENCE OF HEREDITARY ATAXIA IN AFRICA 
Information concerning the late onset cerebellar ataxias from 
the African continent is sparse. The results of a field survey 
in Tunis was published in the French literature (Hamida et 
al., 1991). These authors analyzed 392 cases of spino-
cerebellar degeneration belonging to 188 families and 227 
cases of Friedreich's Ataxia and 74 cases of "Pierre Marie 
type cerebellar ataxia" were identified. They found evidence 
of clinical heterogeneity as some of these cases had features 
of peroneal atrophy similar to Charcot Marie Tooth disease 
while in others there was spastic paraplegia. 
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Prior to this study there was no data on the spectrum or 
prevalence of these disorders in South Africa as no population 
based studies had been done. Philcox et al. (1972) documented 
a large family of mixed ancestry with late onset cerebellar 
ataxia in which vestibular dysfunction was an early 
manifestation. This family has been restudied in detail as 
part of the present survey. 
4.3 DEMOGRAPHY OF THE POPULATION OF SOUTH AFRICA 
The Republic of South Africa occupies the southernmost part of 
the African continent and stretches from the Limpopo river in 
the north to Cape Agulhas in the south (figure 4.1). The 
country has an area of 471447 square miles including the 
previously self administered homeland states (viz.:TBVC 
homelands: Transkei, Bophuthatswana, Venda and Ciskei) which 
all lie within the borders of South Africa. Four major ethnic 
groups are present in South Africa: 
a) White persons whose ancestors came from western Europe. 
These may be further subdivided into two linguistic subgroups: 
the Afrikaners who are descendants of Dutch, French, and to a 
lesser degree German forebears and speak Afrikaans; and the 
English-speaking group. The Afrikaners comprise more than half 
the white population and the English speaking make up most of 
the remainder. 
b) Black persons who are indigenous to this region of Africa. 
This group can be further subdivided into four major 
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ethnolinguistic groups. These are: the Nguni, including the 
Xhosa, Zulu, Swazi and Ndebele peoples who comprise more than 
half the Black people of South Africa and live mainly in the 
eastern coastal regions; the Sotho, found mostly in the 
central and western areas, and the Venda and Tsonga who 
comprise the smallest group and are found in the Northern 
Transvaal. 
c) Individuals of mixed ancestry. This population has its 
roots in the early period of the Dutch East India Company's 
regime at the Cape of Good Hope. These persons are an 
admixture of Caucasian, Khoisan (Hottentot and Bushman), Malay 
(Javanese and Sumatran) and Black ancestry. The majority of 
this group live in the western part of the Cape province where 
they comprise the largest ethnic group. 
d) Asian individuals whose ancestors are of Indian or Sri 
Lankan stock. The South African community originated in 1860 
when a number of Indians came under contract to work on the 
Natal sugar plantations. This community grew and the majority 
still live in Natal province. 
South Africa has not escaped the phenomenon of rapid 
urbanization. Nearly 90% of the White population has been 
urbanized, 93% of the Asian population, 77,8% of the "Mixed 
Ancestry" population and nearly 40% of the black population 
(population census 1985). Black urbanization has accelerated 
in the last five years following the abolition of influx 
control laws. The Cape peninsula or greater Cape Town 
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metropolitan area is one of the six largest urban 
concentrations in the country (SA yearbook 1990) 
The population figures quoted in table 4.1 are according to a 
mid-year estimate for 1993 released by the central statistical 
services (5 February 1993). The data refer to the Republic of 
South Africa according to 1991 boundaries and exclude the TBVC 
states. The total population of South Africa for June 1993 was 
estimated at 32,6 million based on the 1991 census. 
TABLE 4.1: 
POPULATION OF REPUBLIC OF SOUTH AFRICA: MID YEAR ESTIMATE 






5 149 000 
3 402 000 
1 022 000 
23 016 000 
32 589 000 
The estimated population of the TBVC states on census day in 
1991 was 6,751,000 (Statistical news release Feb.1993). The 
annual increase in the black population since 1985 was 
estimated at 2,78% giving an estimated population of the TBVC 
states for 1993 of 7,131,600 and a total estimated population 
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4.4 DEMOGRAPHY OF THE POPULATIONS IN THE WESTERN CAPE 
The Western Cape region is illustrated on the map (figure 4.2) 
and covers an area of 4,260 square kilometers. The area 
includes those magisterial districts which fall under the 
administration of the metropolitan state body called the 
Regional Services Council of the Western Cape. The population 
of this region based on the 1991 census and released by the 
City Planners Department of Cape Town is shown in table 4.2 
below. 
TABLE 4.2: 







1 256 291 
27 057 
454 610 
2 350 159 
The health needs of the population of the Western Cape region 
is served by several primary care clinics and day hospitals, a 
number of private and provincial secondary care hospitals and 
two large tertiary referral academic hospitals. These two 
hospitals each have a Neurology service and a Clinical 
Genetics department and have been the major source for case 
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RETROSPECTIVE PILOT STUDY 
5.1 BACKGROUND TO PILOT STUDY 
In the Western Cape region patients with Spinocerebellar 
ataxia have been assessed as both inpatients and outpatients 
in the department of Neurology at Groote Schuur Hospital over 
many years. The hospital is one of two academic tertiary 
referral centres which service this area. The collective 
impression of the neurologists in the department was that the 
disorder was relatively common in the local population. For 
this reason a pilot study was undertaken to determine the 
validity of this impression. 
5.2 OBJECTIVES OF THE PILOT STUDY 
The objectives of the pilot study were as follows: 
i) determine the number of patients with familial and 
sporadic SCA seen at Groote Schuur Hospital over a 10 year 
period. 
ii) obtain information with regard to the present location 
and size of affected kindred with a view to a future 
prospective survey of these families. 
iii) document the various phenotypes in this sample of 
affected persons. 
iv) determine the natural history and prognosis in this 
group. 
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v) compare the phenotype and natural history of the familial 
group with individuals with sporadic SCA. 
5.3 METHODS 
The pilot study was a case finding investigation which took 
the form of a retrospective analysis of all patients with SCA 
admitted to Groote Schuur Hospital over a ten year period 
(1982-1992). Three independent sources were used to ensure 
optimal ascertainment: 
i) Groote Schuur Hospital records: computer retrieval over a 
ten year period. All patients admitted and discharged from 
Hospital are summarized and assigned a numerical code 
according to the diagnosis which is computerized. 
ii) Neurology department records. All patients admitted to the 
neurology wards have a full clinical summary completed on 
discharge which is kept in the department. Most patients known 
to have SCA have been assessed as inpatients at least once. 
iii) Records of the department of Human Genetics. Since 1972, 
patients with hereditary diseases have been referred to the 
department of Human Genetics from sources throughout the 
country and from within the local population for assessment 
and genetic counselling. Clinical records detailing the 
phenotype as well as pedigree are kept in the department. 
Those pertaining to SCA were accessed. 
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All patients identified with SCA from the above sources had 
their medical folders retrieved from the records department. 
The entire folder was scrutinized including the microfilm 
containing clinical data and investigations relating the 
assessment of a patient at the hospital. 
5.4 RESULTS OF THE PILOT STUDY 
A total number of 67 patients were seen at Groote Schuur 
Hospital and diagnosed as having SCA. Of these, 29 were 
familial and 38 were sporadic cases. On careful scrutiny of 
all available information, 6 of the sporadic cases were found 
likely to have alternative diagnoses such as multiple 
sclerosis, alcoholic cerebellar degeneration or 
cerebrovascular disease. These patients were excluded from 
this study leaving a total of 32 patients with idiopathic 
sporadic cerebellar ataxia. 
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5.4.1 FAMILIAL CEREBELLAR ATAXIA 
5.4.1.1 SAMPLE OF AFFECTED PERSONS WITH FAMILIAL ATAXIA 
A total of 18 separate families with cerebellar ataxia were 
identified (families:A,B,D,E,F,G,H,I,J,M,O,Q,S,T,U,V,W, and X; 
see appendix for pedigrees). 
The table below indicates the sex and ethnic groups of the 29 
patients with familial ataxia. 

















The mode of inheritance was clearly autosomal dominant in 9 
families (families: A,B,D,E,F,G,H,I,and J) and was probably 
autosomal dominant in another 4 families (families: M,S,W, and 
X). In family O the mother was mildly affected and her 3 sons 
were more severely affected. This observation suggests that 
she may be a hemizygous carrier of an x-linked recessive 
disorder or alternatively that the disorder is transmitted in 
an autosomal dominant manner with variable phenotypic 
expression. In family Q the mode of inheritance was probably 
autosomal recessive and in the remaining families (families: 
T,U, and V) the mode of inheritance could not be determined 
because of uncertain status of the parents. 
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5.4.1.3 PHENOTYPE OF FAMILIAL LATE ONSET CEREBELLAR ATAXIA 
In 14 of the 18 pedigrees identified, the phenotype was 
similar to the autosomal dominant cerebellar ataxia type I of 
the Harding classification. In addition to the cerebellar 
manifestations other associated features such as pyramidal 
signs, optic atrophy, ophthalmoplegia, tremor and sensory loss 
was found in some of the affected individuals. These 14 
families are very similar at a clinical level and none were 
considered to have a unique phenotype in terms of Harding's 
nosologic criteria. 
The symptoms and signs of this of this group of patients are 
presented in table 5.2 and 5.3. 
TABLE 5.2 - SYMPTOMS OF FAMILIAL CEREBELLAR ATAXIA 
(TOTAL NO 24 PATIENTS) 
SYMPTOM NO OF PATIENTS 
Progressive gait disturbance 24 
Impaired hand coordination 22 
Dysarthria 20 
Weakness of limbs 17 
Dysphagia 8 
Involuntary movement 6 
Sphincter disturbance 5 
Mental disturbance 3 












TABLE 5.3 - CLINICAL SIGNS OF FAMILIAL CEREBELLAR ATAXIA 
TYPE I 
SIGNS NO OF PATIENTS 
Cerebellar ataxia 
Dysarthria 










































The clinical manifestations of this phenotype are discussed in 
detail in the prospective survey (see chapter 7). 
Time to reach dependency: 
A total of 6 patients reached a state of severe dependency 
being completely chair bound. The mean time to reach 
dependency was 11.5 years (range: 9 - 13 years) Two patients 
died 10 and 14 years after the onset of their illness. 
42 
5.4.1.4 DISTINCT PHENOTYPES 
Four families had clinically distinct phenotypes which merited 
separate consideration and categorization from the group 
above. In family M, the index patient was an Ovambo female 
who was referred to Groote Schuur Hospital from Northern 
Namibia. She presented at the age of 54 years with 
deteriorating vision and became totally blind within a few 
years. A gait ataxia developed some years later. She had 
severe optic atrophy with retinal degeneration as well as 
cerebellar dysarthria and pyramidal tract signs. She has a 
young affected son who lives in the Western Cape and attends a 
special school for the blind. These two affected persons were 
traced and reassessed prospectively (see 8.3.1) 
In family V, the index patient was a white female who 
presented at the age of 23 years with visual impairment which 
progressed to blindness. Gait ataxia developed later. 
Clinically she had pigmentary retinal degeneration, together 
with cerebellar and pyramidal tract signs. An affected brother 
had a pigmentary retinopathy and peripheral neuropathy. Both 
parents had pigmentary retinopathy but were not known to have 
cerebellar ataxia. This family left the Western Cape region 
and were not available for prospective evaluation. 
In family Q, the index patient was a white male who was noted 
to be mentally retarded at the age of 14 and in whom mental 
function progressively deteriorated. Early pyramidal tract 
signs with weakness and markedly spastic legs with flexion 
contractures at the knees were noted. There was marked 
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wasting of the proximal and distal muscles. Cerebellar signs 
were mild and difficult to interpret in view of the marked 
spasticity and weakness. Two other siblings and a cousin were 
subsequently traced and assessed prospectively. 
In family 0, two brothers, both white males, were assessed. 
The older brother was found to have a short stature. His 
symptoms started at the age of 30 years with a mild gait 
disturbance. He also developed generalized seizures, 
myoclonic jerks, mild cerebellar signs, nystagmus and a 
sensory neuropathy in the legs. The younger brother died at 
the age of 34 years. He had presented with a gait disturbance 
and weakness in the limbs with deteriorating mental function. 
He had features of hypothalamic hypogonadism, a sensory 
peripheral neuropathy, cerebellar ataxia and dysarthria as 
well as a dementia. 
Serum lactate and pyruvate were not measured and a muscle 
biopsy was not undertaken in either brother. A mitochondrial 
encephalopathy was considered a possible diagnosis in view of 
the multisystem involvement. This family was reassessed 
prospectively and the phenotype is discussed in detail in 
8.5.1 
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5.4.2 SPORADIC CEREBELLAR ATAXIA: 
5.4.2.1 SAMPLE OF PERSONS WITH SPORADIC ATAXIA 
According to the records 38 patients were initially diagnosed 
as having sporadic cerebellar ataxia. Careful scrutiny of all 
data revealed that in 6 of these patients an alternate 
diagnosis such multiple sclerosis, cerebrovascular disease and 
alcohol related cerebellar degeneration could best explain 
their symptoms and signs. 
Thirty two patients with sporadic cerebellar ataxia were 
therefore identified. 
The following table indicates the sex and ethnic group of 
patients with sporadic cerebellar ataxia: 



















Twenty one of the 32 sporadic cases had a phenotype consistent 
with olivopontocerebellar atrophy as described by Dejerine and 
Thomas in 1900. This phenotype was clinically 
indistinguishable from the familial group (Harding ADCA type 
1). By way of comparison symptoms and signs are presented in 
Table 5.5: 
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TABLE 5.5 CLINICAL MANIFESTATIONS OF SPORADIC ATAXIA 
Symptoms 
progressive gait disturbance 
impaired hand coordination 
speech difficulty 









pyramidal tract signs 
abnormal involuntary movements 
sensory deficit 
dementia 
































A total of 6 patients reached a state of dependency. The mean 
time to reach dependency was 8,8 years (range: 3-20 years). 
5.4.2.3 DISTINCT PHENOTYPES OF SPORADIC CEREBELLAR ATAXIA 
Clinical features such as sensorineural deafness, myoclonus 
and pigmentary retinal degeneration which seem to run true 
within families in the inherited group have been also been 
used as a rubric to define distinctive subgroups within the 
sporadic group. 
Two patients with sporadic cerebellar ataxia had phenotypes 
consistent with Friedreich's Ataxia and another patient had 
the features of Friedreich's Ataxia with retained reflexes 
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(Currier classification - table 3.4). Two patients had 
features of the "Ramsay-Hunt syndrome" in which cerebellar 
ataxia and myoclonic jerks are common denominators. This is 
considered a heterogeneous group of disorders which may be 
familial or sporadic and associated with other neurologic 
signs. Within this group are undoubtedly a subgroup who are 
found to have mitochondrial myopathies when adequately 
evaluated. In addition to the myoclonus and ataxia, one of 
these patients had pigmentary retinal degeneration which would 
favour this diagnosis. 
Another group of 4 patients had cerebellar ataxia and 
sensorineural deafness as well as other evidence of 
multisystem involvement (viz. dementia, peripheral neuropathy 
and optic atrophy). A single patient had cerebellar ataxia 
with athetosis and pigmentary retinal degeneration; it is 
uncertain what this entity represents. The last patient in 
this sporadic group with a distinct phenotypes had spastic 
paraparesis with ataxia. 
5.4.2.4 COMMENT 
Olivopontocerebellar atrophy (OPCA) is a term first used by 
Dejerine and Thomas in 1900 when describing two late onset 
sporadic cases with atrophy of the cerebellar hemispheres, 
olives and pontine nuclei. Harding has noted that features 
such as optic atrophy, ophthalmoplegia and retinal 
degeneration which are found in some cases of hereditary 
ataxia are seldom if ever reported in sporadic OPCA or 
parenchymatous cerebellar cortical atrophy (PCCA). This latter 
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disorder represents a more "pure" cerebellar syndrome and was 
described by Archambault (1918) and studied again in detail by 
Marie, Foix and Alajouanine (1922) who thought this to be a 
separate entity. Harding (1984b) has highlighted many of the 
difficulties in any attempt to classify this sporadic 
idiopathic group. The polarization between OPCA and PCCA is 
unsatisfactory and not particularly useful to clinicians. Many 
patients with sporadic ataxia have clinical evidence of 
pathology outside the cerebellum and brainstem. Harding found 
that the majority of her patients with idiopathic ataxia 
corresponded to those reported as sporadic OPCA. A smaller 
group had a predominantly gait ataxia with relatively mild or 
no ataxia in the upper limbs and a later age of onset. Another 
small group was identified with a prominent resting or 
postural tremor. It remains uncertain, however, whether these 
subgroups represent distinct clinical syndromes. 
Some of the individuals with sporadic ataxia in this pilot 
study almost certainly reflect a hereditary variety. These 
persons almost certainly represent the only affected member of 
the family at the time the neurological assessment was done 
and a number of explanations would account for this 
phenomenon. If the condition were inherited as an X-linked 
trait or as an autosomal recessive trait then both parents 
would be unaffected and the affected person may represent the 
only affected sibling. This would certainly account for the 
three unrelated individuals with Friedreich's ataxia. 
Similarly, those patients with retinal degeneration are almost 
certainly familial (Harding, 1984). X-linked recessive 
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cerebellar ataxia with or without spastic diplegia has also 
been described (Apak, 1989). 
The largest group of individuals with sporadic ataxia, 
however, have a phenotype resembling those reported as OPCA. 
In the medical literature there are very few reported 
pedigrees with definite autosomal recessive late onset 
cerebellar ataxia. Autosomal recessive inheritance is 
therefore an unlikely explanation to account for all these 
sporadic cases (Kumar and Timperley, 1988). 
A lack of adequate ancestral history and illegitimacy are two 
factors not infrequently encountered in our local population. 
This phenomenon could account for some sporadic cases which 
may be genetically determined. Alternative explanations 
include unusual genetic mechanisms such as non-penetrance, 
mitochondrial inheritance patterns and polygenic inheritance. 
The question of what proportion of sporadic late onset ataxias 
represent new dominant mutants is clearly relevant in relation 
to genetic counselling and has been addressed by Harding 
(1984b) who concluded that the proportion of patients with 
autosomal dominant cerebellar ataxia who are fresh mutants is 
probably very small. 
It is possible that as yet unexplained environmental factors 
may be responsible for these sporadic phenocopies but the 
various possible mechanisms involved in the pathogenesis of 
this group remains speculative. At present they are best 
considered within the spectrum of disorders that have been 
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METHODOLOGY OF PROSPECTIVE ANALYSIS 
6.1 ASCERTAINMENT OF AFFECTED FAMILIES 
An attempt was made to identify all persons in the Western 
Cape region affected with late onset familial cerebellar 
ataxia through the following resources: 
a) Patients identified in the pilot study utilizing the three 
sources outlined in 5.1 (viz. Groote Schuur Hospital computer 
retrieval, Neurology Unit and Department of Human Genetics 
records). 
b) The record system from the Neurology Unit of Tygerberg 
Hospital. 
c) Written requests for patient referral were sent to all 
seven neurologists on the South African Medical and Dental 
Council register who are in private practice in the area. 
d) Colleague referral from the Departments of Human Genetics 
and Neurology from the two medical schools and teaching 
hospitals in the Western Cape. 
e) Papers on the clinical and genetics aspects of familial 
ataxias were delivered at appropriate South African congresses 
during which appeals for referrals were made. 
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Day Hospitals and secondary care hospitals were not 
individually canvassed as it was felt that if any patients 
were to manifest the characteristic symptoms and signs of this 
disorder then they would probably be referred to a private 
neurologist or to the Neurology or Human Genetics Departments 
of the two academic tertiary hospitals. None of the primary or 
secondary care hospitals in the area have a Neurology or 
Genetics service or any neurologists on their staff, making 
referral of such cases to a tertiary centre almost certain. 
All patients were initially interviewed and detailed 
genealogical data was recorded. Pedigrees were carefully 
drafted (see appendix for all pedigrees included in this 
study) and the names and addresses of both affected and 
unaffected members were recorded for the purpose of 
prospective recall and assessment. 
6.2 DIAGNOSTIC CRITERIA 
Only those individuals with late onset familial cerebellar 
ataxia were included in the study and all were required to 
have affected relatives. Kindreds in which the majority of 
affected members were over the age of 20 years when they first 
had symptoms of the disease, were included in the study. In 
all such cases progressive cerebellar ataxia was the cardinal 
clinical manifestation. The presence or absence of other 
clinical features (ophthalmoplegia, optic atrophy, retinal 
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degeneration, dementia, amyotrophy of limbs and tongue, 
extrapyramidal signs eg. rigidity, facial impassivity, 
choreiform movements and athetosis) as described by Harding 
(1982a) and noted in the Currier classification, did not 
preclude inclusion into the study. Any members of a known 
kindred with familial ataxia found to have an alternative 
explanation for the cerebellar signs, such as chronic 
alcoholism, were excluded from the subsequent linkage studies. 
The congenital and early onset familial cerebellar ataxias of 
known and unknown aetiology, including Friedreich's ataxia, 
were excluded from the analysis. 
6.3 CLINICAL EVALUATION 
All patients referred for the study were examined by a 
specialist trained in internal medicine and neurology (the 
author), usually undertaken in the Department of Neurology at 
Groote Schuur Hospital, but sometimes in their homes or a 
local rural clinic. In each case, a thorough medical history 
was obtained and each patient was evaluated according to a set 
protocol, a copy of which is included in the appendix. 
6.3.1 GENERAL AND NEUROLOGICAL EXAMINATION 
The physical examination was performed using standard clinical 
procedures. A detailed appraisal of each of the body systems, 
with a full neurological examination, was done by the author. 
If there was uncertainty relating to the presence of early 
signs of the disease, or if the diagnosis was in question in 
any way, then patients were reviewed in the Groote Schuur 
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Hospital Neurology Unit so that all relevant information could 
be augmented by evaluations from colleagues. 
6.3.2 ATAXIA SEVERITY SCORE 
Currently there is no universally accepted scale or scoring 
system to grade the severity of ataxia and in the past 
_individual researchers have devised their own methods of 
evaluating it. In September 1993, the Ataxia Research Group 
of the World Federation of Neurology elected a sub-committee 
to address this issue. This group (author included) intend to 
devise a standardized scoring system that is comprehensive and 
will be widely and reliably applied by clinical researchers in 
different countries. In this study, the author tested co-
ordination using the following well known clinical tests: 
1. Finger/nose test 
2. Repetitive and alternating hand movements 
3. Copy drawings 
4. Heel-shin test 
5. Toe/finger test 
6. Truncal sway 
7. Balancing on one leg 
In all instances both left and right limbs were individually 
tested. The tests are briefly described below: 
1. Finger/nose test: the person was asked to hold an arm 
outstretched and then touch the tip of his nose with the tip 
of his index finger and then touch the end of the examiner's 
finger which was held at arms length away from the person. 
This action was repeated several times, after which the 
examiner moved his index finger from place to place whilst the 
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person's finger was en-route to it. Care was taken to ensure 
that the person fully extended the arm to reach the target and 
did not adduct the upper arm against the trunk for support. 
The examiner evaluated this manoeuvre for dysmetria and 
intention tremor. 
2. Repetitive and alternating movements: The person was 
requested to tap repeatedly the dorsal aspect of one hand 
(held stationary) with the palmar aspect of the other from a 
height of approximately 40cm. He/she was then requested to 
pronate and supinate the forearm and repeatedly slap the 
dorsal aspect of one hand (held stationary) with the dorsal 
and palmar aspect of the other hand. The person was then 
asked to increase the speed of the manoeuvre. The rhythm, 
amplitude and force of the repetitive tapping movements and 
the individual's ability to make the alternating movements was 
evaluated and scored. 
3. Copy drawings: the person was asked to copy two diagrams 
(i.e. a spiral and a 5 pointed star - see appendix), without 
resting thee pen-holding hand on the writing surface, and with 
the upper arm abducted from the trunk. 
4. Heel/shin test: The test was performed with the individual 
in the supine position. He/she was requested to raise one leg 
and then place the heel on the knee of the resting leg and 
then slide the heel down the anterior tibial surface of the 
resting leg towards the ankle. On reaching the ankle joint 
the leg was again raised in the air to a height of 
approximately 40cm and the action was repeated. The action 
was evaluated for dysmetria and ataxia (causing the heel to 
shift off the anterior tibial surface). 
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5. Toe/finger test: This test is similar to the finger/nose 
test; the individual lay in the supine position and was 
requested to repeatedly raise one leg with the big toe aiming 
to touch the examiner's finger tip which was held 
approximately 40cm above the resting position of the leg. 
6. Truncal sway: The person was observed sitting erect with 
the arms folded in front of the chest, and also in the 
standing position. The presence and degree of truncal sway was 
assessed and scored. 
7. Balancing on one leg: The person was requested to stand on 
one leg and maintain balance without holding onto adjacent 
objects (the examiner was positioned close to the patient to 
provide support in the event of the individual being unable to 
maintain balance). 
8. Intention tremor: a separate score was assigned for the 
severity of the intention tremor depending on the performance 
of tests numbers 1, 3, 4, and 5. 
The scores for these clinical tests were assigned as follows: 
1 = normal 
2 = mild impairment 
3 = moderate impairment 
4 = severe impairment 
5 = unable to perform the task 
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Gait: The person was requested to walk in a straight line for 
a distance of approximately 6 metres or more and then turn 
around and walk back. This was repeated a few times if 
necessary. Gait was assigned and scored as follows: 
1 = normal; 
2 = person has subjective sensation of unsteadiness, 
but no definite ataxia observed by the examiner; 
3 = objective evidence of mild gait ataxia; 
4 = moderate gait ataxia; 
5 = severe ataxia (walks with a stick or requires 
support); 
6 = chair bound. 
The scores for the gait and the other tests outlined above 
were summated for a global ataxia severity score and 5 
categories were defined (table 6.1). 
TABLE 6.1 ATAXIA SEVERITY SCORE 
9 10 = normal 
11 21 = mild ataxia 
22 26 = moderate ataxia 
27 31 = moderately severe ataxia 
> 32 = severe ataxia 
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6.3.3 OPTOKINETIC NYSTAGMUS AND SMOOTH PURSUIT EYE MOVEMENTS 
Optokinetic nystagmus is easily demonstrated in normal 
persons. It consists of nystagmus which is elicited by 
repetitive visual stimuli moving through the visual field, or, 
conversely when a person moving past a series of stationary 
objects refixes vision. There is a slow and a rapid phase to 
the nystagmus. The slow phase tracks the moving target and 
the fast phase is a saccadic movement in the opposite 
direction. 
OKN is tested in the horizontal and vertical planes but is 
less well sustained in the vertical plane. A metallic 
optokinetic tape painted with alternating black and white 
bands spaced at 3cm intervals was used to test this 
phenomenon. The person directed gaze at the tape, which was 
held approximately 30cm from his/her eyes and was slowly moved 
in the horizontal plane to the right and then to the left. 
Normally, there is a slow movement in the direction of the 
movement of the bands and a rapid, ''refixation" movement in 
the opposite direction. When the tape is moved up or down in 
the vertical plane the nystagmus is vertical. Results were 
then graded from O (absent) to 3+(normal). 
Optokinetic nystagmus was introduced as a clinical tool by 
Barany in 1921 but knowledge of the mechanisms underlying the 
phenomenon and all the anatomic substrates involved in its 
production is incomplete. It would appear that OKN is a 
phenomenon engaging many areas of the brain and is a product 
of a visual input and an oculomotor output (Carmichael et al., 
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1954). Both horizontal and vertical OKN are very sensitive 
indicators of oculomotor dysfunction (Davidoff, 1966). 
Lesions in the deep parietal lobe cause a deficit in OKN when 
movement is towards the side of the lesion. The brain stem 
areas act as integrators and final common pathways for the 
optokinetic response. Discrete lesions involving the pontine 
nuclei (ie. dorsolateral, lateral, and dorsomedian pontine 
nuclei, which represent a crucial relay between cerebral 
cortex and the cerebellum in the control of eye movements) 
cause an impairment of OKN and smooth pursuit eye movements 
(Johnston et al., 1992; Gaymard et al., 1993). The slow phase 
velocity of the optokinetic response is characteristically 
impaired in individuals with brainstem or cerebellar lesions 
(Yamada et al., 1991). The optokinetic response overrides many 
voluntary eye movements and vestibular nystagmus and can also 
be used to estimate visual acuity in infants (it is present 
within a few months after birth) and may be useful 
establishing the presence of vision in patients who are 
hysterically blind or malingering. In a study of 150 patients 
with spinocerebellar degeneration, an abnormal optokinetic 
response correlated with the duration of the disorder (Mizuno 
and Yamane, 1993). 
Pursuit eye movements stabilize on the fovea the images of an 
object moving slowly in the environment. Moving targets can be 
followed smoothly and accurately (with eye velocity about 
equal to target velocity provided the target velocity is less 
than about 50 degrees per second and, for periodic targets, 
the frequency is less than about 1 hertz) (Miller, 1985). The 
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cerebellum plays an important part in the generation of smooth 
pursuit eye movements and OKN (Buttner, 1989; Pierrot-
Deseilligny et al., 1990). The same neural elements are 
responsible for an initial jump in slow phase eye velocity 
during constant velocity stimulation and for the optokinetic 
response (Buttner, 1989). Impaired smooth pursuit movements 
are associated with lesions in the hemispheres, cerebellum or 
brainstem pathways, but may also be induced by drugs 
(eg.barbiturates, phenytoin), anxiety and fatigue (Newman, 
1993). 
Smooth pursuit eye movements were tested by asking the 
individual to follow a target moving slowly and smoothly 
across the field of vision, with the head held still. 
Normally, the subject should do this both smoothly and 
precisely. Inability to maintain smooth pursuit results in 
interruption by microsaccades (cogwheel pursuit) 
(Bogousslavsky and Meienberg, 1987). 
The range of ocular movement and binocular co-ordination of 
motility was evaluated while testing smooth pursuit movement. 
Normally, both eyes move conjugately into all extremes of 
gaze. A normal full horizontal movement conceals the limbus 
(the border of the cornea and sclera) under the medial and 
lateral canthus. Vertically, upgaze should reach at least 30 
degrees (Newman, 1993). 
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6.3.4 ASSESSMENT OF VISUAL FUNCTION 
Affected members from any kindred who had visual impairment 
were examined and assessed by specialists in ophthalmology at 
Groote Schuur Hospital. Visual acuity and formal computerized 
visual field perimetry were tested in these individuals and 
the ophthalmologists performed the relevant investigations (eg 
ERG and fluorescein angiography) if indicated. 
6.3.5 ASSESSMENT OF UNAFFECTED PERSONS 
An experienced and qualified nursing sister with training in 
human genetics assisted the author in locating affected and 
unaffected members at risk in the different families (figure 
6.1). This nursing sister is well versed in the recognition of 
both early and late manifestations of the disorder. During 
two visits to a peripheral clinic which was attended by over 
sixty members from a single large kindred, the author was 
assisted by two other doctors trained in clinical genetics who 
helped with the evaluation of unaffected members (figure 6.2). 
Persons with any relevant symptoms or signs were then referred 
to the author for appraisal. 
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FIGURE 6.1 CLINICAL ASSESSMENT OF AN UNAFFECTED FAMILY 
MEMBER An unaffected person (family B) is assessed for impaired balance 




FIGURE 6.2 THE "TEAM" EN ROUTE TO A PERIPHERAL CLINIC 
On a visit to a rural clinic, the author was assisted by 2 other doctors 
trained in clinical genetics, a psychologist, an occupational therapist, 2 
nursing sisters, and a laboratory technician. 
THE METHODOLOGY OF THE DIAGNOSTIC IMAGING IS DETAILED IN 
CHAPTER 9. 
THE METHODOLOGY OF THE NEUROPHYSIOLOGICAL TESTING IS DETAILED 
IN CHAPTER 10. 
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CHAPTER 7 
PROSPECTIVE ASSESSMENT OF AFFECTED FAMILIES 
A total of 18 families were identified (ethnic groups: mixed 
ancestry 9, white 7, black 2). In 10 of these families the 
phenotype was similar, and the remaining 8 had clinically 
distinct phenotypes. 
A total of 40 affected persons from the 10 families were 
prospectively assessed. The manifestations of the disorder in 
these persons from the 10 families with the same phenotype are 
reviewed in detail in this chapter and the 8 families with 
clinically distinct phenotypes are discussed in chapter 8. 
Many of the unaffected first degree relatives in each family 
were also assessed, often repeatedly, for signs of the 
disorder. The pedigrees, which were carefully constructed are 
illustrated in the appendix. Nine of these families were of 
mixed ancestry and the remaining family was white. 
7.1 SYMPTOMATOL<X.;Y 
The mean age of onset in ten families was 30.7 years with a 
range of 16 years to 48 years. In 90% of affected persons, the 
symptoms started before the age of 40 years. The duration of 
the illness varied from less than 1 year to 20 years with 
members showing varying degrees of severity at time of the 
prospective assessment. The presenting symptomatology in this 
group is shown in table 7.1. The symptoms are not correlated 
with the duration of the disorder. 
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Table 7.1 SYMPTOMS OF FAMILIAL LATE ONSET CEREBELLAR ATAXIA 
IN FAMILIES WITH THE SAME PHENOTYPE 
Symptom No of patients Percentage 
Gait disturbance 39 98 
Frequent falls 23 58 
Impaired hand co- 33 83 
ordination 
Abnormal involun- 12 30 
tary movements 
Speech disturbance 35 88 
Dysphagia 13 33 
Weakness in the legs 25 63 
Weakness in the arms 18 45 
Visual impairment 7 18 
Cognitive deterioration 7 18 
Sphincter disturbance 13 33 
Muscle cramps 13 33 
The symptomatology of the disorder, illustrated with anecdotal 
reports, is reviewed below. A formal account of the clinical 
signs follows in 7.2. 
7.1.1 GAIT DISTURBANCE 
Gait disturbance was the earliest and most troublesome symptom 
in the majority of persons. Initially affected individuals 
noted the gait disturbance to be intermittent. A slight 
stagger or veering to one side would occasionally occur with 
normal walking between these episodes. Sometimes family 
members or work colleagues would be the first to observe or 
remark on this phenomenon. 
A young man (family C), who was later assessed to be mildly 
affected at the age of 34, had trained in karate for several 
years and at the age of 25 first noticed that when he had to 
kick above a certain height he would lose his balance. 
Despite vigorous training, this did not improve and only 
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months later did he become aware of some unsteadiness while 
running and subsequently while walking. A number of affected 
individuals reported that in the initial stages, the severity 
of the gait ataxia would fluctuate from day to day ("I 
sometimes walk straight and then skew like a drunkard and I 
can't run because of the feeling that I am going to fall"). 
Several people reported that walking was always more unsteady 
after a period of inactivity (eg. after being sedentary for 
more than 15 minutes). Once the gait ataxia was well 
established, individuals frequently compared their walking to 
that of a drunken person. Many individuals reported that 
their gait was much more troublesome when walking on uneven 
surfaces, when physically tired, or when standing on moving 
vehicles or climbing steps; walking uphill was often easier 
than walking downhill. One man (family A), who had been 
ataxic for 20 years commented: "My walking is unsteady, as if 
I did not lift my foot high enough to take the step". 
A tendency to fall frequently accompanied the onset of the 
gait disturbance. This problem occurred predominantly in the 
early stages of the disorder in individuals with mild ataxia 
who had not yet restricted their physical activities. With 
progression, individuals became more aware of persistent gait 
ataxia and tended to be more cautious, restricting their 
physical activities and falling less frequently. As the ataxia 
progressed, falling became more frequent until the person 
became wheelchair bound. Two individuals sustained major 
fractures following falls in the advanced stages of the 
disorder. 
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7.1.2 UPPER LIMB INCOORDINATION 
Dysarthria and incoordination in the upper limbs invariably 
occurred some months or even years after the initial symptom. 
The onset and awareness of ataxia in the upper limbs depended 
on the fine motor skills and needs of the particular 
individual. One man (family A) worked as a draftsman on a 
computerized drawing board and first became aware of the 
problem when he observed that he took longer to use the 
keyboard and his production dropped ("I was on the carpet 
because I failed to meet deadlines"). Changes in handwriting 
and clumsiness with the tendency to drop items were not 
infrequently an early symptom of limb ataxia. 
7.1.3 SPEECH DISTURBANCE 
A change in the rhythm and fluency of articulation was often 
noted by family members or friends of affected individuals. 
They described speech as being slurred or mumbled and this was 
predictably more evident when the individuals had to speak on 
the telephone. One young lady commented "I have to speak 
slowly because I can't pronounce the words properly". 
7.1.4 MUSCLE CRAMPS 
Muscle cramps, occurring especially at night or during periods 
of inactivity, were not an infrequent complaint. They did not 
respond to treatment with quinine and were most troublesome in 
the thigh and calf muscles. This observation was made by 12 
individuals with the disorder varying in severity from the 
mild to severe stages. 
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7.1.5 WEAKNESS 
Although muscle fatigue in the legs was a frequent complaint, 
objective weakness on clinical testing was only evident in 6 
individuals all of whom had moderately severe or severe 
ataxia. It is likely that affected persons often incorrectly 
attributed the symptom of incoordination to one of weakness in 
the limbs. Similarly, in the 18 people who complained of 
weakness in the upper limbs only 5 had objective weakness on 
clinical examination. Twelve individuals complained of 
abnormal involuntary movements such as tremor, titubation or 
chorea. 
7.1.6 URINARY SYMPTOMS 
Eleven people with moderate to severe disease complained of 
urinary urgency (often passing urine seven or more times per 
day) with episodic urge incontinence. The latter usually 
occurred when individuals were unable to get to the toilet 
speedily because of the ataxic gait. Sexual function was 
usually preserved even in more advanced stages of the 
disorder. Only 2 affected individuals complained of impaired 
ability to obtain an erection. 
7.1.7 VISION 
Six individuals complained of some impairment of vision but 
this was not severe and did not restrict their activities of 
daily living. Dysphagia was reported by 13 affected members 
and was usually a symptom which occurred late in the course of 
the illness. However, 3 individuals developed the symptom 
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early and their ataxia score was noted to be in the mild 
category of severity. The dysphagia was worse with soft foods 
and liquids and there was a tendency to nasal regurgitation 
and aspiration in the late stages. A barium swallow was 
undertaken on one affected person with dysphagia; this 
revealed a marked oesophageal motility disorder to be the 
cause of the symptom. 
7.1.8 COGNITIVE DETERIORATION 
An awareness of cognitive deterioration usually occurred late 
in the course of the illness and was more often reported by 
unaffected close family members. Impaired concentration and 
forgetfulness were the first symptoms of the dementia. 
However, 1 individual who had been symptomatic with ataxia for 
5 years (ataxia score: moderate) had worked as a cashier in 
her husband's store. She had to stop working because she found 
that she would forget the price of items commonly purchased 
and the names of long-standing customers; she struggled to 
count and calculate the amounts of money for transactions . 
Psychosocial problems were encountered in both affected and 
non-affected individuals and will be discussed in detail in 
chapter 12. 
7.2 CLINICAL SIGNS 
The clinical signs present in the affected individuals from 
the ten families with the same phenotype are presented in 
table 7.2. In each individual the degree of ataxia was 
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assessed and assigned a score of severity as outlined in 
chapter 6. 
TABLE 7.2 
CLINICAL SIGNS OF FAMILIAL LATE ONSET SPINOCEREBELLAR ATAXIA 
Clinical signs 
Gait ataxia 
Upper limb ataxia 
Dysarthria 
Pyramidal tract signs 






























OCULAR SIGNS IN FAMILIAL LATE ONSET SPINOCEREBELLAR ATAXIA 
Clinical signs No of patients Percentage 
Reduced or absent 38 95 
optokinetic nystagmus 
Loss of smooth 36 90 
pursuit 
Optic atrophy 6 15 
Ophthalmoplegia 12 30 
Staring eyes 8 20 
Ptosis 5 13 
Nystagmus 8 20 
TABLE 7.4 
SEVERITY OF ATAXIA AT PROSPECTIVE ASSESSMENT 




















The disorder usually presents with a gait ataxia. The gait 
looses its usual rhythmicity and becomes jerky and irregular. 
Affected individuals initially walk on a narrow base with a 
tendency to take unequal steps which may veer off to the side 
of the line of direction. Arm-swinging movements also become 
jerky and irregular and an affected individual may develop 
titubation while walking. Abrupt turning may evoke postural 
instability with a stagger and difficulties maintaining 
equilibrium are evident. Tandem walking (viz: heel of one 
foot in line and in contact with toe of the other foot) 
accentuates the gait deficit and reveals problems with walking 
on a narrow base or the tendency to fall to one side. These 
typical phenomena were described in great detail in the 
Croonian lectures on the Clinical Symptoms of Cerebellar 
Disease by Sir Gordon Holmes in 1922 (Holmes, 1922). As the 
gait deteriorates the person becomes more unsteady and tends 
to walk on a wider base to secure better balance (Figure 7.1). 
With further progression assistance will be required with 
walking, either by holding onto another person or by grasping 
furniture and adjacent walls for support. Finally, the 
complex sequence of movements required for gait disintegrate 
to a degree where the person is no longer able to walk and 
becomes confined to a wheelchair. 
7.2.2 LIMB ATAXIA 
Months or even years after the gait disturbance begins, ataxia 
in the upper limbs develops with the characteristic intention 
tremor, dysmetria and typical past pointing. Rapid repetitive 
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movements are slowed, with a change in the force, timing and 
amplitude of successive movements such as hand tapping. 
Dysdiadochokinesia (ie a derangement of the function of 
arresting one motor impulse and substituting one that is 
diametrically opposite) is evident on testing alternate 
movements of the hands which are performed with increasing 
clumsiness and slowness. Irregularity of the rate and range 
of movements is prominent, pronation and supination being 
separated by intervals which vary constantly. Handwriting 
becomes more jerky and illegible as upper limb ataxia 
progresses. The dysmetria (inability to properly direct or 
limit voluntary movement) is clearly visible when asking 
affected individuals to copy a diagram such as a five cornered 
star or spiral without resting the hand or arm on the writing 
surface. Examples from different individuals are illustrated 
in figure 7.2. Similarly these individuals were unable to 
make repeated dots with a pen within a circle with the hand 
held above the paper (figure 7.3). 
FIGURE 7.1 AN AFFECTED PERSON 
WITH A BROAD BASED GAIT 
A 28 year old affected member 
(family A) standing on a broad 
base for better balance. 
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FIGURE 7.2 (a, b, c, d) COPIED DIAGRAMS - EXAMPLES BY 
INDIVIDUALS WITH MILD TO SEVERE ATAXIA 
a) Examiner's diagrams (spiral and star) 
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c) Diagrams by a person with moderate ataxia 
d) Diagrams by a person with severe ataxia 
~-
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FIGURE 7.3 CIRCLE AND DOT TEST 
Examples by 2 affected persons who were unable to make 
repeated dots within a circle with the hand held above the 




Dysarthria was a common clinical finding. The character of 
speech was both staccato and slurred with loss of normal 
cadence. Rapid repetition of syllables (eg la-la-la, go-go-
go) accentuated the dysarthria. Dysarthria usually evolved 
months to years after the appearance of the gait ataxia. It 
was observed in all affected persons except five individuals 
who had mild ataxia scores. The slow monotonous quality of 
the voice gradually became more indistinct and unintelligible. 
7.2.4 PYRAMIDAL TRACT INVOLVEMENT AND MUSCLE WEAKNESS 
Signs of pyramidal tract involvement (viz. abnormally brisk 
reflexes, extensor plantar responses, spasticity) were present 
in 27 affected individuals and was first evident in the lower 
limbs. They usually occurred in persons with moderate to 
severe ataxia scores and not in those with early signs. Only 
10 individuals, all with moderately severe to severe ataxia, 
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had evidence of mild proximal muscle weakness (grade 4+/5, 
British Medical Research Council grades) and the remainder had 
normal muscle power. In the advanced stages of the disorder 
eight people had profound weight loss with diffuse muscle 
wasting. Fasciculations were seen in the calf muscles in one 
individual. 
7.2.5 ABNORMAL INVOLUNTARY MOVEMENTS 
A postural tremor of the head or trunk was observed in 10 
individuals. This rhythmic rocking movement, which was either 
forward and backwards or from side to side, occurred at a rate 
of several times per second and was often more noticeable when 
the subject stood upright. This sign is well described in 
individuals with disease of the midline cerebellar zones and 
has little localizing value (Gilman, 1985). In addition to 
the characteristic intention tremor, a static or rest tremor 
was evident in 7 people with ataxia. This usually involved 
the limbs (except for one person with tremor of the lips) and 
was asymmetrical and intermittent in some individuals. This 
clinical sign was also well recognized in the early literature 
(Holmes, 1922). A single individual with severe ataxia of 
early onset developed choreiform movements of her fingers late 
in the course of her illness. She has impaired position sense 
in the extremities and this may well have accounted for these 
movements. 
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7.2.6 DYSPHAGIA AND UPPER AIRWAY DYSFUNCTION 
Persistent dysphagia was present in 7 individuals. This was 
associated with nasal regurgitation during swallowing, and in 
the later stages of the illness with recurrent aspiration 
pneumonia. The cough reflex was often weak. Four of the seven 
individuals have since died. A barium swallow carried out on 
one of the individuals (family A, IV-19) showed a marked 
oesophageal motility disturbance. One affected individual 
(family A, IV-20) was admitted to hospital complaining of 
great difficulty swallowing food, and bouts of repeated 
choking and coughing after swallowing. He was treated for 
bilateral aspiration pneumonia and was noted to have a very 
weak cough reflex which contrasted with well preserved power 
in the limbs. Despite the severe ataxia he was still able to 
walk in his home using the walls for support. After the 
pneumonic illness had resolved, full pulmonary function tests 
were undertaken in order to elucidate the problem as little 
has been written on the subject (Schiffman, 1992). This man 
had no family history of asthma and he denied any wheezing or 
episodic shortness of breath. He previously smoked 5 
cigarettes per day for 5 years but had not smoked for the past 
6 years. The results of lung function studies are listed in 
table 7.5 below. 
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TABLE 7.5 
LUNG FUNCTIONS ON AN INDIVIDUAL WITH RECURRENT ASPIRATION 
PNEUMONIA 
Spirometry Actual value Predicted value 
FEV1 2480 3400 
FVC 2942 4280 
FEV1/FVC % 84.3 78 
PEF 211 421 




SVC 2220 4280 
FRC 5560 3280 
RV 4260 1840 
TLC 6640 6120 
RV/TLC % 64.2 
MIPS 40 124 
MEPS 35 233 
FIGURE 7.4 FLOW-VOLUME LOOP OF AN AFFECTED PERSON WITH 
RECURRENT ASPIRATION PNEUMONIA 
[Flow Ex. = flow during expiration 
Flow In= flow during inspiration 
1/s = litres per second 








Lung function tests showed some evidence of gas trapping with 
slightly reduced volumes but these were difficult to interpret 
(particularly the MIPS and MEPS) because of technical 
difficulties secondary to the patient's impaired muscle 
coordination. The flow-volume loop is shown in figure 7.4 and 
this is remarkably similar to that shown in the paper of 
Schiffman (1992). 
On fibre-optic laryngoscopy, the naso and oropharynx as well 
as the vocal cords appeared normal anatomically. The vocal 
cords closed well on phonation. During coughing, the cords 
leaked air throughout the attempted adduction and there was 
obvious global glottic and supraglottic incoordination in that 
the explosive action necessary for cough could not be 
generated. The glottis appeared to be adequately protected by 
the epiglottis during swallowing. There was no detectable 
intercostal or diaphragmatic weakness; this observation was 
confirmed by the spirometric values which did not reveal a 
major drop in the values in the erect and supine positions. 
The major clinical problem was the clearing of secretions as 
well as a loss of glottic protection. 
7.2.7 SENSORY IMPAIRMENT 
Impairment of joint position sense and vibratory sensation in 
the distal lower limbs was documented in 9 individuals, most 
of whom had severe ataxia scores. Not unexpectedly this 
feature was detected less frequently in the upper limbs (4 
individuals) and was not thought to be a significant causative 
factor for disability. Two individuals had evidence of 
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peripheral neuropathy with a distal sensory loss to touch and 
pinprick. Nerve conduction studies will be discussed in 
chapter 10. 
7.2.8 OCULAR SIGNS 
Reduced or absent vertical and horizontal optokinetic 
nystagmus was the most common ocular manifestation of the 
disorder. This tended to be an early clinical sign but was 
not observed clinically in 2 individuals with mild gait 
ataxia. Reduced smooth pursuit with the individual using short 
saccadic movements to track a moving target occurred in 80% of 
affected individuals. Eight individuals had fine horizontal 
nystagmus (rapid phase to the side of gaze) on lateral gaze 
which was often not sustained. A striking feature was the 
"staring" look of the eyes observed in eight patients. Eyelid 
retraction with a rim of sclera visible above the iris, and 
also, possibly, reduced blinking and small random lateral eye 
movements accounted for this appearance (figure 7.5). This 
clinical sign, although seldom mentioned in the literature, 
has been observed in other families with ataxia (Jampel et 
al., 1961, Healton et al., 1980). Ocular signs evident with 
advanced illness included supranuclear ophthalmoplegia (12 
persons), optic atrophy (6 persons) and partial ptosis (5 
persons). Failure to sustain upward gaze was the earliest sign 
of ophthalmoplegia. Those individuals with optic atrophy did 
not complain of any visual deficit. 
Many of the affected persons with moderate and severe ataxia 
also exhibited facial impassivity. The decrease in the normal 
facial expressions was not matched by detectable facial muscle 
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weakness (figure 7.Sa and 7.Sb). These individuals could 
frown, blow up their cheeks and purse their lips and did not 
demonstrate the typical facial apraxia observed in Huntington 
Disease (Harper, 1991). 
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A decline in cognitive function was recorded in 10 
individuals. As many people were assessed in their own homes 
or at peripheral clinics, formal psychometric testing was not 
undertaken for logistic reasons. Furthermore 9 of the 10 
individuals had severe or moderately severe ataxia with 
dysarthria, rendering formal testing difficult or impossible 
to execute. The assessment of a dementia was done by 
interview of first degree relatives, and during clinical 
history-taking and by bedside testing for short-term memory 
including mini-mental examination where appropriate. Memory 
impairment was recorded in 9 of these individuals. Two 
persons had a severe mood disorder for which they required 
hospitalization. Behavioral disorders (eg aggression, 
disinhibition) were a major problem for the family of four 
persons. Only one affected person who had previously worked as 
a schoolteacher, was formally tested and found to have an 
full-scale IQ of 86 following admission to hospital for 
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delusional ideation. This score was considered to be below an 
expected score required to perform her previous profession 
with competence. 
A factor which hindered the accurate assessment of a cognitive 
decline in these circumstances was the uncertainty with regard 
to the previous level of intellectual ability and cognitive 
performance, particularly in those individuals with a 
rudimentary formal education. Furthermore, severely affected 
individuals with motor and speech disabilities are frequently 
not expected or required to manage their own affairs and their 
relatives often do not test or rely on their memory ability. 
Relatives may thus be unaware of (and therefore under-report) 
any cognitive decline. 
Of note were two other affected persons (family A, IV-61, IV-
34), both still working at the time of prospective analysis, 
who complained of forgetfulness. The first worked as a store 
planner and complained of difficulty recalling certain 
familiar items which he felt he ought to have remembered. The 
second, worked in the accounts department of a firm and 
observed that he was no longer as quick with numbers as he 
used to be and was having to use a calculator more frequently. 
Both individuals had no difficulty performing the mini-mental 
examination and other basic tests of short-term memory. These 
complaints may reflect early changes in cognitive function but 
it is conceivable that anxiety relating to their ataxia in the 
work environment may have contributed to some impairment of 
concentration. Formal psychometric testing was not done. At 
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the time of last assessment, both were coping adequately in 
their work and home environments. 
7.2.10 EVOLUTION OF THE PHENOTYPE 
Although much has been written about phenotypic variability 
and the wide range of clinical signs which may be present even 
within a single family (Pedersen, 1980; Diaz et al., 1990), a 
recognizable pattern emerges when individuals are followed up 
serially as the disorder progresses . Longitudinal 
descriptions of the evolving phenotype are, however, scant in 
the literature. Reports document the frequency and range of 
clinical signs encountered within a family, but seldom relate 
these findings to the duration or severity of the ataxia. In 
order to address this problem affected individuals were 
divided into four groups (table 7.4) depending on the 
severity of ataxia. As the rate of progression varies 
considerably within a given family (younger onset often 
tending to a more rapid course), the ataxia severity score was 
used to chart the evolution of the disorder rather than the 
duration of disease, which is a more subjective and variable 
parameter. Figure 7.6 documents the clinical signs present at 
different stages of ataxia severity for this particular group 
of individuals with the same phenotype. A particular clinical 
sign had to be present in more than one third of individuals 
within each category of severity to be included in the 
appropriate segment of the diagram, which graphically depicts 
the evolution of the disorder in these individuals. A recent 
study, of 6 Italian families with autosomal dominant ataxia, 
also demonstrated that clinical manifestations appeared 
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concordant when patients with the same disease duration were 

































































































7.3 TIME TO REACH DEPENDENCY 
At the time of the last assessment a total of 9 people had 
become dependent and wheel-chair bound. The mean time to reach 
a state of dependency was 10.1 years ( range: 6 years to 13 
years). There were however, other individuals in this group 
who had been symptomatic for longer and were not yet 
dependent. One man (family A, III-18) had developed the first 
symptoms at the age of 35, and though he had moderately severe 
ataxia (score 27) twenty years later, he was still able to 
walk with the aid of a stick. 
7.4 DEATHS 
Five affected individuals died during the course of this 
study. All had severe or moderately severe ataxia scores at 
the time of their last assessments. The mean age at the time 
of death was 39.2 years with a range of 26 years to 47 years. 
The mean duration of the illness in these individuals was 11.4 
years with a range of 9 to 19 years. 
7.5 MINIMUM PREVALENCE 
The frequency of a disease may be expressed in terms of the 
prevalence (ie. total number of affected persons in a defined 
population at a specific time) or the incidence (ie. total 
number of affected persons newly ascertained in a given time 
period). A number of factors are pertinent to the recording of 
accurate incidence data (eg. the insidious onset of the 
disorder which may require prolonged follow-up to be certain 
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of the diagnosis) and for this reason prevalence figures are 
more widely quoted in the few epidemiologic studies of 
familial ataxia (see 4.1) in the literature. An earnest 
attempt was made in this study to identify all affected 
persons with late onset ataxia in the Western Cape region (see 
6.1). Factors such as incomplete referral, however, and the 
reluctance of some affected persons (who are aware of the 
familial nature of the condition and that there is no curative 
treatment at present) to present themselves for medical 
evaluation, has almost certainly prevented complete 
ascertainment. Nevertheless, a minimum prevalence rate of the 
occurrence of the disorder in the Western Cape region of South 
Africa was calculated for the December 1993 population 
statistics (see 4.4). Prevalence was calculated according to 
the following formula: 
Prevalence= AX 10 6 
population 
A= the total number of living affected persons on the 
prevalence day. 
The number of living affected persons with late onset ataxia, 
including all the different phenotypes (as described in 
chapters 7 and 8) was 58. The minimum prevalence was 24.68 per 
million for the population of the Western Cape. 
The prevalence of familial ataxia in the various ethnic groups 
within the region is presented in Table 7.6 below: 
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TABLE 7.6 MINIMUM PREVALENCE OF FAMILIAL ATAXIA IN THE 
WESTERN CAPE POPULATION 
Ethnic group No. of persons Prevalence X 
White 13 21. 24 
Mixed ancestry 41 32.64 
Black 4 8.80 
10-=£ 
The highest prevalence was observed in the group which were of 
mixed ancestry ( total of 9 families including the 2 largest 
families A and B. see appendix) 
7.6 CONCLUSIONS 
The phenotype described in this chapter would meet the 
criteria for classification as Adult onset dominant ataxia 
with retained reflexes (Currier/Subramony classification) or 
Autosomal dominant cerebellar ataxia type 1 (Harding). 
Although the minimum prevalence data indicate that familial 
late onset ataxia is an uncommon disorder in the region, a 
total of 163 individuals (each with unaffected parent) from 
these families carry a 50 % risk (autosomal dominant 
inheritance only) of developing the disorder. The problems 
pertaining to the high risk status of these individuals will 
become the greatest challenge facing the resources of the 
Neurogenetics clinical service in the future. 
Autosomal dominant spinocerebellar ataxia is a devastating 
disease and there is an urgent need to develop an accurate and 
reliable presymptomatic test. If a gene carrier could be 
identified prior to the onset of the illness, appropriate 
counselling might be given with regard to the 50% risk to the 
offspring, although this approach is not without ethical 
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issues. In addition, with the availability of modern 
techniques, such as chorionic villus biopsy and the polymerase 
chain reaction, prenatal diagnosis would allow the option for 
abortion of an affected foetus. 
Studies to determine the genotype of this group will be 
discussed in detail in chapter 10. 
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CHAPTER 8 PROSPECTIVE ASSESSMENT OF EIGHT AFFECTED FAMILIES 
WITH CLINICALLY DISTINCT PHENOTYPES 
8.1 Late onset cerebellar ataxia without dysarthria 
and ocular signs 
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PROSPECTIVE ASSESSMENT OF EIGHT AFFECTED FAMILIES WITH 
CLINICALLY DISTINCT PHENOTYPES 
In the previous chapter, 10 families with the same phenotype 
have been discussed. A further 8 families with diverse 
phenotypes form the subject of this chapter. A total of 17 
affected persons from 8 families were prospectively assessed. 
Six of these families were white and the remaining two 
families were black. These 8 kindreds had phenotypes which 
were clinically distinct from each other and from the 
phenotype described in chapter 8. These represent rare 
disorders and for the sake of clarity the phenotype of each 
family is discussed separately in paragraphs 8.1 to 8.8 of 
this chapter. 
8.1 LATE ONSET CEREBELLAR ATAXIA WITHOUT DYSARTHRIA AND 
OCULAR SIGNS 
8.1.1 PHENOTYPE OF FAMILY K 
Two individuals (family K) with very late onset cerebellar 
ataxia were assessed. The pedigree is illustrated in the 
appendix. The proband (II-6) developed a gait disturbance at 
the age of 63 years. Eight years later her gait had worsened 
but she had developed no new symptoms. On clinical 
examination she had gait ataxia (ataxia score 22 : moderate) 
with only mild incoordination in the upper limbs. She had 
brisk tendon reflexes but normal tone and power in all limbs 
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with equivocal plantar responses. Optokinetic nystagmus and 
smooth pursuit eye movements were both present, possibly 
slightly reduced. After eight years of symptoms her speech 
did not have the typical characteristics described in 7.2.3. 
She was followed up over a three year period and at the time 
of her last assessment at the age of 70 years, her daughter 
commented that she thought that her mother's memory had become 
impaired. She tended to forget certain appointments and had, 
for example, asked the family what they had done on a 
particular day when she had in fact been with them during that 
period. A mini-mental test score was 29/30 at that time. 
None of her four children (aged between 33 to 40 years) had 
any symptoms of the disorder. 
A younger brother (II-9), aged 61, developed similar symptoms 
at the age of 48 years. He was assessed 13 years later at the 
age of 61 years. He remembered that initially he was unsteady 
when walking on uneven surfaces and that he had fallen a few 
times when "there was no reason for falling". He complained 
that "my walking has definitely got worse but it is a very 
slow process". Clinical examination again revealed a gait 
ataxia without upper limb ataxia. Biceps and tendon reflexes 
were brisk and the plantar responses extensor. Speech was 
normal and the ocular signs were subtle (minimally reduced 
optokinetic nystagmus). Although he complained that he was a 
little more forgetful than in previous years, this did not 
interfere with his life in any way (mini-mental examination 
30/30). All of his children were asymptomatic (ages 25 to 36 
years). On clinical examination both the proband and her 
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brother did not have any abnormal involuntary movements, 
dysphagia, ophthalmoplegia, optic atrophy or sensory 
disturbance. Neither drank excessive amounts of alcohol. An 
older brother (II-1) had developed similar symptoms at the age 
of 50. A CT scan was done and he was told that he had 
"problems with his cerebellum". He subsequently died at the 
age of 58 years of a cardiac condition. Both parents were 
deceased (father died aged 76 and mother at age 58) and 
neither had any gait disturbance prior to their deaths. None 
of the paternal or maternal aunts and uncles or cousins of the 
affected individuals had had a similar disorder. 
8.1.2 DISCUSSION OF FAMILY K 
The affected members of this family developed a late onset 
gait ataxia with very slow progression. The typical 
cerebellar type of dysarthria and ocular signs described in 
chapter 7 were not evident. Mild forgetfulness occurred late 
in the course of the disorder. The ataxic gait with 
relatively unimpaired limb coordination suggests 
anterosuperior vermal cerebellar involvement (Gilman, 1982). 
The mode of inheritance is consistent with an autosomal 
recessive pattern. However, taking account of the very late 
onset of the disorder, autosomal dominant inheritance cannot 
be excluded as it is conceivable that the mother of the 
affected individual (I-2) may have died prior to developing 
any symptoms. The phenotype described in this family can 
tentatively be classified as "adult onset recessive ataxia 
with retained reflexes, locus not known" (Currier/Subramony 
classification). 
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8.2 VERY LATE ONSET CEREBELLAR ATAXIA WITH DEPRESSED REFLEXES 
8.2.1 PHENOTYPE OF FAMILY L 
The proband in family L (III-2) developed symptoms of a slowly 
progressive cerebellar syndrome at the age of 63 years. The 
initial symptom was a gait disturbance with frequent falls and 
this was followed by dysarthria. Twelve years later at the 
age of 75 she was assessed prospectively and found to have a 
moderate, gait ataxia (ataxia score 24) with mild 
incoordination in the upper limbs. Cognitive function was 
normal and her speech was slurred. She had rotatory nystagmus 
on lateral gaze and optokinetic nystagmus was absent. Smooth 
pursuit movements were reduced. Muscle power and tone were 
normal but the tendon jerks were depressed in the upper limbs 
and absent in the lower limbs. Plantar responses were flexor 
and sensory examination was normal. 
A younger sister (III-3) had developed a similar gait 
disturbance at an earlier age and died at the age of 64 years. 
She apparently had a more severe gait disorder but additional 
details were not available. Their mother (II-2) had a similar 
disorder and died in 1947 at the age of 58. Attempts to trace 
her medical records were unsuccessful. The maternal 
grandparents (I-l,I-2), both died at the age of 78 and were 
apparently unaffected, but there was insufficient information 
to be certain about their neurological status. Two younger 
siblings, a sister and a brother were apparently unaffected 
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and died at the age of 54 years and 39 years from cardiac 
failure and multiple myeloma respectively. 
8.2.2 DISCUSSION OF FAMILY L 
Only the proband was alive and available for prospective 
assessment. The mode of inheritance appeared to be autosomal 
dominant. The full spectrum of the phenotype could not be 
reliably ascertained as no other affected relatives were 
available for evaluation. The most notable clinical features 
in the proband were the late onset, the slow course of the 
gait ataxia with dysarthria and reduced or absent tendon 
reflexes. It is uncertain whether the phenotype described 
above represents a distinct entity or whether it is a variant 
of the more commonly encountered phenotype described in 
chapter 7. 
8.3 AUTOSOMAL DOMINANT CEREBELLAR ATAXIA WITH MACULAR 
DEGENERATION 
8.3.1 PHENOTYPE OF FAMILY M 
At the age of 34, the index case (family M, I-2) started to 
develop progressive visual loss. Three years later she 
developed the first symptoms of gait ataxia followed by 
dysarthria, incoordination in the upper limbs, muscle cramps 
and urinary frequency. 
At the age of 48 years, she had severe visual impairment being 
able to see hand movements only. Fundoscopy revealed a 
maculopathy with retinal degeneration and optic atrophy. 
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External ocular movements were normal but optokinetic 
nystagmus and smooth pursuit movements could not be tested 
because of poor vision. She had a cerebellar type of 
dysarthria and signs of pyramidal tract involvement in all 
four limbs (viz increased tone, abnormally brisk reflexes and 
an extensor plantar response on the left). Sensory 
examination was normal. Her gait was ataxic and broad-based. 
She had incoordination in the upper limbs with a typical 
intention tremor. Nerve conduction studies in the arms and 
legs did not reveal any electrophysiologic evidence of a 
sensorimotor peripheral neuropathy. 
The eldest of her seven children (II-1) has a similar 
disorder. He spent several years at a local school for the 
blind before leaving the area. He had been assessed at one of 
the local teaching hospitals (Tygerberg Hospital - Neurology 
Unit) before he left the region. He was apparently well until 
the age of 13 when he started developing progressive visual 
loss in both eyes followed by gait ataxia. Five years after 
the onset of his symptoms, his vision had deteriorated to the 
level where he was only able to count fingers at 50 cm. 
Fundoscopy showed macular degeneration with a non-pigmentary 
retinopathy. Like his mother, he had limb and gait ataxia and 
pyramidal tract signs in his legs. The remaining six siblings 
were said to be asymptomatic, but could not be assessed for 
early signs of the disorder as they did not live locally. 
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8.3.2 DISCUSSION OF FAMILY M 
The phenotype in this family is similar to that designated as 
"Adult onset dominant ataxia with retinal or optic nerve 
involvement" (Currier/Subramony classification) or "Type II 
autosomal dominant cerebellar ataxia with retinal 
degeneration" (Harding classification). Harding (1984a) has 
reviewed earlier reports and argues convincingly that the 
association of hereditary ataxia and retinal degeneration 
constitutes a phenotype which is clinically and genetically 
distinct from autosomal dominant cerebellar ataxia type I. 
Molecular studies in this family which support this contention 
of syndromic identity are discussed in chapter 11. 
The combination of ataxia and retinopathy has been reported as 
concordant within families to a greater extent than the 
"cerebellar ataxia plus" syndromes (Harding, 1984a). 
In nearly all the families reported with this association, 
every member has had retinal degeneration. The age of onset 
is usually earlier than type I ataxia (see chapter 8) and the 
disorder may develop in the first five years of life 
(Carpenter and Schumacher, 1966; Colan et al., 1981). Most 
affected people have the onset of symptoms in their second and 
third decades and symptoms seldom begin after the age of 40. 
Visual deterioration is characteristically the first symptom 
and usually precede the ataxia by several years. The 
degenerating retina may show pigmentary changes which seem 
primarily to affect the macula (Halsey et al., 1967); in some 
reported cases, however, the periphery is more severely 
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affected (Carpenter & Schumacher, 1966). Optic atrophy is 
common in these persons (Weiner et al., 1967). Visual acuity 
is severely reduced and many patients are blind by the fourth 
decade of life. Ophthalmoplegia has also been described in 
combination with retinal degeneration in a number of families 
but was not present in all affected persons (Jampel et al., 
1961; Halsey et al., 1967; Weiner et al.,1967; Harding 1982). 
Dysarthria and pyramidal tract signs are well described in 
affected individuals with this phenotype (Halsey et al., 1967; 
Harding, 1984a). Variability of clinical features and 
pathological manifestations within some families has been 
reported (Colan et al., 1981; To et al., 1993). 
The inheritance pattern in family M appears to be autosomal 
dominant and although the six younger siblings were 
asymptomatic, these individuals have not been formally 
assessed. In this context, it is noteworthy-that 
electroretinographic changes may be present in affected family 
members who are entirely asymptomatic and have a normal 
ophthalmologic evaluation (To et al., 1993). These authors 
emphasize the usefulness of electroretinogram in providing 
early evidence of retinal degeneration. In their experience 
the earliest change in the retina of affected individuals was 
reduction of amplitudes in the isolated cone responses, 
indicative of a cone dysfunction. 
Ocular histopathology studies in families with cerebellar 
ataxia with retinal degeneration show similar findings in the 
different families (Weiner et al., 1967; Ryan et al., 1975; To 
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et al., 1993). In the study of To et al., the inner and outer 
segments of the photoreceptive layer of the retina and macula 
showed diffuse degeneration affecting both rods and cones. The 
photoreceptor degeneration involved the entire retina, but was 
more severe in the macula. 
Molecular studies (chapter 11) in this South African family 
support the contention that this phenotype is clinically 
distinct from that described in chapter 7 (viz. autosomal 
dominant cerebellar ataxia type I Harding). 
8.4 AUTOSOMAL DOMINANT CEREBELLAR ATAXIA WITH MACULAR 
DEGENERATION AND SLOW EYE MOVEMENTS 
8.4.1 PHENOTYPE OF FAMILY N 
The proband (family N, IV-3; figure 8.1) developed slowly 
progressive visual impairment at the age of 24 years. This 
symptom was followed by a gai.t ataxia and impaired hand 
coordination. At the age of 28 years, the visual acuity was 
severely reduced (6/60 on the left and finger movements only 
in the right eye). Fundoscopy revealed a "bulls-eye" 
maculopathy (figure 8.2). A striking feature was the very 
slow eye movements; random and voluntary eye movements 
(saccades) were smooth but very slow in all directions. She 
could not abduct the eyes fully on extreme lateral gaze 
(figure 8.3). Titubation with mild but definite ataxia of gait 
and limbs (ataxia score 21) was observed. She was not 
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dysarthric but had difficulty with rapid repetition of short 
syllables (eg la-la-la). 
Electroretinogram results were consistent with a cone 
dystrophy ( unrecordable cone responses; rod responses 
normal). CT scan showed gross cerebellar atrophy. Serum 
concentrations of lactate, Vitamin E and alphafetoprotein 
were all normal. Aminoacid levels and organic acid profiles 
were also normal. According to the proband, her mother, aged 
70 years, started developing progressive visual impairment 
with gait ataxia at the age of 66 years. She lives in a 
remote rural area of the Transkei and was not available for 
clinical assessment. However, her cousin (IV-16) who 
developed similar symptoms at the age of 26 years, was 
assessed (figure 8.1). In this person, visual symptomatology 
also preceded the gait disturbance. At the age of 28 years 
her visual acuity was reduced (6/60 on the left and 12/60 on 
the right) and fundoscopy showed a maculopathy. Eye movements 
were very slow in all directions. She had titubation and a 
moderate gait and limb ataxia (ataxia score 25). The rest of 
the examination was normal apart from absent ankle jerks. 
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FIGURE 8.1 PROBAND AND COUSIN (FAMILIY N) 
The proband (IV-3) and her cousin (IV-16) stand and walk on a 
broad base. 
FIGURE 8.2 "BULLS-EYE" MACULOPATHY 
Photograph of the retina of the proband of family N 
demonstrating a "bulls-eye" maculopathy. 
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FIGURE 8.3 IMPAIRED LATERAL GAZE 
The proband is attempting to gaze to the left and is unable to 
adbuct the left eye fully. 
8.4.2 DISCUSSION OF FAMILY N 
The mode of inheritance is autosomal dominant in this family. 
The separation of this kindred from the family described in 
8.3.1 was based on the presence of very slow eye movements. 
This may well prove to be a tenuous basis for sub-division. 
Wadia (1971,1977,1984) described 37 patients from 23 Indian 
families with very slow eye movements and suggested that these 
families form an identifiable subgroup. In these Indian 
families, the disorder began with a slowing of the horizontal 
random and voluntary eye movements through the full range. 
The slowing of the eye movements gradually became more obvious 
in all directions. Limitation of gaze in the terminal range of 
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horizontal and vertical movement occurred and a staring 
expression of the eyes was observed in some affected people. 
Individuals used compensatory head movements for looking at 
objects. Electro-oculographic recordings demonstrated that 
the slowing was restricted to saccadic movements, although 
this may be difficult to distinguish clinically (Kulkarni, 
1975). The available histopathology from the Indian families 
falls within the spectrum of olivopontocerebellar atrophies. 
The phenotype is characterized by the presence of cerebellar 
ataxia, typical slow eye movements and clinical or subclinical 
affection of the spinal lower motor or sensory neurones. 
Wadia (1984) suggests that this phenotype represents a 
recognisable recurrent clinico-pathological pattern in the 
Indian population. However, none of the affected persons from 
the Indian families had macular degeneration or severe loss of 
vision. Harding (1984a) has commented that slow eye movements 
have been observed in families with hereditary ataxias of many 
types and she questioned if the group of patients with slow 
eye movements has a separate syndrome. 
Although family Mand family N both have cerebellar ataxia 
with macular degeneration and severe visual impairment, the 
slow speed of the eye movement in the two affected members of 
family N is a distinguishing clinical feature. For this 
reason family N cannot be readily classified under the 
existing schema because those families classified as having 
slow eye movements do not have macular degeneration and vice 
versa. 
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8.5 CEREBELLAR ATAXIA AND HYPOGONADISM 
8.5.1 PHENOTYPE OF FAMILY 0 
The propositus ( family O, III-4) was identified in the pilot 
study (chapter 5). He had been seen by the neurology service 
in the advanced stages of a progressive neurologic condition 
and had died at the age of 31 years. He presented two years 
prior to this with progressive cerebellar ataxia. In the late 
stages of this illness he was found to have severe gait and 
limb ataxia with dysarthria, dementia, hypogonadotropic 
hypogonadism and diffuse muscle wasting. Reflexes were 
depressed in the lower limbs and there was a distal sensory 
neuropathy. His two younger brothers were assessed 
prospectively. 
A brother (III-2) died at the age of 33 years with a similar 
illness which evolved over an eight year period. Prior to 
this, he had been documented as having hypothalamic 
hypogonadism (by the Endocrine service at Groote Schuur 
Hospital), mild mental retardation and progressive cerebellar 
ataxia, as well as generalized tonic clonic seizures and 
peripheral neuropathy. He also had depressed tendon reflexes, 
amyotrophy and predominantly proximal weakness. 
The oldest sibling ( family O, III-1), aged 46 years, had a 
one year history of mild weakness of the legs. He had mild 
kyphoscoliosis and features of hypogonadism (small genitalia 
with poorly developed secondary sexual characteristics). The 
clinical impression was that he had a low intelligence 
109 
quotient but he not formally tested. Muscle tone and reflexes 
were increased in the limbs and there was mild proximal 
weakness. He was not clinically ataxic, but complained of 
slight unsteadiness when walking. Optokinetic nystagrnus and 
smooth pursuit eye movements were normal. 
Endocrine function tests were undertaken and these revealed 
low serum testosterone (5.6 nrnol/1, normal: 10-35) and normal 
levels of LH (15 nrnol/1, normal: 3-18) and FSH (8.4 nrnol/1, 
normal: 3-15). Both FSH and LH showed a normal but slightly 
delayed incremental response to stimulation with gonadotropin 
releasing hormone. This finding is consistent with 
hypothalamic hypogonadism (ie. the hypogonadism is not due to 
the inability of the pituitary gland to secrete gonadotrophins 
but is due to the absence of pituitary stimulation by the 
hypothalamic releasing hormones). Growth hormone and thyroid 
function tests were normal. 
A mitochondrial encephalopathy was considered as a possible 
diagnosis in this family in the light of the muscle weakness, 
history of seizures and multisystem involvement (although 
hypogonadism is not one of the recognized features of this 
group of conditions). A muscle biopsy was done but this did 
not reveal ragged red fibres and there were no morphologic 
abnormalities of the mitochondria on electron microscopy of 
the biopsy specimen. 
At that time the technology to study the point mutations of 
mitochondrial DNA had not yet become available locally. MRI 
scan showed mild cerebellar atrophy. 
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A younger brother (III-3), complained of gait deterioration 
with weakness in the limbs and troublesome muscle cramps at 
night. Clinically there were no features of hypogonadism. He 
had horizontal nystagmus, loss of smooth pursuit eye movements 
and reduced optokinetic nystagmus. There was mild (grade 
4+/5) proximal weakness and the tendon reflexes in the lower 
limbs were reduced. He had mild incoordination in the limbs, 
worse on the left, together with a moderate gait ataxia 
(ataxia score 17). Higher mental function and sensory 
examination were normal. He gave a history of having had two 
generalized seizures prior to the assessment. 
The mother of the affected males (II-2) was asymptomatic, but 
when assessed at the hospital she was found to have mild 
cerebellar signs in the lower limbs, mild proximal weakness of 
the hip girdle and absent ankle jerks. 
8.5.2 DISCUSSION OF FAMILY 0 
Affected individuals in this family show a wide variety of 
clinical signs. Two brothers (III-1, III-3) had hypogonadism 
and had not reproduced, and a third brother had neurological 
involvement without hypogonadism. The mother was asymptomatic 
but had neurological signs. Holmes (1907a) described a 
familial autosomal recessive progressive cerebellar ataxia 
associated with hypogonadism, and Harding (1984c) has reviewed 
subsequent reports of this association. Affected individuals 
have progressive gait and limb ataxia, usually starting in the 
third or fourth decade, associated with dysarthria, nystagmus, 
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titubation and intention tremor (Volpe et al., 1963). Tendon 
reflexes are normal, hypoactive or even increased (Berciano 
et al., 1982b). Distal sensory loss (Boitelle et al., 1956) 
and mental retardation (Lowenthal et al., 1979) were reported 
in some families. Dementia may develop (Matthews & Rundle, 
1964; Berciano et al., 1982). The external genitalia are 
small, secondary sexual characteristics are poorly developed. 
These features are evident from the expected time of puberty. 
The hypogonadism associated with this disorder is usually 
hypogonadotropic (low levels of circulating sex hormones and 
gonadotrophins) (Berciano et al., 1982b). Endocrine evaluation 
in 4 sporadic cases (De Michele et al., 1993) showed 
heterogeneity of the hypogonadism with both high and low 
levels of gonadotrophins in the affected individuals. In 
contrast to family O above, others (Fok et al., 1989; Bhatia 
et al., 1993) have described individuals with a similar 
phenotype who had low gonadotrophin levels which did not rise 
on stimulation with gonadotrophin-releasing-hormone, 
indicating a defect in the production or release of 
gonadotrophins by the pituitary gland. 
Although ataxia and hypogonadism usually occur together, 
Lowenthal et al. (1979) described a family in which a 
neurologically affected sibling had normal sexual development. 
This finding parallels that in family O (individual III-3 had 
ataxia but no hypogonadism). Incomplete expression of a 
pleiotrophic gene may explain this phenomenon. 
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A number of other less frequently described clinical features 
have been reported in certain families. These include deafness 
(Matthews and Rundle, 1964; Edwards et al., 1976), distal 
amyotrophy (Neuhauser and Opitz, 1975), choreoathetosis 
(Altschul and Kotlowski, 1956), pigmentary retinal 
degeneration (Boucher and Gibberd, 1969; Edwards et al., 1976; 
Limber et al., 1989; Baroncini et al., 1991), pes cavus 
(Boucher and Gibberd, 1969; Volpe et al., 1963) and scoliosis 
(Neuhauser and Opitz, 1975). In a review of reported 
pedigrees containing individuals with cerebellar ataxia and 
hypogonadism, Harding (1984c) has noted that the majority are 
compatible with autosomal recessive inheritance and some with 
x-linked recessive inheritance. The latter mode of 
transmission is supported by the fact that the ratio of 
affected males to females in reported families is about 2 to 
1. In addition the consanguinity rate is not as high as would 
be expected for a rare autosomal recessive disorder. 
In family O above, the mode of inheritance is likely to be x-
linked recessive as the mother, at the age of 72 years, has 
subtle but definite neurological signs, and all her male 
offspring have the disorder. Although affected individuals 
from different families have several features in common, the 
presence of additional clinical manifestations, such as 
deafness or pigmentary retinal degeneration, suggest genetic 
hetrogeneity (Harding 1984c). 
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8.6 CEREBELLAR ATAXIA, OPTIC ATROPHY AND DEAFNESS 
8.6.1 PHENOTYPE OF FAMILY P 
The proposita (family P, II-2,) was assessed at the age of 63 
years. Slowly progressive visual deterioration commenced in 
childhood and she recalled having difficulty seeing in the 
dark at the age of 8 years; at 18 years she wore very thick 
spectacles and was completely blind at 45. When she was 35 
years old she became aware of impaired balance and hearing 
loss which were progressive. At the age of 62 she was confined 
to a wheel-chair. Cognitive function became impaired during 
the last year of her illness and she became emotionally labile 
and had lapses in short term memory. Her husband complained 
that she had experienced visual and auditory hallucinations. 
On clinical examination she was blind and had a supranuclear 
ophthalmoplegia in all directions. Fundoscopy revealed severe 
bilateral optic atrophy, but no pigmentary retinopathy. She 
had bilateral partial sensorineural deafness, absent tendon 
reflexes, muscle weakness (greater distally with wasting of 
the small muscles of the hands and feet), and a sensorimotor 
peripheral neuropathy. She was ataxic in the upper limbs and 
unable to walk because of ataxia and muscle weakness. 
Psychometric evaluation of her short term memory was 
inconclusive. She could read brail fluently. She tended to 
have verbal perseveration with flight of ideas. She died one 
year later at the age of 64 years. 
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Her daughter (III-2) was first assessed at the age of 25 
years. Her optic discs appeared normal and her visual acuity 
(formally tested) was normal. Two years later, however, the 
left optic disc showed pallor and the acuity in the left eye 
had deteriorated from 6/6 to 6/12. There were also subtle 
visual field defects in the left eye field on formal perimetry 
testing. Six years later at the age of 33 years, there had 
been further deterioration (visual acuity 6/6 on right and 
6/24 on left). The right optic disc appeared normal but in the 
left eye there was optic atrophy without glial tissue or 
retinopathy. Visual evoked responses were normal on the right 
and absent on the left. This finding is consistent with 
unilateral optic nerve pathology. Because of a suspected 
radiological abnormality in the intraorbital portion of the 
left optic nerve seen on MRI scan, surgical decompression and 
exploration of the left optic nerve was undertaken. However, 
the left optic nerve appeared normal at operation and there 
was no evidence of an optic nerve meningioma. At the age of 35 
years, the left optic disc was unchanged but there was 
definite optic disc pallor on the right. No other neurological 
signs have evolved. 
A brother (III-1), aged 32 years, was assessed and thought to 
have mild optic disc pallor. He had worn spectacles since the 
age of 17 years. He had bilateral pes cavus with surgically 
corrected hammer toes. Ankle jerks were absent and joint 
position sense and pinprick sensation were reduced in the 
toes. Five years later he had mild bilateral optic atrophy 
with pupillary escape. His visual acuity was normal and the 
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fields showed mild peripheral constriction. There were no 
other abnormal neurological signs, but nerve conduction 
studies showed electrophysiologic evidence of an axonal 
sensorimotor peripheral neuropathy. 
Clinical examination of the sole surviving sibling (II-3) of 
the proposita was entirely normal. 
Post Mortem findings from the proposita: 
Macroscopically the hemispheres were symmetrical, without 
midline shift or significant enlargement of the third or 
lateral ventricles; the cortical ribbon appeared intact 
throughout and the basal ganglia normal, although the 
Substantia nigra was paler than expected; the white matter 
was unremarkable and the corpus callosum was not obviously 
thinned. No other focal lesions were evident macroscopically. 
Horizontal sections of the hindbrain confirmed the impression 
of a reduction in size especially of the pons and cerebellum. 
Symmetrical pallor of the substantia nigra was noted and the 
inferior olives were reduced in size. Histological sections 
of four muscles showed evidence of neurogenic atrophy which 
was most pronounced in the right deltoid muscle. Sections of 
the cerebrum showed no evidence of infection, infarction, 
haemorrhage, vasculopathy, myelin-pallor or obvious gliosis. 
Senile plaques and granuolo-vacuolar degeneration were 
inconspicuous and Lewy bodies were not demonstrated. There 
was loss of pigmented neurons in the substantia nigra and 
locus ceruleus. The inferior olives were atrophic. Sections 
of the cerebellum revealed diffuse slight diminution in the 
number of Purkinje cells with thinning of the molecular layer 
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and atrophy of the dentate nucleus. The middle cerebellar 
peduncles were reduced in size. The cervical cord showed a 
symmetrical diminution in the number of anterior horn cells 
with some of the remaining cells appearing degenerate. The 
white matter of the anterior, lateral and posterior funiculi 
was not well preserved. The pathologist attributed these 
findings to a multi-system atrophy. 
8.6.2 DISCUSSION OF FAMILY P 
The proposita presented with a slowly progressive neurological 
illness characterized by optic atrophy and blindness, late 
onset cerebellar ataxia, peripheral neuropathy and 
sensorineural deafness. In the later stages intellectual 
deterioration, ophthalmoplegia and chorea evolved. Both her 
children are in their late thirties and have asymmetrical 
optic atrophy without cerebellar signs or deafness. In this 
family the mode of inheritance is likely to be autosomal 
dominant with variable penetrance. 
There are very few descriptions of familial ataxia with severe 
symptomatic optic atrophy, deafness and peripheral neuropathy. 
Van Bogaert (1974) described a family with early onset (first 
decade) cerebellar ataxia associated with optic atrophy and 
severe visual impairment, deafness and mental retardation. 
Some affected members did not have optic atrophy or hearing 
impairment. Similarly, in another family (Hogan & Bauman, 
1977), affected siblings had early onset cerebellar ataxia, 
optic atrophy and signs of pyramidal tract involvement and 
some also developed deafness and intellectual deterioration. 
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The mode of inheritance was thought to be autosomal recessive. 
Iwashita et al. (1970) described two siblings with bilateral 
optic atrophy, hearing loss and distal muscle wasting. 
In an earlier report, Rosenberg (1967) described a family in 
which 3 affected males had early onset optic atrophy, 
sensorineural deafness and polyneuropathy without ataxia. In 
this article he discussed the considerable overlap in clinical 
signs that are seen in the hereditary spinocerebellar ataxias, 
inherited neuropathies (including Charcot-Marie-Tooth 
Disease), inherited optic atrophies and Refsum's disease. 
Similarly, Hoogendijk and DE Jong (1991) reviewed rare 
variants of the hereditary motor-sensory neuropathies. 
Although these unusual descriptions of the hereditary 
neuropathies were associated with sensorineural deafness, 
optic atrophy, ataxia and other features, none match the 
phenotype of family P. 
Refsum's disease enters into the differential diagnosis. This 
rare disorder is inherited as an autosomal recessive trait and 
has its onset in childhood or early adulthood. Affected 
individuals develop cerebellar ataxia, chronic polyneuropathy 
and visual impairment. However, these individuals have 
retinitis pigmentosa coupled with elevated blood phytanic acid 
levels. Other features of this disorder which may occur 
include neurogenic deafness, cardiomyopathy, cataracts, 
pupillary abnormalities, and ichthyotic skin changes. The 
onset, ocular findings and normal phytanic acid levels in 
family Pare not consistent with this diagnosis. Similarly, 
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other rare metabolic disorders (GM2 Gangliosidoses, abeta-
lipoproteinaemia) were excluded on biochemical testing. 
Because of the diffuse involvement of the nervous system in 
the index case and the presence of bilateral optic atrophy in 
the offspring, a mitochondrial encephalopathy was also 
considered in the differential diagnosis. The phenotype of 
this family was not typical, however, of any of the better 
characterized subgroups of the mitochondrial cytopathies (viz. 
Kearns-Sayre syndrome, MERRF, MELAS, Leber's hereditary optic 
neuropathy). Nevertheless, the clinical spectrum of these 
disorders is wide and still not fully clarified. A wide range 
of neurological signs has been described following mutations 
of the mitochondrial DNA and these include cerebellar ataxia, 
optic atrophy, dementia, myoclonus, generalized seizures, 
deafness, spasticity, impairment of position and vibration 
sense, myopathy, lactic acidosis, stroke-like episodes, 
external ophthalmoplegia, retinitis pigmentosa, and cardiac 
conduction defects (Morgan-Hughes, 1986; Bercovic et al., 
1989). The mitochondrial encephalopathies have emerged as an 
important cause of hitherto undiagnosed progressive neurologic 
syndromes. There is also considerable intrafamilial variation 
in the clinical presentation of these disorders (Berkovic et 
al., 1989). This may be due to varying ratios of wild type and 
mutant mitochondrial DNA present in different oocytes, as well 
as to different patterns of mitotic segregation of 
mitochondrial DNA during early embryogenesis (Di Mauro et 
al., 1985; Rosing et al., 1985). 
More recently, molecular techniques for the study of the known 
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mutations of the mitochondrial DNA (Hammans et al., 1991) have 
become available locally. Blood and skin biopsy specimens were 
obtained from an affected member of this family (III-1) and 
the assays of pyruvate dehydrogenase and pyruvate carboxylase 
activity were normal. There were no mutations at the 
mitochondrial DNA base pairs 3242, 3271, and 11778 (this work 
was undertaken by Dr. E.P. Owen, Department of Chemical 
Pathology, Medical School, UCT). Further tests for other 
mitochondrial DNA mutations are to be done in the future. 
In conclusion, it must be emphasized that although the autopsy 
findings from the proposita fall within the spectrum of the 
spinocerebellar ataxias, the phenotype in this family may well 
be unique. 
8.7 CEREBELLAR ATAXIA, MENTAL RETARDATION, MOTOR NEURONE 
SYNDROME AND MACULAR DEGENERATION 
8.7.1 PHENOTYPE OF FAMILY 0 
The index case (III-5) in family Q was referred for assessment 
by a local institute for the mentally handicapped where he has 
been living with two younger similarly affected siblings for 
many years. In his early twenties he developed a gait 
disturbance which gradually deteriorated and by the age of 39 
he was confined to a wheelchair. The clinical assessment at 
age 45 revealed a mentally retarded man with a maculopathy and 
peripheral pigmentary retinal changes. Optokinetic nystagmus 
and smooth pursuit movements were present but reduced. He had 
a spastic dysarthria, increased tone in the limbs (greater in 
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the legs) and distal amyotrophy, particularly affecting the 
small muscles of the hands. Muscle strength was slightly 
reduced in the upper limbs (4/5 power) but absent (0/5 power) 
in the legs. All tendon reflexes were brisk except the ankle 
jerks which were absent. Sensation was difficult to assess 
because of his mental state. In the upper limbs he had mild 
cerebellar signs but these could not be evaluated in the legs 
because of the paraplegia. 
A sister (III-8) was similarly affected. Her gait started to 
deteriorate at the age of 22. At 39 years of age she was 
assessed and found to be mentally retarded with a spastic 
paraplegia. She had distal amyotrophy and mild incoordination 
in the upper limbs. Fasciculations were noted in the thighs. 
She had a pigmentary maculopathy. Her phenotype was identical 
to that of the index case. 
A younger brother (III-10) started to develop progressive gait 
ataxia at the age of 15 years. According to the records he 
was able to walk normally during childhood. By the age of 37 
he had spastic paraplegia (grade 3/5 power in the upper limbs, 
grade 0/5 power in the legs). Both the trapezius and 
sternocleidomastoid muscles were weak. There was diffuse 
muscle wasting and fasciculations which were more noticeable 
in the proximal large muscles. He had wasting of the 
temporalis muscles and weakness of the facial muscles 
(obicularis oris and oculi). He had spastic dysarthria with 
mild dysphagia; the tongue was not wasted or fasciculating. 
He was mentally retarded and sensation could not be reliably 
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tested (although it appeared that pinprick sensation was 
perceived). Optokinetic nystagmus was absent and fundoscopy 
revealed a maculopathy. 
The Gland G2 gangliosidoses were excluded on specific 
biochemical testing. Serum lactate level was normal. EMG 
revealed chronic neurogenic changes (large polyphasic units 
with decreased recruitment of motor units - see 10.3.2) 
indicative of lower motor neurone pathology. He died at the 
age of 38 years from bronchopneumonia. 
An affected cousin (III-1) was assessed at the age of 47 
years. He had been mentally retarded since childhood and his 
motor symptoms started at the age of 14 years. By 35 years he 
was confined to a wheelchair and at the age of 47 years he had 
a spastic paraplegia with diffuse muscle wasting and 
fasciculations. There were mild cerebellar signs in the upper 
limbs. 
8.7.2 DISCUSSION OF FAMILY Q 
The mode of inheritance in this family is not clear cut, but 
the fact that 3 affected siblings of unlike sex in one branch 
of the family had normal parents is suggestive of autosomal 
recessive inheritance. The occurrence of the disorder in a 
male cousin whose parents were also unaffected is consistent 
with this pattern but it would imply that his father, who was 
not known to be a blood relative of either branch of the 
family, was heterozygous for the faulty gene. Alternative 
explanations are autosomal dominant inheritance with non-
penetrance, and non-paternity. These issues could not be 
further elucidated and remained unresolved. 
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Although affected members of this family had evidence of 
ataxia in the upper limbs, the spastic paraparesis and diffuse 
neurogenic atrophy dominated the clinical picture as this 
disorder progressed. Mental retardation and macular 
degeneration were the other notable features. 
Early descriptions of hereditary spastic paraplegia date back 
to the late 19th century (Seeligmtiller, 1876; Strtimpell,1880). 
The "pure" syndrome (in which the abnormality is virtually 
confined to a spastic paraparesis) is more common than the 
complex varieties of the disease (Harding, 1984d). Clearly, 
family Q does not fall within the scope of "pure" familial 
spastic paraplegia. Sutherland (1975) and Harding (1984e) 
have reviewed a variety of very rare and heterogeneous 
familial disorders with spastic paraplegia and additional 
neurological features (such as cerebellar ataxia, amyotrophy, 
mental retardation, retinal degeneration, optic atrophy, 
extrapyramidal involvement, sensory neuropathy and skin 
changes). The phenotype in this family is similar to that 
described by Kjellin (1959,1975) in two pairs of brothers from 
separate families. In his description, the affected 
individuals had mental retardation from birth and developed 
progressive spastic paraparesis around the age of 25 years. 
This was associated with distal amyotrophy, dysarthria and 
central retinal degeneration. The pigmentary changes appeared 
to affect the macula more than the peripheral retina and 
visual acuity was relatively well preserved. Only a few 
isolated reports of a similar phenotype have appeared in the 
literature (Ledic and Van Bogaert, 1960; Gilman and 
Horenstein, 1964). Ataxia was not a feature in Kjellin's 
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report. Cross and McKusick (1967) described a recessive form 
of spastic paraplegia with cerebellar signs and distal 
amyotrophy. In Kjellin's patients with spastic paraplegia, the 
distal amyotrophy and fasciculations were noted in the small 
muscles of the hands, but two affected individuals also had 
fasciculations and atrophy of the leg muscles. Muscle biopsy 
from one of these persons showed chronic neurogenic changes. 
Kjellin's report does not include a description of the 
phenotype in the advanced or terminal stages of the disorder 
and it is uncertain whether these individuals ultimately 
developed more generalized atrophy and fasciculations. Garland 
and Astley (1950) described a pattern of global atrophy with 
familial spastic paraplegia. 
The combination of upper motor neurone signs and severe 
generalised muscle wasting with fasciculations in the later 
stages of the disorder is seen in amyotrophic lateral 
sclerosis. The mental retardation and maculopathy, however, 
are not in keeping with those unusual familial amyotrophic 
lateral sclerosis variants in which some affected persons also 
have dementia or parkinsonism (Hudson, 1981; Mulder et al., 
1986). 
It is conceivable that similar cases to those seen in family Q 
are under-reported in the literature as the retinal changes 
may be easily overlooked if the macular region is not 
examined. 
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8.8 SPASTIC PARAPARESIS WITH ATAXIA AND DYSTONIA 
8.8.1 PHENOTYPE OF FAMILY R 
In family R, only the proposita (II-2) was living in the Cape 
Town area and available for assessment. At 28 years she 
developed a gait disturbance with frequent falls. This 
progressed very slowly and twelve years later, she was still 
able to walk independently with a stick. In addition to her 
deteriorating gait and progressive weakness in her legs, she 
also complained of urinary frequency and a tendency for her 
head to move backwards spontaneously, so that she appeared to 
be looking at the ceiling. 
By the age of 56 years she was confined to a wheel chair. At 
66 years she was assessed and found to have a spastic 
paraparesis (5/5 power in the upper limbs and 2/5 power in the 
legs). All the tendon reflexes were increased and the plantar 
responses were extensor. Her speech was slightly slurred and 
there was mild ataxia with an intention tremor in the upper 
limbs. She had horizontal nystagmus, impaired optokinetic 
nystagmus, reduced smooth pursuit eye movements, supranuclear 
ophthalmoplegia, and partial ptosis. There was no retinopathy 
or optic atrophy. In addition to these clinical signs , she 
had a focal dystonia with retrotorticollis. Sensation was 
normal. 
A brother (II-5) aged 61 years, who lived in East London, was 
confined to a wheel chair because of paraparesis. His speech 
was also severely affected. His symptoms had apparently begun 
at the age of 25 years. The two remaining siblings were 
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unaffected. All the members of the third generation (oldest 
aged 43 years) are asymptomatic, but none have as yet been 
examined for early signs of this disorder. According to the 
proposita, her maternal grandfather who died at the age of 79 
years, was unable to walk normally from a young age. However, 
further clinical details concerning his condition were not 
available. 
8.8.2 DISCUSSION OF FAMILY R 
Only the index case in this family has been evaluated. The 
predominant clinical feature in this person was the slowly 
progressive paraparesis. This was associated with a focal 
dystonia, mild upper limb ataxia and supranuclear 
ophthalmoplegia. As discussed in 8.7.2, a variety of 
associated clinical signs have been reported with familial 
spastic paraparesis. Ferguson and Critchley .(1929), and 
Mahloudji (1963) have described the unusual association of 
hereditary spastic paraparesis with supranuclear 
ophthalmoplegia and extra-pyramidal disorders. Brown (1966, 
1975) reviewed the data on four families with spastic-ataxic 
paraplegia, urinary symptoms, dysarthria, mild mental changes, 
nystagmus, supranuclear ophthalmoplegia and extra-pyramidal 
signs (viz. limb rigidity, tremor with Parkinsonian features). 
Other extra-pyramidal abnormalities (eg. involuntary 
movements, torticollis, dystonia) have also been reported in 
association with spastic paraplegia (Dick and Stevenson, 1953; 
Gilman and Horenstein, 1964). 
The full spectrum of the phenotype cannot be characterized in 
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family R without additional prospective data from other 
affected members. 
8.9 CONCLUSIONS: 
In this chapter a group individuals with rare atypical 
syndromes are described. Although the phenotypes in these 
families show some similarity to diverse and obscure reports 
in the literature, there are also significant differences. It 
remains an open question whether there is considerable 
heterogeneity or whether this merely reflects a variable 
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In order to complete delineation of the phenotype appropriate 
diagnostic imaging was undertaken in a group of persons with 
familial cerebellar ataxia. The CT scan topographic patterns 
of cerebellar atrophy have been described in the literature 
(Koller et al., 1981; Huang and Plaitakis, 1984; Ramos et al., 
1987; Wittkamper et al., 1993). MRI permits better delineation 
of the posterior fossa structures than does CT scan. It is 
therefore ideal for documenting the radiographic changes of 
spinocerebellar ataxia in which the pathological changes are 
maximal in the cerebellum, brainstem, and spinal cord. A group 
of individuals from the South African families were selected 
to have MRI scans in order to document the radiologic changes 
and to try to correlate the degree of atrophy with the 
severity of the ataxia. It was not possible to perform MRI 
scans on every affected person from these families because of 
geographic and logistic reasons. 
9.1.1 BACKGROUND TO DIAGNOSTIC IMAGING 
There is a paucity of reports describing the MRI findings in 
this group of disorders. In sporadic cases of spinocerebellar 
ataxia, the differential diagnosis from other diseases, in 
particular multiple sclerosis, can sometimes be difficult and 
MRI is very useful in solving this problem. Ormerod at al. 
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(1987) described the MRI findings in 8 persons with inherited 
ataxia (5 persons with autosomal dominant late onset ataxia 
and 3 with autosomal recessive ataxia). The frequency and 
anatomical distribution of the atrophy of the intracranial 
structures in this small series of affected persons was in 
accordance with the pathologic descriptions. In addition to 
the atrophy of the cerebellum and brainstem structures, these 
authors observed high intensity signal lesions in the 
periventricular regions on the scans of 3 of the 5 persons 
with autosomal dominant cerebellar ataxia. These lesions 
differed from those seen in patients with multiple sclerosis. 
The number of persons in each subgroup was too small to permit 
characterization of MRI changes. In 2 subsequent reports 
(Nabatame et al.,1988; Bradac et al.,1989) atrophic changes 
seen on MRI in persons with familial and sporadic ataxia were 
described but high intensity periventricular lesions were not 
observed. MRI scanning of 28 persons with sporadic late onset 
cerebellar ataxia differentiated a group with pure cerebellar 
atrophy from another group with cerebellar and brainstem 
atrophy (Klockgether et al.,1993). The scan findings 
correlated with the clinical assessments as some of these 
individuals were thought to have a pure cerebellar syndrome 
and others were thought to have olivopontocerebellar atrophy 
because of additional non-cerebellar signs. Wlillner et al. 
(1993) used MRI to study 61 persons with various types of 
ataxia including 13 individuals with autosomal dominant ataxia 
(type 1 Harding). In this group the morphologic changes were 
not uniform, but the authors did not attempt to correlate the 
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extent and degree of the morphologic changes with the duration 
and severity of the disorder. 
More recently, in certain specialized centres, cerebellar and 
brainstem morphology can be evaluated quantitatively with an 
image analyzer and a computerized interpretation programme 
(Schroth et al.,1990). These measurements require newly 
developed software which calculates the amount of cerebral 
tissue within an defined region of interest. A different, 
steriological method of systematic sampling (Escalona et al., 
1991) was devised and used on 37 normal volunteers to 
determine cerebellar volumes. This particular study 
demonstrated that gender accounted for significant variability 
in cerebellar volumes. Although these exciting techniques 
offer the potential for providing determinations of the 
volumes of anatomic structures, the standardized values based 
on data from large numbers of controls of different ages and 
sex are not widely available for any given method. The 
technology to calculate cerebellar volumes is not currently 
available locally and for this reason a qualitative assessment 




27 persons with familial ataxia had MRI scans. 
Twenty three (10 males and 13 females) had the same phenotype 
(viz. Adult onset autosomal dominant ataxia with retained 
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reflexes) which has been discussed in detail in chapter 7; the 
remaining 4 individuals had clinically distinct phenotypes. 
9.2.2 PROCEDURE AND SETTINGS 
The scans were performed using MRI equipment operating at 0.5 
Tesla. Supra and infratentorial regions as well as the 
cervical spinal cord were investigated using spin-echo 
techniques with proton density, Tl and T2 weighted images in 
the axial and sagittal planes. The MRI settings are listed in 
table 9.1. 
TABLE 9.1 MRI SETTINGS 
Axial T2 and proton density: 
Axial Tl images: 
Tl saggital images 
TR: 2000ms 
TE: 30 ms and 90 ms 
slice width: 6nm1 
slice gap: 3nm1 
field of view: 20cm 
acquisition matrix: 256 x 256 
number of averages: 1 
TR: 700 ms 
TE: 27 ms 
slice width: 6nm1 
slice gap: 3nnn 
field of view: 20cm 
acquisition matrix: 256 x 256 
number of averages: 2 
TR: 600 ms 
TE: 27 ms 
slice width: 5 IIlIIl 
slice gap: 1 mm 
field of view: 24 cm 
acquisition matrix: 256 x 256 
number of averages: 2 
[TE: time to echo; TR: time to repetition) 
9.2.3 EVALUATION AND SCORING OF SCANS 
Each scan was evaluated independently by 3 neuroradiologists, 
all of whom had extensive MRI experience. All 3 examiners were 
regularly interpreting MRI scans including the assessment of 
many normal scans. The radiologists were asked to score the 
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severity of the atrophic changes on each scan in 5 categories 
(viz.: cerebellar atrophy; brainstem atrophy; spinal cord 
atrophy; cortical atrophy; as well as a"global score" for the 
whole scan). A numerical scoring system ranging from O 
(normal) to 9 (severe) was applied to each category. The 
radiologists were unaware of the severity of the clinical 
signs. 
Inter-observer reliability was assessed by correlating the 
rating scores of the 3 examiners in each category using the 
Spearman rank correlation test. An "averaged global score" was 
derived in order to obtain an optimal qualitative evaluation 
of the atrophic changes for each scan (ie. summation of global 
scores by the 3 raters divided by 3). All the averaged global 
scores for each scan were then correlated with the individual 
global scores of the 3 examiners in order to verify their use 
as a reliable radiologic index. Finally, the averaged global 
scores for each scan were correlated with the individual's 
clinical scores (of ataxia severity) in order to determine 
whether the severity of the atrophic changes paralleled the 
severity of the clinical signs. 
9.3 RESULTS 
The MRI scans of those individuals who share the same 
phenotype were analysed separately from the 4 individuals with 
clinically distinct phenotypes. 
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9.3.1 AUTOSOMAL DOMINANT ATAXIA: 
9.3.1.1 INTER-OBSERVER RELIABILITY 
There was good inter-observer reliability for the assessment 
of the degree of cerebellar atrophy on the MRI scans. The high 
correlations between the rating scores of the 3 examiners are 
shown in table 9.2. These were consistent and none of the 
correlations between the 3 raters were significantly 
different. 
TABLE 9.2 CORRELATION TABLE FOR THE SCORING OF CEREBELLAR 
ATROPHY 
A B C 
A r: 1.0000 0.7739 0.8012 
p: 0.0000 0.0003 0.0002 
B r: 1.0000 0.8126 
p: 0.0000 0.0001 
C r: 1. 0000 
p: 0.0000 
[A = examiner A, B = examiner B, C = examiner C] 
Similarly, there was good inter-observer reliability in the 
scoring of the degree of atrophy for the brainstem, spinal 
cord and cerebral cortex (see Tables 9.3 to 9.5). The inter-
observer reliability in the scoring of cortical atrophy was 
not as good as that for the cerebellum, brainstem and spinal 
cord, but was nevertheless homogeneous in that the correlation 
coefficients did not differ significantly from one another 
(see Table 9.5) 
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TABLE 9.3 CORRELATION TABLE FOR THE SCORING OF BRAINSTEM 
ATROPHY 
A B C 
A r: 1.0000 0.8236 0.8825 
p: 0.0000 0.0001 0.0000 
B r: 1.0000 0.8128 
p: 0.0000 0.0001 
C r: 1.0000 
p: 0.0000 
[A= examiner A, B= examiner B, C= examiner CJ 
TABLE 9.4 CORRELATION TABLE FOR THE SCORING OF SPINAL CORD 
ATROPHY 
A B C 
A r: 1. 0000 0.6091 0.6704 
p: 0.0000 0.0052 0.0021 
B r: 1. 0000 0.7907 
p: 0.0000 0.0003 
C r: 1. 0000 
p: 0.0000 
[A= examiner A, B= examiner B, C= examiner C] 
TABLE 9.5 CORRELATION TABLE FOR THE SCORING OF CEREBRAL 
CORTEX ATROPHY 
A B C 
A r: 1.0000 0.5858 0.6802 
p: 0.0000 0.0060 0.0014 
B r: 1. 0000 0.5042 
p: 0.0000 0.0180 
C r: 1.0000 
p: 0.0000 
[A= examiner A, B= examiner B, C= examiner C] 
There was a good correlation between the global scores for 
each scan by the 3 examiners and the averaged global scores 
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(viz. summation of the global scores of each scan by the 3 
raters divided by 3). Table 9.8 shows the correlation between 
the global score of the 3 examiners as well as the averaged 
global score. This table verifies the application of an 
averaged global score as a reliable index of severity for the 
individual scans. 
TABLE 9.6 CORRELATION TABLE OF GLOBAL SCORES AND AVERAGED 
GLOBAL SCORES 
A B C AVGS 
A r: 1. 0000 0.7426 0.8339 0.9042 
p: 0.0000 0.0000 0.0021 0.0000 
B r: 1.0000 0.7302 0.8704 
p: 0.0000 0.0001 0.0000 
C r: 1. 0000 0.9058 
p: 0.0000 0.0000 
AVGS r: 1.0000 
p: 0.0000 
[A= examiner A, B= examiner B, C= examiner C, AVGS= averaged 
global score] 
9.3.1.2 MRI MORPHOLOGY: 
The MRI scans of the 23 individuals with autosomal dominant 
late onset cerebellar ataxia revealed variable degrees of 
atrophy of the cerebellum, brainstem, spinal cord and cerebral 
cortex. In the cerebellum the atrophic changes were diffuse 
and not confined to the upper vermis or anterior part of the 
cerebellum. No high intensity signals were observed on any of 
the scans. The variation in the degree of the atrophic 
changes in the cerebellum, brainstem, spinal cord and cerebral 
cortex observed in each of the 23 scans (average scores) is 
shown in table 9.7. The global average scores of the 23 scans 
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revealed that 2 were graded as normal, 11 were graded as mild, 
4 had moderate atrophic changes, 5 were moderately severe and 
1 had severe atrophic changes. Figure 9.1 is an example of a 
normal MRI scan and figures 9.2, 9.3, 9.4, and 9.5, 
illustrate examples of the mild, moderate and severe atrophic 
changes. All three examiners were in complete agreement with 
the grading of the severity of the morphologic changes 
observed in these three examples. 































































































































FIGURE 9.1 (a, b) NORMAL MRI SCAN 
a) Midline sagittal Tl weighted image 
b) Axial Tl weighted image through the posterior fossa. 
FIGURE 9.2 (a, b) MILD ATROPHY OF THE CEREBELLUM AND 
BRAINSTEM 
a) Midline sagittal Tl weighted image 
b) Axial Tl weighted image through the posterior fossa. 
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FIGURE 9.3 (a, b) MODERATE ATROPHY OF THE CEREBELLUM AND 
BRAINSTEM 
a) Midline sagittal Tl weighted image 
b) Axial Tl weighted image through the posterior fossa. 
1 4 1 
FIGURE 9.4 (a, b) SEVERE ATROPHY OF THE CEREBELLUM AND 
BRAINSTEM 
a) Midline sagittal Tl weighted image 
b) Axial Tl weighted image through the posterior fossa. 
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FIGURE 9.5 MILD (a), MODERATE (b), AND SEVERE (c) ATROPHY OF 
THE SPINAL CORD 




9.3.1.3 CLINICAL CORRELATIONS: 
The grade of ataxia severity of each affected person was 
correlated with the grade of the atrophic changes on the MRI 
scan (averaged global scores). This revealed a moderate 
correlation between the clinical and radiographic scores 
(p > .514 and r < 0.0121 Spearman rank correlation co-
efficient). Table 9.8 demonstrates the clinical and 
corresponding radiographic grades of severity. In 16 of the 
23 individuals the severity of the ataxia was graded in a 
higher category (ie more severe) than the severity of the 
atrophic changes on MRI scan. In 2 individuals the degree of 
atrophy on the scans was greater than the clinical score for 
ataxia and 5 persons had the same grade for ataxia and 
atrophy. Two individuals with normal scans had definite mild 
ataxia. This data indicates that in most individuals with 
this phenotype the clinical signs are more severe and tend to 
precede the morphologic changes seen on the MRI scan. 
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TABLE 9.8 COMPARISON OF CLINICAL AND RADIOGRAPHIC INDICES 
Severity of Ataxia Severity of Atrophy 
(ataxia score) on MRI (ave global 
score) 
scan 1 severe moderately-severe 
scan 2 moderate severe 
scan 3 severe moderately-severe 
scan 4 severe moderate 
scan 5 mild mild 
scan 6 mild mild 
scan 7 moderate moderately-severe 
scan 8 severe moderately-severe 
scan 9 severe moderately-severe 
scan 10 moderately-severe mild 
scan 11 severe moderate 
scan 12 severe mild 
scan 13 moderate mild 
scan 14 mild normal 
scan 15 severe moderate 
scan 16 mild mild 
scan 17 mild mild 
scan 18 moderate mild 
scan 19 moderate mild 
scan 20 moderate normal 
scan 21 moderate mild 
scan 22 moderate moderate 
scan 23 moderately-severe mild 
9.3.2 MRI SCAN OF 4 INDIVIDUALS WITH DISTINCT PHENOTYPES 
The eldest sibling in family O (see chapter 8.5) presented 
with hypogonadism, mild kyphoscoliosis and mild cerebellar 
signs. MRI scan revealed mild atrophy of the cerebellum, 
brainstem, and cerebral cortex while the spinal cord was 
considered to be normal. 
The illness of the proposita of family P was characterised by 
optic atrophy with blindness, sensorineural deafness, 
cerebellar ataxia, sensorimotor peripheral neuropathy and 
dementia. Her MRI scan revealed moderate generalized atrophy 
of the cerebral cortex, brainstem, spinal cord and cerebellum. 
The MRI scan of the index case in family M showed similar 
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generalized moderate atrophy involving cerebellum, brainstem, 
and spinal cord, with mild cortical atrophy. The phenotype 
was characterised by late onset visual failure due to macular 
degeneration, along with cerebellar ataxia. 
The youngest affected sibling in family Q was found to be 
mentally retarded at an early age and developed progressive 
ataxia followed by spastic paraplegia. Ultimately diffuse 
muscle wasting and fasciculations developed (see chapter 8.7). 
The MRI scan showed mild cerebellar, brainstem and spinal cord 
atrophy with severe cortical atrophy. 
9.4 DISCUSSION 
In the group of patients with autosomal dominant cerebellar 
ataxia MRI scan demonstrated the morphological changes which 
affect the cerebellum, brainstem, spinal cord and cerebral 
cortex to varying degrees. These findings were in accordance 
with the gross neuropathological changes described in this 
group of disorders (see chapter 1.6; Koeppen and Barron,1984). 
No focal high intensity lesions were observed in this 
subgroup. There was a moderate correlation between the 
severity of the atrophic changes and the clinical ataxia 
syndrome. In the majority of affected persons the clinical 
scores for ataxia were greater than the scores allocated to 
their corresponding MRI scans. This finding is not unexpected 
and a number of factors could account for these discrepancies. 
Although five categories of severity (ie. normal, mild, 
moderate, moderately severe, severe) were defined for the 
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scoring of both the morphology of the MRI scans and the 
clinical severity of ataxia, both were essentially qualitative 
measurements. The presence of pyramidal tract signs, sensory 
abnormalities and dementia would not be reflected in the 
clinical score, which only attempted to quantify the severity 
of cerebellar ataxia. Conversely, the morphologic changes 
observed on the scans reflect a wider disease process. 
Although there was good correlation between the scores 
allocated to the scans by the three different examiners, 
volumetric assessments are likely to provide a more accurate 
evaluation of the atrophic changes once this technology 
becomes more widely available. Early in the course of the 
disorder it is likely that the clinical signs reflect the 
underlying biochemical abnormalities and that this precedes 
any radiologically evident changes. 
In our hands MRI scans were not helpful in confirming the 
diagnosis in instances where the clinical signs were equivocal 
or mild. Two individuals with early signs of the disorder 
(mild ataxia) had MRI scans which were rated as normal. In 
Huntington disease, patients may also have normal CT scans in 
the early stages (Hayden et al., 1986). In my experience, when 
the scans demonstrated equivocal abnormalities, there was 
usually little doubt of the clinical diagnosis. The MRI scan 
was unhelpful as an early or presymptomatic indicator of the 
disorder, but proved to be particularly useful in the 
evaluation of persons with sporadic late onset cerebellar 
ataxia by excluding other potential causes for the clinical 
manifestations. 
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MRI scans of the 4 individuals with unique phenotypes 
demonstrated atrophic changes in the central nervous system. 
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A few reports have described peripheral neuropathy in 
individuals with dominantly inherited ataxia. Nerve 
conduction studies have been performed in a small number of 
individuals and the results have been inconsistent (McLeod and 
Evans, 1981). Some reports have described reduced or absent 
sensory action potentials in individuals with dominant ataxia 
and reduced tendon reflexes (Wadia, 1980). Although sensory 
neuropathy may be a feature of ADCA, sensory nerve conduction 
may be normal in the presence of clinical sensory loss 
(Harding, 1982). She suggests (1984) that the clinical, 
pathological and electrophysiological data favour a dying-back 
axonopathy, which selectively effects centrally directed nerve 
fibres in the posterior columns before the peripherally 
directed ones, to account for sensory abnormalities and the 
loss of tendon reflexes. Loss of anterior horn and dorsal 
root ganglia cells at autopsy has been reported in some 
individuals with OPCA and distal amyotrophy (Sigwald et 
al.,1964; Taniguchi and Konigsmark, 1971; Woods and 
Schaumberg, 1972; McLeod and Evans, 1981). Evidence favours 
the primary pathological lesion to be in the anterior horn 
cell rather than the peripheral nerves (Woods and Schaumberg, 
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1972) although extensive pathological studies of motor nerves 
have not been done. 
10.2 METHODS 
For logistic reasons it was not feasible to undertake 
electrophysiological studies on all the affected persons in 
the studies. A group of individuals representing the spectrum 
of familial ataxia in the Western Cape were selected for 
electrophysiologic studies. 
10.2.1 SAMPLE 
A total of 22 affected individuals were studied. Seventeen of 
these persons from 7 different families had the same phenotype 
(ie adult onset dominant ataxia with retained reflexes; 
chapter 7). The remaining 5 persons were from 3 families with 
differing phenotypes (family P: 1 person; family M: 1 person; 
family Q: 3 persons). In the group of individuals with the 
same phenotype there were 9 males and 8 females with a mean 
age of 38.5 years (range= 18 - 57 years). The severity of 
the ataxia within this group is illustrated in table 10.1. 
TABLE 10.1 SEVERITY OF ATAXIA IN THE SAMPLE 














All the nerve conduction studies were performed according to 
Groote Schuur Hospital neurophysiology laboratory protocol on 
the Medelec Mystro MS25 machine (figure 10.1). The common 
peroneal motor and posterior tibial motor responses and the 
sural sensory (or medial plantar sensory) response were done 
on all persons in the sample. Electrophysiologic nerve 
conduction responses were measured with supra-threshold 
stimuli. Maximum motor amplitudes were measured from baseline 
to the negative peak of the compound motor action potential 
and sensory amplitudes were measured from peak to peak after 8 
responses were averaged. The sensory latency was measured 
from stimulus onset to the negative peak of the sensory action 
potential. Electromyography (EMG) with a standard concentric 
needle electrode was undertaken in those persons with distal 
amyotrophy. Skin surface temperature was measured 5 cm above 
the lateral malleolus and the limb was heated (in a warm water 
bath at 40 C for 10 minutes if the surface temperature was 
below 28.5 C). Protocols for nerve conduction studies have 
been standardized in the Groote Schuur Hospital laboratory and 
the normal values for the relevant nerves are listed in table 
10.2. Consent was obtained from all participating persons by 
the author. 
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TABLE 10.2 NERVE CONDUCTION STUDIES : NORMAL VALUES (GSH 
LABORATORY) 
Nerve Distal Amplitude Conduction 
latency velocity 
motor: 
Peroneal 3.1 - 5.9 msec > 2.0 mV > 41 m/sec 
Tibial 3.0 - 6.0 msec > 4.0 mv > 41 m/sec 
sensory: 
Sural 3.2 - 4.4 msec > 6.0 µV 
[msec = milliseconds; mV = millivolts; µV = microvolts; 
m/sec = metres per second] 
FIGURE 10.1 NERVE CONDUCTION STUDIES (GSH, EMG LABORATORY) 




10.3.1 NERVE CONDUCTION STUDIES IN PERSONS WITH THE SAME 
PHENOTYPE 
Of the 17 persons with the same phenotype only 4 persons had 
abnormal results on electrophysiologic testing. The nerve 
conduction velocities in both the posterior tibial motor 
nerves and common peroneal motor nerves were reduced to values 
ranging from 33.6 to 37.3 m/s. The distal latencies were 
normal in all 4 persons and the amplitude of the compound 
muscle action potential was reduced in only 1 of the 4 
persons. The sural sensory response was absent in 1 person 
and normal in the remaining 3. Needle electromyography was 
done on 2 of the 4 persons and this confirmed the presence of 
mild denervation with reinervation in the distal leg muscles. 
All four individuals with abnormal nerve conduction studies 
had a moderately severe or severe ataxia score. The results 
are illustrated in table 10.3. Only the results of the 4 
individuals with abnormal tests are reflected. 











































[CV= conduction velocity; CMAP= compound motor action 
potential; No= number; yrs= years; ampl = amplitude; resp 
= response; m/sec = metres per second; MS= moderately 
severe; S = severe; N = normal; A= absent; R = reduced] 
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10.3.2 NERVE CONDUCTION STUDIES IN PERSONS WITH DISTINCT 
PHENOTYPES 
The proposita from family P who developed optic atrophy, 
deafness and cerebellar ataxia (chapter 8.6.1) had an EMG 
which confirmed the presence of a distal axonal sensorimotor 
polyneuropathy. The CMAP's of the peroneal and tibial motor 
nerves were reduced (1.0 mv and 0.2 mv respectively) and the 
conduction velocities were also mildly reduced (40.9 ms and 
39.2 ms respectively). The sural sensory response was also 
reduced (amplitude 3.0 microvolts). The distal latencies in 
the peroneal, tibial, and sural nerves were all normal. 
Consent for needle EMG examination was refused. 
Electrophysiologic studies in the proposita of family M, aged 
48 years, with macular degeneration and cerebellar ataxia 
(chapter 8.3.1) did not reveal any evidence of a 
polyneuropathy. The common peroneal motor, sural sensory, 
median ulnar and sensory responses were all normal. 
The 3 affected persons from family Q, age 37, 42, and 50 (with 
cerebellar ataxia, motor neurone syndrome, mental retardation 
and macular degeneration; see chapter 8.7.1), had extensive 
EMG studies in both upper and lower limbs. In the lower limbs 
the motor responses were absent or markedly reduced in 
amplitude and the sural sensory response was either absent (2 
persons) or reduced in amplitude (1 person). The motor 
responses in the upper limbs revealed reduced CMAP amplitudes 
with mildly reduced or normal conduction velocities in all 3 
persons. The median and ulnar digital sensory responses were 
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reduced in 2 of the 3 persons. Needle EMG of several proximal 
and distal muscles (eg tibialis anterior, gastrocnemius, 
abductor hallucis, quadriceps femoris, gluteus medius, 
deltoids, abductor digiti minimi, first dorsal interosseous 
muscles) revealed electrophysiologic evidence of extensive 
denervation with reinervation (ie increased insertional 
activity with frequent complex repetitive discharges, 1 to 3+ 
fibrillation potentials, large polyphasic motor unit 
potentials and reduced recruitment of motor units). 
10.4 DISCUSSION 
Four individuals with autosomal dominant ataxia had evidence 
of a mild motor polyneuropathy with reduced motor conduction 
velocities in at least 2 peripheral nerves. Although all had 
moderately severe or severe ataxia scores, motor signs were 
not clinically prominent. All 4 persons were subsequently 
shown to have the same genotype. This is clearly a late 
finding in this phenotype and is not valuable clinically in 
differentiating between those individuals with the same 
phenotype but a different genotype (2 other individuals, with 
a moderately-severe and a severe ataxia score respectively, 
had normal nerve conduction studies and were subsequently 
shown to have the same genotype as the 4 persons with 
neuropathy). These findings indicate that a motor or sensori-
motor neuropathy is a variable and often late manifestation of 
this phenotype. Nousiainen et al. (1988) found 
electrophysiological evidence of lower motor neurone 
involvement, which did not seem to correlate with the duration 
156 
or severity of the disease, in a small sample of 10 patients 
with late onset ataxia. The mean duration of disease in this 
small sample was, however, 10.7 years ( 9 of the 10 patients 
had a duration of disease of 7 years or more). 
With regard to those individuals with different phenotypes, 
the electrophysiologic studies confirmed the presence of a 
sensorimotor axonal polyneuropathy in the proposita of family 
P which was evident clinically. Similarly, the affected 
persons in family Q, all of whom had extensive muscle wasting 
and fasciculations, were shown to have evidence of widespread 
chronic active denervation with reinervation in keeping with 
anterior horn cell disease. Sensory neurones were also 
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LINKAGE ANALYSIS IN AFFECTED FAMILIES 
11.1 INTRODUCTION 
In a few previously published families with autosomal dominant 
cerebellar ataxia the gene has been assigned to chromosome 6p 
(SCAl locus) on the basis of the demonstration of linkage of 
the disorder to the HLA gene cluster (Yakura et al., 1974; 
Jackson et al., 1977; Lamm et al., 1985; Rich et al., 1987; 
Zoghbi et al., 1988,1989; Frontali et al., 1991; Wilkie et 
al., 1991). 
The South African families in the present study were evaluated 
at different stages of the clinical survey and the 
chronological sequence of the linkage investigations, 
initiated at different times during the course of the study, 
followed developments in the field. Initial linkage studies 
were an attempt at broad localization of the disorder using 
several conventional polymorphisms. With the recognition of 
linkage to the HLA cluster in family A, this locus alone was 
tested in subsequent families. Once microsatellite DNA markers 
were available in this region, they were used in preference to 
earlier markers. 
Linkage studies in the largest family (family A) involved the 
HLA locus (Bryer et al., 1992), serum proteins, red blood cell 
antigens and enzymes (see 11.2.1), Five other families 
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(families: B, C, D, E, F), subsequently identified as having 
the same phenotype as family A were studied for linkage to 
HLA. The description of closely linked highly polymorphic PCR-
based markers led to the analysis of the 5 largest families 
(families: A, B, C, D, E) using microsatellite markers on 
chromosome 6 (see 11.2.2). 
More recently, the discovery of an expanded trinucleotide 
repeat at the SCAl locus (Orr et al., 1993) facilitated the 
investigation of 11 South African kindreds for this mutation 
(see 11.2.3). 
The methodology and results of the linkage analyses 
undertaken in the South African ataxia families are discussed 
in detail. 
11.2 METHODS 
11.2.1 LINKAGE ANALYSIS WITH HLA, RED BLOOD-CELL AND SERUM 
PROTEIN MARKERS 
A large five generation kindred of mixed ancestry with an 
autosomal dominant form of the disorder (family A) was 
analysed for linkage to 13 genetic markers (Bryer et al., 
1992). Forty four persons of the affected family, spanning 
three generations, were examined for evidence of the disease 
and were regarded as being affected if there were clinical 
signs of gait or limb ataxia. The pedigree of this family is 
shown in the Appendix. The disorder was inherited as an 
autosomal dominant trait, no generations were skipped and an 
equal number of males and females were affected. The age at 
onset varied from 16-48 years with a mean of 33 years. The 
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phenotype has been discussed in detail in chapter 8. In view 
of the late onset, individuals under the age of 16 were 
excluded from the linkage analysis. 
The family was investigated for genetic polymorphisms; the 
red cell antigens: ABO, Rhesus (RH), Kell (KEL), MNS and Duffy 
(FY) were detected using standard serological methods 
(Dunsford et al., 1967). The red cell enzymes: acid 
phosphatase (ACPl), adenosine deaminase (ADA), adenylate 
kinase (AK), esterase-D (ESD), 6-phosphogluconate 
dehydrogenase (PGD), phosphoglucomutase-1 and -2 (PGMl and 
PGM2), carbonic anhydrase II (CA2), glyoxalase 1 (GLOl) and 
the serum proteins haptoglobin (HP), transferrin (TF) and 
properdin factor B (BF) were determined using standard 
electrophorectic techniques (Alpers et al., 1972, Harris et 
al., 1976). HLA-A, Band C typing was done using the standard 
microlymphocytotoxicity technique (Terasaki et al., 1974). 
Five other families (families: B, C, D, E, F) with the same 
phenotype were found to be suitable for a similar analysis, 
using HLA markers only. HLA haplotypes were assigned to 
various members of these families using the same standard 
microlymphocytotoxicity techniques as above (family A). 
Ancestral individuals who were required for the linkage 
analysis but who were not available for examination were 
classified as "affected" or "not affected" on medical records 
or histories obtained from surviving relatives. 
A total of 195 individuals were at risk of developing the 
disorder in these 6 families. A person was considered to be 
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at risk if one parent was affected and the individual was less 
than 40 years of age. 
The method of analysis for HLA haplotypes recommended by Ott 
(1978) was utilised. The program LIPED was used to compute lod 
scores with a modification for age-dependent penetrance (Ott, 
1974). 
11.2.2 MICROSATELLITE DNA MARKERS 
Prior to the availability of the microsatellite DNA markers, 
several RFLP markers were used on the two large South African 
families with late onset autosomal dominant ataxia (family A 
and family B). These markers were uninformative, however, and 
were superceded by the more highly polymorphic PCR-based 
microsatellite markers. In order to determine the localization 
of the SCAl gene on chromosome 6p more precisely, two highly 
polymorphic microsatellite DNA markers were investigated for 
linkage with the disease locus. 
Five of the largest South African families (families:A, B, C, 
D, E) were investigated for linkage with the highly 
informative dinucleotide repeat markers at the D6S89 (Litt, 
1990), and D6S260 (Weissenbach et al., 1992) loci distal to 
the HLA region on the short arm of chromosome 6. These PCR-
based polymorphisms were shown to be more closely linked to 
the SCAl locus than HLA and are considered to be more 
definitive markers for the localization of the disorder. All 
five families had a similar phenotype as described previously 
in chapter 8. Allele frequencies for each marker were 
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established by screening a background mixed ancestry 
population of 50 unrelated individuals. 
One hundred and seventeen members spanning three generations 
were examined for signs of gait and limb ataxia and the 
pedigree of each family is shown in the appendix. In these 
kindreds the disease was inherited as a classical autosomal 
dominant trait, with no generations being skipped and equal 
numbers of males and females being affected. All 5 families 
were from the Western Cape geographical region of South Africa 
and it is possible that they shared a common ancestry. 
Genomic DNA was isolated from heparinized blood samples taken 
from affected and unaffected family members. Analysis of 
dinucleotide repeat length-polymorphisms at the D6S89 and 
D6S260 loci was performed on 46 individuals from family A, 18 
individuals from family B, 8 individuals from family C, 7 
individuals from family D and 9 individuals from family E. 
PCR was carried out in a volume of lOul with 200ng of genomic 
DNA, lOpmol of each primer, 1.SmM MgCl2, 250uM dNTPs, 50mM 
KCl, lOmM Tris-HCl pH 8.3 and 1.0 unit Thermus aguaticus (Taq) 
DNA polymerase (BRL). Alpha-dCT3 2p was added to each reaction 
at luCi. The samples were overlaid with liquid paraffin and 
an initial denaturation at 940c for 3 minutes was performed. 
PCR was carried out with each of the microsatellite markers 
subjected to 30 cycles using conditions indicated in table 
11.1 and a final step of 7 minutes at 72°C to stop the 
reaction. 
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After completion of the PCR reaction, 2,Sul of each reaction 
was mixed with 2,Sul of formamide loading buffer, denatured 
for 5 min at 950c and fractionated by electrophoresis on a 6% 
acrylamide 7.65M urea sequencing gel for 3.0h at 60 watts. 
Gels were dried and exposed to Agfa Curix film for 20 hours at 
0 
-70 c. 
The computer program LINKAGE, Version 5.03 [13], was used to 
calculate lod scores between the spinocerebellar ataxia locus 
and the marker loci D6S89, and D6S260. For the purpose of 
linkage analysis, all unaffected persons under the age of 40 
years were classified as phenotype unknown. Allele frequencies 
for the microsatellite markers in the linkage analyses were 
calculated by using 42 independent chromosomes from unrelated 
individuals from the mixed ancestry population group. Linkage 
analysis with each of the microsatellite markers was 
simplified in the families by redefining the observed multiple 
alleles to a five allele system as described by Ranum et al. 
(1991). 
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11.2.3 TRINUCLEOTIDE (CAG) EXPANSION AT SCAl 
Blood was obtained from both affected and unaffected 
individuals from 11 South African families and screened by PCR 
analysis for the presence of the expanded CAG repeat at the 
SCAl locus. In 8 of these families (families: A, B, C, D, E, 
F, G, J) the phenotype was similar (autosomal dominant 
cerebellar ataxia type 1, Harding); the clinical details have 
been discussed in detail in chapter 8. The remaining 3 
families (families: K, N, R) had clinically distinct 
phenotypes which were discussed in chapter 9 (9.1, 9.4, 9.8) 
Genomic DNA was isolated directly from venous blood (Bell, 
Karam and Rutter, 1981). PCR reactions were performed using 
the Rep! (S'AACTGGAAATGTGGACGTA 3') and Rep2 
(S'CAACATGGGCAGTCTGAG 3') primers (Orr et al., 1993). 250ng of 
genomic DNA was mixed with 25 pmol of each primer in a total 
volume of 25ul containing 1.25 mM MgCl2, 250uM dNTPs, 50mM 
KCl, 1.25% formamide, lOmM Tris-HCl pH 8.3 and 1.0 unit Taq 
polymerase. Alpha dCT3 2p was added to the reaction at 2uCi. 
Reaction samples were initially denatured at 94°C for 3 min, 
followed by 30 cycles of denaturation (94°C, 30 sec), 
annealing (55°C, 1 min), extension (72°C, 1 min), and ending 
with one last cycle of 7 minutes at 72°C. 3 ul of each PCR 
reaction was mixed with 2 ul formamide loading buffer, 
denatured at 95°C for 5 min, and electrophoresed through a 6% 
polyacrylamide/7.65 M urea DNA sequencing gel. Allele sizes 
were determined by comparing migration relative to a Ml3 
sequencing ladder. 
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11.2.3.1 STATISTICAL ANALYSIS 
To determine the statistical relation between the size of the 
expanded CAG repeat and the age of onset and duration of the 
disease, a regression analysis was performed. Linear, 
logarithmic, and square root transformed data were used for 
this analysis. Square root and logarithmic transformation of 
the data for age of onset did not improve the correlation 
coefficient. 
Duration of disease is an index of disease severity; severe 
disease is characterized by a more rapid clinical course with 
a shorter interval from onset to a state of dependency or 
death. As the number of individuals who had died in these 
families was too small for a meaningful analysis, the time 
taken to reach a state of dependency {or to acquire a 
moderately-severe or a severe clinical ataxia score) was used 
as the index of duration. The relationship between duration of 
disease and the CAG repeat length was subjected to linear 
regression analysis. 
11.3 RESULTS 
11.3.1 LINKAGE ANALYSIS WITH HLA, RED BLOOD CELL 
AND SERUM PROTEIN MARKERS 
11.3.1.1 HAPLOTYPES AND RESULTS OF LINKAGE ANALYSIS 
IN FAMILY A 
The pedigree of family A is shown in the Appendix. The 
descendants of individuals II-2 and II-3 were available for 
testing and the HLA types are shown in Table 11.2. 
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TABLE 11. 2. HLA TYPES OF THOSE FAMILY MEMBERS THAT WERE 
TESTED 
HLA Haplotypes 
Pedigree number A B C A B C 
III-3 30; 14; 28; w53; w4 
III-5 30; 14; 28; w53; w4 
III-7 30; 14; 28; w53; w4 
III-9 2; w58; w6 2. ' 
37; w6 
III-14 30; 14; 28; w53; w4 
III-15 2· ' 44; 3; 
47; 
III-16b 2· ' 
w58; w7 28; w70; w7 
III-17 30; 14; w8 2; 35; w4 
III-18b 2. w58; w7 28; w70; w7 
' III-19 w33; 7 . 
' 
w6 23; 44; w4 
III-20b 2. 
' w58; 
w7 28; w53; w4 
III-21 3; W70; w2 24; w61; 
III-25 24; 35; w4 l; 8; w7 
III-30b 2; 44; w5 w33; w42; 
III-31 2; 8; w7 11; 35; 
III-32 26; w58; w33; w42; 












w7 30; 13; w6 












IV-25 30; w58; w7 28; w70; w7 
IV-27 2; 44; 30; 14; 
IV-28 2; 44; 30; 14; 
IV-29 2· 
' 
w58; w7 30; 14; w8 
IV-30 2. ' 35; 
w4 28; w70; w7 
IV-31 2· ' w58; 
w7 w33; 7. ' 
w6 
IV-32 w33; 7. 
' 
w6 28; w70; w7 
IV-33 2; w58; w7 23; 44; w4 
Iv-34bc 3; w70; w2 28; w53; w4 
IV-35 2· ' w58; 
w7 24; w61; 
IV-36 2; w58; w7 24; w61; 
IV-38 11; 27; w3 w33; w42; 
IV-41 24; w57; w6 25; w62; w3 
IV-43 24; 35; w4 2. 14; w8 
' IV-45b 2. 44; w5 24; 35; w4 ' IV-48 w33; w42; 11; 35; w4 





w7 w33; w42; 7 
V-15 2. 
' 44; 
wS 24; w57; w6 
V-16 2· 
' 44; 
wS 24; w57; w6 
(a= non-paternity; b• affected individuals; c= recombinant) 
The lod scores computed at various recombination fractions 
between the disease and HLA locus are shown in Table 11.3. 
For purposes of the calculation, HLA haplotypes in generations 
I and II could not be postulated, since for the scheme 
suggested by Ott (1978) to be correct, the genotypes at the 
HLA locus must be known for all originals. The pedigree was 
therefore analysed in two parts, with the lod scores 
calculated separately and then summed, for the descendants of 
individuals II-2 and II-3 respectively. 
TABLE 11.3. LOO SCORES OBTAINED WITH THE MARKERS SITUATED ON 
THE SHORT ARM OF CHROMOSOME 6. 
Marker Recombination Fraction (9) 
locus 0.0 0.001 0.05 0.1 0.2 0.3 0.4 
HLA -~ 2.89 4.13 3.93 3.12 2.00 0.74 
BF -~ -1.97 -0.26 0.04 0.24 0.20 0.08 
GLOl 1.62 1.62 1.51 1.36 1.00 0.58 0.19 
The total lod score reached a maximum of 4.13 at a 
recombination fraction of 0.05, indicating the odds to be more 
than 10,000 to 1 in favour of linkage between HLA and the 
locus for SCA in this family. 
Although individuals in generations I and II could not be 
typed, it is possible to postulate their HLA genotypes (Figure 
11.1). The disease locus is seen to segregate with two 
different HLA haplotypes in the descendants of individuals II-
2 and II-3. There are two possible explanations for this 
observation. Firstly, recombination between the HLA-A and c 
loci could have occurred in individual I-2 (assuming 
heterozygosity at the HLA-A locus). If this is the case, then 
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the disease allele must have segregated with the HLA-A locus 
in individual I-2, thus placing the SCAl locus telomeric to 
the HLA region. Alternatively, this observation may be the 
consequence of recombination between the disease locus and the 
HLA region in individual I-2, who must then have been 
homozygous for HLA-A2. The chances of the former event having 
occurred are approximately twice as great as the latter, based 
on the HLA allele frequencies in this population. 
FIGURE 11.1 POSTULATED HLA HAPLOTYPES IN FAMILY A 
A30; Cw6; B 14; B~F; GL0•1 
A26; Cw?; Bw58; B~S;GL0•1 
II A28;Cw7; Bw70;BF•S;GL0•2 A2;Cw7;Bw58;BF•F;GL0•2 
A28; Cw4;Bw53; BF•F 1 ;GL~ A30;Cw6;B 14;BF•F;GLo•1 
A2; Cw5; B44; BF•s; GL0•2 
A2; Cw?; Bw58; B~F; GL0•2 
A2;Cw5;B44;BF•s;GLo•2 Aw33;Cw6;Bw42;BF"F;GL0•1 
A26;Cw7;Bw58;BF"S;GL0•1 A2;Cw8;B 14;BF"S;GL0*1 
Postulated HLA h 1 t . 
individuals 1 to 4 of ap_o ypes in generation I and 
approximately 2·1 . fgeneration II. The chances are 
having occurred.be~:ee~v~ur_of the recombination in I-2 
the SCAl allele and the H~: A a~d HLA-B rather than between 
the disease allele would h region. In the former instance, 
locus, placing it t 1· _ave segregated with the HLA-A 
e omeric of the HLA region. 
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The evidence for linkage between the SCA! and GLOl locus did 
not reach the level normally regarded as statistically 
significant, with the lod score only reaching 1.62 at a 
recombination fraction of zero (Table 11.3), in spite of 
presumed double heterozygosity in individuals II-2 and II-3. 
This is further evidence favouring the telomeric location of 
the disease locus relative to the HLA region. There is no 
evidence of linkage between the disease and the BF locus 
(table 11.3), which is situated in the class III HLA region, 
but this is because linkage results were not sufficiently 
informative owing to homozygosity at the marker loci of key 
family members. 
The lod scores generated by the analysis at all other loci are 
not shown but could be interpreted as follows: linkage with 
ABO, MNS, RH, FY, ACPl, PGMl, and TF could definitely be 
excluded while the results with C3, DBP, and HP were in the 
indeterminate range. The same results were also uninformative 
due to to homozygosity at the following loci: KEL, ADA, AK, 
ESD, PGD, PGM2 and CA2. 
The results of the linkage analysis using the non-HLA markers 
in this large family are summarized in table 11.4 
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red cell antigens: 



















carbonic anhydrase II 
11.3.1.2 RESULTS OF LINKAGE ANALYSIS WITH HLA IN 
FAMILIES B, C, D, E, AND F 
The results of the linkage analysis for the HLA markers in the 
six families are shown in table 11.5. 
In the second large family (family B) there was no evidence 
for linkage to HLA as lod scores below -2.0 are indicative of 
non-linkage. Similarly in the third family (family C) linkage 
to HLA was excluded (Lod = -4.50 at 9=0.001). In the last 
three smaller families (families: D, E, F) there was evidence 
of probable linkage with lod scores rising at lower 
recombination fractions (table 11.5.) However, the LOO scores 
were not sufficiently high to independently confirm linkage in 
each individual family, because of their size. Despite the 
fact that these families shared the same phenotype, the 
validity of summating their lod scores is questionable in 
light of reports of genetic heterogeneity within the autosomal 
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dominant spinocerebellar ataxias (van Rossum et al., 1981; 
Aubuger et al., 1990; Khati et al., 1993) 
TABLE 11.5 LOD SCORES FOR HLA MARKERS 
Recombination Fraction 0.0 0.001 0.06 0.1 0.2 0.3 
Family no. A -00 2.89 4.13 3.93 3.12 2.0 
Family no. B -3.76 -3.33 -0.64 -0.002 0.47 0.6 
Family no. C -oo -4.60 -1.18 -0.67 -0.26 -0.09 
Family no. D -0.02 -0.02 0.04 0.08 0.09 0.06 
Family no. E 0.18 0.19 0.24 0.26 0.22 0.16 
Family no. F 0.60 0.60 0.64 0.47 0.32 0.17 









11.3.2 LINKAGE ANALYSIS WITH MICROSATELLITE 
MARKERS 
The number and size of the alleles observed at the 2 loci in 
the South African background population and in the 5 families 
with ataxia are shown in Table 11.6. 
TABLE 11.6 MARKER ALLELES: NUMBER AND SIZE OF ALLELES IN THE 
SOU'.;.n AFRICAN BACKGROUND MIXED ANCESTRY POPULATION 











TABLE 11.7 ALLELE FREQUENCIES FOR D6S89 AND D6S260 IN 
THE SOUTH AFRICAN MIXED ANCESTRY POPULATION 
D6S89 D6S260 
Allele no. Frequency Allele no. Frequency 
(percent) (percent) 
1 5.0 1 17.5 
2 15.0 2 5.0 
3 17.5 3 2.5 
4 2.5 4 10.0 
5 10.0 5 10.0 
6 17.5 6 2.5 
7 7.5 7 12.5 
8 7.5 8 5.0 
9 10.0 9 20.0 
10 5.0 10 2.5 
11 2.5 11 5.0 
12 7.5 
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The specific alleles which segregated with the SCA phenotype 
in each family at each locus (viz. D6S89, D6S260) are shown in 
Table 11.8 
TABLE 11.8 ALLELES SEGREGATING WITH THE SCA PHENOTYPE 

















It is clear from Table 11.8 that the genotypes 5,7 for the 
markers D6S89, and D6S260, respectively, segregated with the 
disease in families A, D, E and the genotypes 9, 5 for the 
same markers segregated with the disorder in families Band C. 
The maximum lod scores {at a recombination fraction of 0.00) 
between the disease phenotype in these 5 families and the 
microsatelite marker are shown in Table 11.9. 
TABLE 11.9 RESULTS OF LINKAGE ANALYSIS BETWEEN SCA AND 




















The maximum lod scores at a recombination fraction of 0.00 
between the disease locus and the 2 microsatellite markers 
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show that the disease locus in families A and Bis on the 
short arm of chromosome 6. Maximum lod scores ate= 0.00 for 
the 3 smaller families were suggestive of linkage of the 
disorder to the SCAl locus on 6p. Because of a clear lack of 
recombinants between the disorder and each of the markers in 
the families, the genotype combinations (5,7 and 9,5) may be 
used as haplotypes 
11.3.3 TRINUCLEOTIDE EXPANSION AT SCAl 
All affected individuals from the 2 large families (A and B) 
shown to have SCAl (linked to microsatellite markers; see 
11.3.2) had an expanded trinucleotide repeat on one of their 
alleles. Of the 6 families with the same phenotype as families 
A and B (but linkage to the SCAl locus was not proven), 3 were 
shown to have the expanded CAG repeat (families: C, D, E,). 
The other 3 families (families F, G, J) did not have the 
expanded repeat in the affected size range on either of the 
alleles of the affected persons. 
In the 3 families (families: K, N, R) with clinically distinct 
phenotypes, the expanded repeat was not identified in any of 
the affected persons. An example of an autoradiograph 
indicating the size and distribution of the expanded repeats 
on the alleles of affected individuals with the disease from a 
subset of the families shown to have SCAl is shown in Figure 
11.1. 
The normal alleles range in size from 19 to 36 CAG repeat 
units. Over 95% of the normal alleles contain from 25 to 33 
CAG repeat units, the majority (65%) of which contain 28-30 
repeats. The mean repeat lengths for the South African 
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populations were 29,4 CAG repeat units. The mean size of a 
repeat on normal chromosomes does not vary significantly among 
different ethnic populations studied (Ranum et al., 1994). The 
number of CAG repeats found at SCA! in affected individuals 
was always greater than the number of repeats on normal 































































































In the South African ataxia families the age of onset is 
inversely correlated with the CAG repeat size (see Figure 
11.3). A linear correlation coefficient r=-0.7069 (p< 0.01) 
was obtained indicating that nearly 50% (r2=0.4997) of the 
variation in the age of onset can be accounted for by the size 
of the (CAG)n repeat length. A square root and a logarithm 
transformation of the age of onset did not improve the 
correlation coefficient (age of onset square root r= 0.7099 
p<0.01 r 2= 0.5039 ; age of onset logarithm r= 0.7108 p<0.01 
r 2= 0.5052). 
The correlation was obtained between severity of the disease, 
as measured by duration of illness (age-at-dependency minus 
age-of-onset), and the number of repeats (see figure 11.4). 
A correlation of r= -0.3913 (p>0.05) was obtained where n=ll, 
suggesting that approximately 15% (r2=0.1531) of the variation 
in the duration of the disease is due to the number of CAG 
repeats. The size of this latter sample is too small to make 
meaningful conclusions from these figures (ie. concerning the 




















































































































































































































































































































































































































































































































11.4.1 HLA ANALYSIS: 
This analysis revealed linkage to HLA in one family (family A) 
only. There was evidence of possible linkage in another 3 
families (families: D, E, F) and there was no linkage between 
HLA and the putative disease gene in one large (family B), and 
one small family (family C). These observations indicated 
that the putative gene was located on the short arm of 
chromosome 6 in one family but the locus of the disease gene 
in the others remained uncertain. The findings presented here 
provide support for the concept of genetic heterogeneity in 
the members of these phenotypically similar South African 
families with SCA. 
The predictive value of HLA typing in Family A was estimated 
to be 95% on the basis that of 22 individuals in whom disease 
status could be definitely assigned as either affected or not 
affected, there was only 1 recombinant between HLA and SCAl. 
Keats et al. (1991) detected no linkage to HLA in a family 
which clearly segregated with SCAl, indicating the possibility 
of a high frequency of recombination between SCAl and HLA in 
some families. It is noteworthy that the microsatellite 
marker, D6S89, was subsequently shown to be very closely 
linked to SCAl in some North American families (Zoghbi et al., 
1991, Ranum et al., 1991, see 11.4.2). In the light of these 
findings, HLA linkage alone was not considered to be 
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sufficiently accurate for use as a test for presymptomatic or 
prenatal diagnosis in this large South African family. 
The exact position of the SCAl locus in relation to the HLA 
region was not unequivocally determined in this study. Two 
studies have provided evidence that the disease locus was 
situated distal to the HLA region on chromosome 6p (Zoghbi et 
al., 1991; Ranum et al., 1991). A possible interpretation of 
the results of the South African study is that the SCAl locus 
in family A might be located telomeric to the HLA class I 
region (see 11.3.1.1). Further studies in this kindred using 
the microsatellite markers (including D6S89) were undertaken 
in an attempt to provide additional support for the assignment 
of the locus for SCAl distal to HLA. 
11.4.2 LINKAGE ANALYSIS WITH MICROSATELLITE 
MARKERS 
The preliminary studies showed linkage between HLA markers and 
the disease phenotype in family A (maximum lod score 4.13 at 
9= 0.05). In family B, however, the exclusion of the disease 
locus from at least 11 cM on either side of HLA (maximum lod 
score 0.5 at 9 = 0.30) indicated locus heterogeneity between 
the two kindreds. Tight linkage, however, between the disease 
locus and two dinucleotide repeat markers was shown in both 
families, confirming that these families indeed segregate for 
SCAl. 
The apparent discrepant finding of non-linkage between the 
disease phenotype to HLA in a spinocerebellar ataxia kindred 
(as in family B), but linkage to D6S89 has previously been 
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reported by Keats et al. (1991). These results confirm that 
the exclusion of linkage to HLA does not rule out the 
possibility that the disease locus is SCAl. 
Linkage between the spinocerebellar ataxia phenotype and the 
D6S89 locus has been shown in families from North America and 
Italy (Ranum et al., 1991; Keats et al., 1991; Zoghbi et al., 
1991; Zoghbi et al., 1991; Pandolfo et al., 1991; Perischetti 
et al., 1991; Terrenato et al., 1991). In an Italian study, a 
common D6S89 allele showed strong linkage disequilibrium with 
SCA! in five families in Southern Italy (Terrenato et al., 
1991). This finding suggests genetic homogeneity of the SCAl 
gene and showed that linkage between SCAl and D6S89 is tight 
enough to maintain marker alleles in cis to the mutation 
through at least 12 generations. A multipoint linkage analysis 
and haplotypes from recombinants mapped SCA! between two 
markers, D6S274 and D6S259, 5-6 cM apart in these Italian 
families (Jodice et al., 1993). Linkage results and the 
analysis of recombination events, using 9 large American and 
Italian families confirmed that SCAl maps centromeric to D6S89 
(Kwaitkowski et al., 1993). 
The five South African kindreds reported in the present study 
are of mixed ancestry and reside within a 200 km radius of 
Cape Town. Because the natural history and ages of onset did 
not differ significantly, it was initially suspected that the 
disorder in these kindreds could have been derived from a 
common affected ancestor. The D6S89 and D6S260 haplotype 
results indicate that 2 distinct disease associated haplotypes 
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occur in the 5 families of mixed ancestry, suggesting 
independant origins of the disorder in the two subgroups. The 
linkage of SCAl to D6S89, and D6S260 markers in the South 
African families is particularly important in defining a 
common progenitor in these families, and for confirmation of 
diagnosis where repeats may be indistinct. 
Despite the resolution of earlier apparent genetic 
heterogeneity with regard to spinocerebellar ataxia and HLA, 
Auberger et al. (1990) have shown that the disorder in a large 
Cuban kindred does not map to 6p. Heterogeneity of 
spinocerebellar ataxia is confirmed by several other reports 
which show no linkage between D6S89 and the disorder (Pandolfo 
et al., 1991; Ranum et al., 1992; Lazzarini et al., 1992). 
Following extensive mapping studies, Gispert et al. (1993) 
reported chromosomal assignment of a second disease locus 
(SCA2) for dominantly inherited spinocerebellar ataxia to 
chromosome 12q23-24.1 in the Cuban families previously 
excluded from 6p. These authors provided preliminary data 
supporting the existence of a third locus (SCA3) on the basis 
of negative linkage to the interval containing SCA2 for seven 
French families previously excluded from linkage to SCA!. 
Sixteen families with Machado-Joseph disease were also 
excluded from linkage to the locus on chromosome 12q (Silveira 
et al., 1993) 
The precedent for genetic heterogeneity in the autosomal 
dominant spinocerebellar ataxias, despite their phenotypic 
similarity, was previously established by exclusion of the 
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Cuban, French, and Danish families from the SCAl locus on 
chromosome 6p (Auburger et al., 1990; Khati et al., 1993; 
Lunkes et al., 1993). 
Locus heterogeneity was presumed in the other types of 
autosomal dominant spinocerebellar ataxia which were thought 
to have clinically distinct features. In a family with 
autosomal dominant pure cerebellar ataxia, Frontali et al. 
(1992) showed exclusion of linkage between the D6S89 marker 
and the disease locus. Families with Machado-Joseph disease 
have also been excluded from linkage to the SCAl locus (Carson 
et al., 1992) and the gene for this disorder has recently 
assigned to the long arm of chromosome 14 (14q24.3-q32) by 
linkage to the D14855 and D14S48 loci in five Japanese 
families (Takijama et al., 1993). These reports indicate that 
genetic heterogeneity underlies the phenotypic differences 
within this group of disorders. 
The lack of recombination between the microsatellite markers 
and the disease phenotype in the two large South African 
families supports the localization of the SCAl gene close to 
these markers. Maximum positive lad scores at a recombination 
fraction of 0.00, in the three smaller families, which also 
share relatively rare haplotypes with the 2 larger families, 
strongly suggests locus homogeneity in these 5 South African 
families. 
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11.4.3 TRINUCLEOTIDE EXPANSION AT SCAl 
Expansion of a CAG repeat was observed in all affected 
individuals from 5 of the 11 South African families 
investigated by PCR analysis. In these persons the age of 
onset is inversely correlated with CAG repeat size and 
individuals with large repeats tend to have an earlier age of 
onset. Similarly, CAG repeat size also correlates with the 
severity of the disease; persons with a more rapidly 
progressive illness tend to have a larger repeat size. 
These findings parallel those seen in Huntington disease and 
X-linked spinobulbar muscular atrophy, both of which are 
progressive neurodegenerative disorders. The mutational 
mechanism involves an unstable expanded trinucleotide repeat 
mutation and a definite or putative polyglutamine tract in the 
encoded protein (La Spada et al., 1991; Orr et al., 1993; 
Huntington disease research group, 1993 ). The precise role of 
the trinucleotide expansion in the pathogenesis of SCAl 
remains to be determined; Orr et al.(1993) have hypothesized 
that all three disorders involve gain-of-function mutations 
related to the expansion of the repeats. Recent data indicate 
that repeat instability at SCAl is more complex than a simple 
variation in repeat number (Chung et al., 1993). 
The identification of an expanded repeat at SCAl provides a 
means for rapid genotype analysis of families with autosomal 
dominant inherited ataxia to determine which families have 
SCAl. Detection of the repeats in the 3 smaller families 
(C,D,E) supported the notion of locus homogeneity suggested by 
the results of microsatellite linkage analysis. 
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11.5 CONCLUSION 
The results of the molecular studies outlined in this chapter 
document genetic heterogeneity within the South African 
kindred with familial ataxia. Furthermore, genetic 
heterogeneity is confirmed within those families with the same 
phenotype (viz. autosomal dominant cerebellar ataxia type 1, 
Harding). This observation provides strong evidence against a 
single founder effect. In those families with SCAl, molecular 
techniques now provide an accurate and practical approach to 






Chapter 12 PSYCHOLOGICAL AND SOCIAL PERSPECTIVES 
CHAPTER 12 PSYCHOLOGICAL AND SOCIAL PERSPECTIVES 
"Then out of the blue the thought came to me that it wasn' t 
impossible for me to develop my father's sickness. How I 
managed to cope with the subsequent terror and blackest 
despair is a mystery to me. I started watching myself 
mercilessly for signs of the disease. I checked my movements, 
the way I walked, handled things (objects), talked. This left 
me with an excruciating tension. I walked around in a 
constant depression. At the age of 16 when other kids were 
worrying about acne, I was thinking about suicide. I have 
been working with a psychiatrist for 3 years and I am still 
unable to reduce in any way the tension that I referred to 
earlier. He feels that a large part of my problems is my lack 
of self-esteem and I do agree with him. But on the other hand 
if a psychopathic killer is holding a gun to your head (nature 
is often referred to as just that) and threatened to pull the 
trigger then I think you are quite justified in being a 
nervous wreck after some time. " 
Extracts from letter to author from an affected individual. 
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PSYCHOLOGICAL AND SOCIAL PERSPECTIVES 
12.1 INTRODUCTION 
Throughout the clinical survey it was apparent that the 
disorder had a major psychosocial impact on unaffected persons 
as well as their affected kin. Numerous anecdotes from family 
members led to the investigation of these issues on a broader 
scale. Although many affected individuals previously had 
contact with medical personnel because of their illness, it 
appeared that many knew nothing of the risk of transmitting 
the disorder to their offspring. Other affected persons did 
not seek medical attention when they developed symptoms of the 
disorder as they knew that the condition was familial and that 
there was no specific treatment. Few unaffected relatives 
sought genetic counselling and it was uncertain how well 
informed they were with regard to their personal risk. 
In order to illuminate the plight of these individuals a few 
general observations and anecdotes are briefly mentioned. A 
number of affected individuals reported symptoms of anxiety 
and depression which they attributed to their disease, four of 
whom required long-term psychiatric therapy for these 
problems. One person whose symptoms started at the age of 16 
years, had attempted suicide on two occasions. She became 
socially isolated and was reluctant to leave her home because 
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''people say I am drunktt. Marital discord often occurred when 
a spouse developed signs of this illness. 
One large family (family B) lived in a rural area of the 
Western Cape where the community nursing sister had 
established contact with members of the different branches of 
this family. She reported a high percentage of somatic 
complaints among unaffected individuals, many of whom were 
poorly informed about the disorder. The survey outlined in 
this chapter was planned in response to a request from the 
community nursing sister in order to identify and address 
these issues. The objectives of the survey are listed below: 
1. Assess the psychosocial impact of the disease on both 
affected and unaffected individuals. 
2. Assess the risk awareness amongst unaffected individuals. 
3. Assess attitudes of the unaffected relatives towards their 
affected kin. 
4. Assess the problem of somatic complaints amongst unaffected 
patients. 
5. Evaluate attitudes of both affected and unaffected 
individuals towards reproduction. 




12.2.1 QUESTIONNAIRE DESIGN 
On the basis of the anecdotal reports and frequent 
communications with the community sister, 12 questions were 
formulated independently by two investigators (the author and 
a clinical psychologist). It was necessary to formulate the 
questions ab initio as no previous studies of a similar nature 
have been undertaken on any of the South African families with 
hereditary ataxia. Because of the limited information and the 
uncertainty concerning peoples attitudes towards the disease, 
the questions were structured in an open-ended format except 
for those pertaining to somatic complaints. The following 
questions were posed: 
QUESTIONNAIRE: 
1. How did the family illness influence your life? 
2 . What do you think is the biggest problem for: 
a) the person with the illness 
b) the family 
3. 
4. 
Who in the family do you think will get it? 
Why do you think so? 
S. Did anybody ever say that you would get it? 
6. Who, and why did they say so? 
7. Do you think that you will get it, or that you already have 
it? 
8. Why do you think so? 
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9. How do you feel if you think of, or look at your mother/ 
father/brother/sister, or any other family member who has 
it? 
10. And about those who are healthy? 
11. Have you ever had any of the following problems? How 
often?: 
a) Headaches 
b) Stomach aches 
c) Tearfulness 
d) Difficulty sleeping 
e) Nervousness 
f) Moodiness 
g) Any other problems 
12. Do you want any more children: 
a) If yes, how many? 
b) If no, why not? 
Question 1 attempts to quantify the psychosocial impact of the 
disorder on the unaffected family members. 
In the analysis, a score was assigned by the investigators to 
the response of this question: 0 = no effect; 1 = don't 
know; 2 = moderate effect; 3 = major effect; 4 = positive 
effect (see 12.3.1). There was agreement between the 2 raters 
who scored the responses to this question. 
The response to question 2 indicates the individual's 
perception of the major problems which face the affected 
person and their family. The investigators assigned the 
responses to the following descriptive categories: 
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1 Physical disability (ie. physical disability due to 
impaired walking, speech or limb coordination). 
2 Cognitive disability (ie.symptoms of dementia) 
3 Emotional problems (disorder of mood or behaviour). 
4 Occupational disability (eg.loss of income). 
5 Social problems (eg social stigma/embarrasment). 
6 Burden to the family (ie.unaffected members have to care 
for affected persons). 
Questions 3 to 8 concern risk awareness. In this family the 
condition is inherited as an autosomal dominant trait with 
full penetrance. 
All unaffected individuals were assigned a risk status by the 
author based on criteria shown below: 
Low risk status: this was assigned to unaffected individuals 
in whom a grandparent was affected, but the parent was 
unaffected and over the age of 49 years (clinical data in this 
family indicate a range of age of onset from 16 yrs to 49 yrs 
- see chapter 8). A low risk status was also assigned to 
individuals in whom both parents and grandparents were 
unaffected, but in whom a great aunt or great uncle had the 
disorder. 
Intermediate risk status: this was assigned to unaffected 
individuals in whom a grandparent was affected and the parent 
was unaffected but less than 49 years of age. 
High risk status: this was assigned to unaffected individuals 
who had an affected parent (ie. 50% risk). 
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Question 3 evaluates whether family members are aware that 
certain unaffected members carry a risk of developing the 
condition. Question 4 probes the insight and perception of 
risk awareness amongst family members. Questions no 7 and 8 
probe the insight and accuracy of perceptions concerning 
personal risk for developing the disorder. 
The response to these questions was analysed and the 
"perceived" risk status of these individuals was categorized 
as follows: 
1) no risk 2) possible risk 3) high risk. Possible risk 
included uncertain or ambiguous responses. 
In this analysis the "assigned" risk status (i.e."true" risk) 
of each person was compared to the "perceived" risk status. 
The "assigned" risk category was determined solely on clinical 
data from the study of the pedigree. At the time of this 
survey, molecular data concerning risk status were not yet 
available for these persons. Furthermore, the objective of the 
survey was to evaluate the accuracy of the individual's 
"perceived" risk status as an indicator of the effectiveness 
of any previous genetic counselling to some members of the 
family. Since all prior genetic counselling by medical or 
paramedical personnel was based on clinical data only, it 
would be invalid to use molecular data to determine an 
"assigned" risk for the purpose of this comparison. 
Questions numbers 5 and 6 probe the issue of preselection as a 
coping strategy in familial ataxia. Preselection refers to the 
"sick"-role assignment given to an asymptomatic individual in 
197 
a family in which a genetic or other disorder with multiple 
uncertainties occurs. The selection process is made often 
when the preselected person is still a child, without 
knowledge of who will eventually be affected. The process 
requires the collusion of family members for its initiation 
and maintenance and serves as a major coping strategy to 
reduce or bind the stresses and anxieties engendered by 
uncertainty. This type of selection has been reported in some 
families in which Huntington disease occurs and the phenomenon 
is promoted by the delayed age of onset of the disorder and 
uncertain gene status of the person at risk (Kessler, 1988). 
Questions 9 and 10 evaluate personal attitudes towards 
affected and unaffected persons. Question 11 probed the 
prevalence of somatic complaints in unaffected individuals. 
Question 12 assessed the attitudes of unaffected and affected 
individuals towards reproduction (7 of these persons were 
younger than 16 years of age and were not asked this 
question). 
12.2.2 PROCEDURE 
The study was planned jointly with the community nursing 
sister. She was able to liaise with family members and relay 
information to the author concerning their expectations and 
willingness to participate in the survey. Informed consent was 
obtained for the survey. Prior to administering the 
questionnaire, all participants were personally informed by 
the author of the objectives of the survey. Thereafter, the 
participants were interviewed individually by two 
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investigators. The questionnaire was bilingual (English and 
Afrikaans) and all participants were interviewed in their 
mother-tongue. Caution was exercised not to ask any leading 
questions when probing responses. 
12.2.3 SAMPLE 
Forty volunteer subjects participated in the study. 
Thirty persons were unaffected (all examined by author) and 6 
were affecte~. Four spouses of affected persons were also 
interviewed and their responses were analysed separately. 
The mean age and sex of the sample are indicated in table 12.1 






mean age 40 yrs 
r: 37-47 yrs 





r: 12-35 yrs 
The educational level of the persons in the sample was 
ascertained. The mean standard achieved at school was: 
Standard 7.27 in the unaffected group (range :4-10) ; and 
Standard 6.50 in the affected group (range 4-10). Three 
persons had tertiary education. 
The occupational levels of the persons in the sample appear in 
table 12.5. Six categories were identified: Unemployed; 
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Unskilled (eg. labourer); Semi-skilled (eg. factory worker); 
Skilled (eg. clerical); Professional (eg. nurse,teacher); 
Scholars. 
TABLE 12.2 OCCUPATIONAL LEVEL OF THE PERSONS IN THE SAMPLE 
affected unaffected 
unemployed 5 3 
unskilled 0 1 
semi-skilled 0 10 
skilled 1 2 
professional 0 2 
scholars 0 12 
The assigned ("true'') risk status of the 30 unaffected persons 
is illustrated below in table 12.3 : 

















FIGURE 12.1 FOUR OF THE PARTICIPANTS IN THE SURVEY 





12.3.1 PSYCHOSOCIAL IMPACT ON UNAFFECTED PERSONS 
Table 12.4 indicates the impact of the disorder on the lives 
of the unaffected persons interviewed. 
TABLE 12.4 PSYCHOSOCIAL IMPACT OF THE DISORDER 
ON THE LIVES OF UNAFFECTED PERSONS 
Effect Number Percentage 
No effect 2 6.7% 
Uncertain 6 20.0% 
Moderate negative effect 5 16.7% 
Major negative effect 15 50.0% 
Positive effect 2 6.7% 
The 2 individuals who felt that the presence of the disorder 
had a positive effect on their lives cited religious 
conviction and the desire to support one another ("in the 
beginning I ignored the disease, but I became positive through 
religion"; "we were not close but I now feel we must support 
each other"). 
Table 12.5 indicates the perceptions of the unaffected and 
affected individuals concerning the major problems which face 
affected family members (i.e. response to question 2). 
The majority of both affected and unaffected family members 
perceived physical disability to be the major problem facing 
the affected members. 
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TABLE 12.5 PROBLEMS FACING AFFECTED INDIVIDUALS 
affected persons unaffected persons 
Disability No. % no. % 
Physical 5 83 18 60 
Cognitive 0 0 5 17 
Emotional 2 33 4 13 
Occupational 1 17 2 7 
Social 1 17 4 13 
Burden to family 0 0 6 20 
Two affected members identified emotional lability as a major 
problem for them. They tended to cry easily and expressed fear 
and concern that their children might develop the disease. 
Unaffected individuals (4 persons) observed that affected 
persons were not infrequently short-tempered and prone to 
bouts of depression. 
Five of the unaffected persons believed that cognitive decline 
("can't think properly'',"the mentality becomes like that of a 
child") was a problem for some of the affected individuals. 
None of the affected individuals made this observation. Only 3 
people (1 affected, 2 unaffected) mentioned loss of income as 
a problem. Social problems concerned only 14% of the total 
sample (1 affected, 4 unaffected). They described a sense of 
social isolation ("do not feel part of the family") and 
embarrassment (eg. affected persons falsely accused of being 
drunk when seen in public places). 
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Six unaffected individuals felt that a major problem for more 
severely affected persons was their inability to care for 
themselves. This placed a burden on the unaffected relatives 
who had to assist them. None of the affected persons reported 
being a burden to their family. 
Table 12.6 indicates the perceptions of family members 
concerning the major problems which face the family of an 
affected person. 
TABLE 12.6 MAJOR PROBLEMS FOR FAMILIES OF AFFECTED 
INDIVIDUALS 
affected persons unaffected persons 
Problem: No. % no. % 
Emotional 1 16.7 11 36.7 
Burden to family 1 16.7 11 36.7 
Loss of income 2 33.3 2 6.7 
Emotional problems pertaining to the whole family were that 
they all had to deal with the knowledge that the affected 
individuals died prematurely and that others may also succumb. 
Frustration and anxiety were the most common complaints and a 
loss of religious conviction was reported by a few members. 
Relatives also had to cope with the emotional lability which 
developed in some of the affected persons. 
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12.3.2 RISK AWARENESS OF UNAFFECTED INDIVIDUALS 
12.3.2.1 GENERAL RISK AWARENESS: 
Ten unaffected individuals believed that no other unaffected 
relatives were likely to develop the disorder. Eighteen of the 
unaffected individuals believed that other family members may 
develop the disorder and 2 unaffected persons were uncertain. 
They assigned this risk to a parent (5 individuals), a sibling 
(11 individuals), or an uncle or aunt (2 individuals). 
Four of the affected persons believed that others were likely 
to develop the disorder (all 4 assigned this risk to a 
cousin), 1 affected person was uncertain and 1 did not believe 
that any other member would get the disorder. Those 
individuals who understood the genetic risk for the disorder 
were uncertain which individuals carried a genuine risk and 
what the magnitude of the risk was for a particular person. 
Explanations offered for the assignment of risk to a 
particular individual related to the physical and emotional 
characteristics of that person (eg. "has a similar nature to 
her mother"; "the way he walks"; "he stutters"; "he has a 
bewildered look";"has a nervous disposition") 
12.3.2.2 PERSONAL RISK AWARENESS 
All 30 of the unaffected individuals correctly said that they 
did not have the disorder. Eighteen of the unaffected 
individuals believed that they would not get the disease, 11 
believed that they might get the disorder, and 1 believed that 
he would get the disorder (see table 12.7). 
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Of the 12 individuals who perceived a positive risk for 
developing the disorder (ie. high risk and possible risk 
categories), 3 cited genetic reasons (viz. they knew the 
disease was inherited but were unsure of the absolute risk), 1 
person said that his father had told him that he would get the 
disease, 5 were uncertain and 2 cited physical problems (eg. 
pains in the legs and knees) as possible explanations for 
their perceived risk. Another person believed that she may be 
able to avoid developing the disorder because she consumed 
certain calcium powders. 
The 18 unaffected persons who believed that they would not 
develop the disorder frequently offered more than one 
explanation for this. These included strong religious beliefs 
(eg."I believe in God and He will not allow it", "I am a child 
of God"), a lack of any symptoms (eg. "because I am healthy", 
"I don't get any pains") and a belief that regular exercise or 
sport would prevent the disease from manifesting. One person 
believed that the regular application of "Deep Heat" cream to 
the limbs would prevent the disorder, and another said that he 
would not develop symptoms because a parent had told him this. 
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Others offered less specific reasons (eg."I have confidence in 
myself" and "a feeling that I am not going to get it"). 
In table 12.8 the assigned (ie."true") risk status of these 
individuals is compared with their perceived risk status. 
TABLE 12.8 "TRUE" vs "PERCEIVED" RISK STATUS 
"true" risk category no. perceived risk 
low risk 7 3 low 
4 possible 
0 high 
intermediate risk 4 2 low 
2 possible 
0 high 
high risk 19 13 low 
5 possible 
1 high 
This comparison of "true" risk to perceived risk indicates 
that 24 of the 30 unaffected persons had incorrect perceptions 
of their risk status. It is noteworthy that of the 19 
individuals with a high "true" risk status, 13 believed that 
they had a low risk for developing the disorder. 
12.3.3 PRESELECTION 
A total of 9 individuals reported that they were told by 
another person that they would get the disorder. This 
information was conveyed by a parent (5 individuals), a 
grandparent (1 individual), a spouse (1 individual) and a 
cousin (1 individual) and a paramedic (1 individual). In all 
but one instance it appeared that this occurred sporadically 
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and no persistent collusion of other family members occurred. 
Explanations for this warning included: "all the children may 
get it because it is a family sickness"; "when I am impatient 
my husband says I will get the illness because my mother was 
impatient". In one branch of the family in which the parents 
and 7 unaffected siblings were interviewed, the affected 
mother and 2 of the siblings each identified the same sibling 
as likely to get the disease. They cited her nervous 
disposition which was said to be similar to her mother's as 
the reason for this increased risk. 
12.3.4 ATTITUDES TOWARDS AFFECTED FAMILY MEMBERS 
When questioned about their attitudes toward their affected 
kin, a variety of emotions elicited from the unaffected 
persons. These included feelings of sympathy, concern, "a 
sense of duty", "heartache'', helplessness, anguish, fear• 
tearfulness and a sense of "emotional burden". One person 
wished that a close relative would rather die than suffer in 
such a way. Another expressed concern at the inability of an 
affected parent to fulfil parental duties. Others were 
uncomfortable with the social embarrassment which affected 
members caused them (eg. strangers often ascribed the 
manifestations to alcohol abuse). The feelings of fear related 
not only to the predictable future of the affected persons, 
but were also evoked by being continually reminded of the 
potential threat which the disorder holds for the unaffected. 
The affected individuals expressed very similar feelings 
towards other affected kin (eg. "pity", "concern", 
"embarrassment"). Some became anxious because they were 
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concerned that they would "get as bad as" their affected 
siblings. 
12.3.5 ATTITUDES TOWARDS UNAFFECTED FAMILY MEMBERS 
The majority of individuals (both affected and unaffected) 
expressed a feeling of "happiness" (Afrikaans:"bly") towards 
those who did not have the disease (eg."happy at their 
health";"! am happy because it would be terrible if everyone 
got it"). In some this happiness was tempered by feelings of 
uncertainty about the future ("those who have the sickness 
were well at first"). Others felt that those who were spared 
had responsibilities towards the affected persons and that 
they were obliged to look after them. One individual commented 
"I am ashamed for those who are healthy but don't work because 
my mother, who is sick, still works". Another person was 
worried that the unaffected persons may be taking something 
that prevented them from getting the illness and that they 
were concealing this information from others in the family. 
12.3.6 SOMATIC COMPLAINTS IN UNAFFECTED INDIVIDUALS 
Seventy percent of unaffected persons reported at least one 
frequent somatic complaint. Table 12.9 show the prevalence of 
somatic complaints in unaffected persons. 
Other complaints, which probably had a non-psychological 
origin, included pains in the legs (1 person), asthma (1 
person), hayfever (1 person), and a "kidney problem" (1 
person). 
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TABLE 12.9 SOMATIC COMPLAINTS 
affected persons unaffected persons 
Complaints No. % No. % 
Headache 3 50 11 36.7 
Stomach ache 0 0 3 10.0 
Tearfulness 2 33 8 26.7 
Sleep disturbance 3 50 2 6.7 
Nervousness 4 67 12 40.0 
Mood swings 2 33 11 36.7 
12.3.7 ATTITUDES OF UNAFFECTED PERSONS TO REPRODUCTION 
The majority of unaffected persons (69.6%) wanted more 
children. The attitudes of unaffected· individuals towards 
having further children is shown in table 12.10. 
TABLE 12.10 ATTITUDES OF UNAFFECTED INDIVIDUALS TOWARDS 
REPRODUCTION 
Want more children 












All 6 unaffected individuals who did not want more children 
already had children. Only 2 of the 6 unaffected persons cited 
the risk for the disease as a reason for not having additional 
children. The other reasons given were financial, physical 
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(eg.sterilization) and a completed family. Of the 16 
individuals who desired additional children, 11 planned on 
having 2 or more children. 
12.3.8 INTERVIEWS WITH SPOUSES 
Four spouses (aged 34, 57, 74 and 82) were interviewed. The 
two older woman were widowed, while the younger woman and man 
were living with their spouses. The responses of the 82 year 
old woman were discarded because she was intellectually 
compromised. The other widow discussed her fears for her one 
(of eight surviving children) healthy son and rationalized her 
distress at the recent diagnosis of her daughter who the 
doctor said ''only had it mildly (net in 'n ligte graad)." She 
thought that the family illness may be divine retribution. 
The 34 year old pregnant wife, a factory worker, also 
expressed her fears for her children, especially her 10 year 
old daughter who suffered from headaches. She empathized with 
the family members who had the disorder, but added that they 
were very impatient people. The 57 year old male, a teacher, 
discussed his frustration, anxiety, insomnia, depression and 
constant tension, and admitted that the unaffected family 
members did not always know how to react when the affected 
person became frustrated and refused help. He was worried that 
his daughter and one of his two sons, who were slightly built, 
would get the disorder, and also expressed similar fears for 
his grandchild. He did not think that his well-built son was 
at risk. Neither of the married spouses wanted more children. 
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12.4 DISCUSSION 
Relatives of affected persons face problems (viz. physical, 
social, occupational, "burden to family") common to those who 
live with and have to care for the chronically ill. The 
progressive nature of the disease and the dementia which 
develops in certain members in the later stages of the 
illness, compounds these difficulties. Furthermore, the 
genetic nature of the disorder and attendant uncertainty as to 
who else will develop the disorder adds another dimension to 
these issues. Most of the unaffected persons had very 
rudimentary understanding of the genetics of the disease, as 
explained to them by relatives, and had not previously 
interacted with genetic counsellors. One third of unaffected 
persons were uninformed or unaware of the inherent risk that 
existed for certain unaffected family members. A high 
percentage (63%) of unaffected persons did not perceive any 
personal risk for developing the disorder. 
In a comparison of "true" risk with "perceived" risk, 80% of 
unaffected individuals (24/30) had incorrect perceptions of 
personal risk status. A number of possible explanations may 
account for these high figures. It is clear that a lack of 
effective genetic counselling, particularly amongst the 
unaffected members of this family may account for some of the 
misconceptions. Religious conviction and psychological 
strategies such as denial and projection would also help 
explain this phenomenon. This was evident in the 
rationalizations which individuals offered (eg."God will not 
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allow it";"because I exercise";"because I take calcium 
powders"). Similar findings have been reported in families 
with Huntington disease:"denial and hope are the twin 
mainstays of survival in impossible circumstances" (Wexler, 
1992). 
There was some evidence to support the preselection phenomenon 
as a coping strategy in only one branch of this family in 
which 3 members indicated their belief that a particular 
sibling would develop the disorder in the future. The 
"preselected" person initially denied that anyone had ever 
told her she would get the illness but later in the interview 
expressed her fear of becoming ill because of what she had 
been told by her family. The strategy of preselection is 
thought to contain and bind the family's anxiety about the 
threat of the genetic disorder. It provides the illusion of 
protection from the disease (viz. it will ha-ppen to him, not 
to me) at the expense of the preselected person (Kessler, 
1988). 
Unaffected persons had predictable responses (eg. sympathy, 
concern, duty-bound) towards their affected kin. For some, 
however, the interaction with affected individuals served as a 
constant reminder of the potential threat to their own future 
well-being. For this reason, a few persons tended to avoid 
contact with affected members. Although many individuals found 
comfort with their religious beliefs, several had abandoned 
religion because they could not rationalize why their family 
should be "cursed with such a disease". Although the 
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overwhelming attitude towards those who appeared to be spared 
was positive (eg."glad","happy"), not unexpectedly, feelings 
of resentment and suspicion were occasionally evident. The 
high prevalence of somatic and psychologic complaints amongst 
unaffected persons is a reflection not only of the stress of 
living and coping with a chronically disabled person, but is 
also a measure of the personal threat and insecurity which the 
disease confers. The very high prevalence of symptoms may 
reflect a fault in the design of the questionnaire in which 
unlike the other more open-ended questions, the direct 
questioning about somatic complaints may have pre-empted 
responses. 
The survey revealed that the disorder had little impact on the 
attitudes of both affected and unaffected persons concerning 
reproduction. No family member, either at risk or affected, 
had chosen not to have children because of the disease. The 
majority of those at risk wanted more children and 2 of the 6 
affected persons wanted additional children despite their own 
disability. These attitudes towards reproduction should be 
considered in the context of a family in which many members 
appear to be poorly informed about three important issues 
viz.: the genetic aetiology of the disorder; which persons 
carry a high risk for the disease; and the magnitude of the 
risk for potential offspring. 
The survey confirmed the profound psychosocial impact which 
the disorder has on all family members and identified a 
variety of issues and misconceptions which must be addressed. 
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Many factors influence the responses o
f persons affected with 
genetic diseases and their families. G
reater understanding of 
these influences and dynamics is requir
ed in order to plan 
effective counselling in the future, p
articularly now that 
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CONCLUSIONS, APPLICATIONS, AND RECOMMENDATIONS 
13.1 PILOT STUDY 
The retrospective pilot study identified 18 families with 
familial ataxia that had been seen over a 10 year period a
t 
Groote Schuur Hospital. Twelve of these families were stil
l 
living in the area and were subsequently contacted and 
reassessed prospectively. This study provided the first 
available data in South Africa on the clinical spectrum, 
natural history and prognosis of the late onset familial 
ataxias. A group of individuals with sporadic ataxia was 
identified and compared with the familial group. Although 
this group of persons did not form part of the prospective
 
survey, records of all individuals with late onset sporadic
 
ataxia has been kept and a study is planned to examine the
se 
individuals (phenotype resembling the familial variety) fo
r 
the expanded trinucleotide repeat on Chromosome 6. 
13.2 PROSPECTIVE SURVEY 
This prospective population-based study of the spectrum of 
late onset spinocerebellar ataxias, was the first to be 
undertaken for a region of South Africa. The survey provid
ed 
information concerning the minimal prevalence, mode of 
inheritance, symptomatology, range of clinical manifestatio
ns, 
course and prognosis of the different phenotypes. In 
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particular, the most commonly encountered phenotype (adult 
onset ataxia with retained reflexes, Currier classification) 
in the Western Cape region of South Africa, is similar to that 
observed in families in Europe and North America. Information 
from this clinical survey has resulted in a more accurate and 
appropriate counselling service at the Neurogenetics clinic, 
Groote Schuur Hospital. Eight other small families with 
unusual phenotypes were identified. These show some 
similarities to reports in the literature, but there were also 
significant differences. It is uncertain whether genetic 
heterogeneity or variable expression of the same defect 
accounts for these observations. This issue will be addressed 
in future studies. 
13.3 DIAGNOSTIC IMAGING AND ELECTROPHYSIOLOGICAL TESTS 
The MRI scan study demonstrated the morphological changes of 
the nervous system present at different stages during the 
course of the disorder. In the early stages of the illness, 
clinical symptoms and signs precede any detectable morphologic 
changes on this scan. Therefore, MRI scans are of limited 
value as a diagnostic tool at the onset of symptoms, when the 
clinical diagnosis may be in question. Later on, there was a 
moderate correlation between the atrophy seen on the scan and 
the clinical ataxia syndromes. 
Similarly, electrophysiologic studies demonstrated that a 
motor polyneuropathy was a variable and usually late 
manifestation in persons with adult onset ataxia. Nerve 
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conduction studies and EMG helped to complete the delineation 
of the phenotype in those individuals with distinctive ataxia 
syndromes. 
13.4 MOLECULAR LINKAGE STUDIES 
Linkage studies have confirmed genetic heterogeneity within 
the South African families with late onset ataxia. The 
results with the microsatellite markers, D6S89 and D6S260, 
indicate that 2 disease-associated haplotypes occur in the 5 
families of mixed ancestry, suggesting independent origins of 
the disorder. Affected members in the five families with 
ataxia were shown to have an unstable expanded trinucleotide 
repeat at the SCAl locus on chromosome 6. This provides a 
means for rapid genotype analysis of families. A major 
advantage is that the result can be obtained in an individual 
if the expanded region is detected, thereby eliminating the 
need for large family studies. The linkage of SCAl to the 
microsatellite markers, D6S89 and D6S260, is important in 
these families for confirmation of diagnosis, particularly 
when the repeats are indistinct. In families with SCAl, 
molecular techniques provide an accurate approach to the 
management of the disorder through presymptomatic and prenatal 
testing. 
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13.5 PSYCHOLOGICAL SURVEY 
In contrast to the breadth of literature on the 
classification, pathology, and genetics of the spin
ocerebellar 
ataxias, there is a paucity of reports addressing th
e 
emotional and social aspects of the disease (Boutte
, 1990). 
Although this study was undertaken on a relatively 
small 
sample of 40 persons, it documents the profound psy
chological 
impact of the disorder of unaffected members of the 
South 
African families. The most striking feature of the 
survey was 
that both affected and unaffected family members had
 a very 
poor understanding of the genetic nature of the diso
rder, even 
though most affected persons had previously sought m
edical 
attention for the condition. The majority of person
s 
interviewed had misconceptions concerning the risk 
status of 
unaffected persons. Attitudes towards reproduction 
were, not 
surprisingly, unaffected by the presence of the fam
ilial 
disorder. The survey highlights the need for effec
tive 
genetic counselling and the provision of a support 
service to 
help family members understand the genetic implicati
ons of the 




13.6 PRACTICAL APPLICATIONS AND FUTURE OBJECTIVES 
13.6.1 ESTABLISHMENT OF NEUROGENETICS CLINIC 
A Neurogenetics Clinic was established at Groote Schuur 
Hospital in 1993. This multidisciplinary clinic runs on the 
first Thursday in each month and serves the following 
functions: 
1. The diagnosis and care of persons with inherited 
neurological conditions; 
2. Genetic counselling for the affected persons and their 
relatives; 
3 Collection of blood samples for DNA banking; 
4 Accurate recording of all relevant pedigrees and the 
creation of a patient database for the inherited 
neurodegenerative conditions. 
The Huntington disease clinic, which has been running at 
Groote Schuur Hospital since 1978, has been incorporated into 
the Neurogenetics clinic. The staff of the clinic comprises 2 
neurologists, 2 medical genetic counsellors, and a genetic 
nursing sister. A psychologist and a social worker are 
available for consultation. 
Numerous lectures and presentations have been given by the 
author throughout the country on various aspects of this 
project (abstracts in the appendix). This has helped to 
increase the awareness of the condition and improve the 
understanding of the disease and the associated psychological 
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and social problems that it creates. Although this project 
was confined to families living in the Western Cape region, 
numerous referrals of individuals with familial ataxia have 
ensued from all parts of the country. Where possible, blood 
samples have been obtained from the relevant persons for DNA 
banking. In 1988 a management system for DNA banking was 
installed in the micro-computer network of the laboratory of 
the Department of Human Genetics, UCT. Details of all persons 
with familial ataxia whose blood is taken for DNA banking are 
stored on this program. Confidentiality is an important aspect 
of spinocerebellar ataxia DNA banking and only authorized 
staff members are allowed access to this data. 
13.6.2 FUTURE STUDIES 
A number of future studies are planned. These include: 
1) A study of persons with sporadic ataxia, for detection of 
the unstable trinucleotide repeat; 
2) A postmortem study of specimens of different tissue to 
examine the expression of the expanded repeat in different 
tissues and specifically in different areas of the nervous 
system. Recent work on Huntington disease has shown 
variable expression of the expanded repeat in different 
areas of the brain (Telenius et al., 1994); 
3) Studies to determine the genotype in those South African 
families not associated with SCAl. 
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13.6.3 ESTABLISHMENT OF LAY SUPPORT GROUPS 
The author has attempted to encourage the formation of a lay 
support group for families with familial ataxia. In 1986 the 
Huntington Society of South Africa was formed with the aim of 
providing affected families with an opportunity to meet one 
another and to share experiences, discuss problems and act as 
a support group. Many of the families with familial ataxia 
and Huntington disease are from lower socio-economic groups, 
and financial constraints may necessitate combining resources 
to form a single society to serve the needs of families with 
either disorder. An important role for the health care worker 
and the lay society would be to educate the community about 
the condition, particularly its genetic nature and progressive 
disability. This would serve to increase awareness and 
minimize the social stigma attached to the disorder. While 
many family members expressed common fears, a myriad of 
individual responses were elicited. This emphasizes the need 
for individual counselling. 
13.6.4 PREDICTIVE TESTING 
Plans are currently under way for the introduction of a 
predictive testing service for spinocerebellar ataxia at 
Groote Schuur Hospital. A number of problems and ethical 
issues are being addressed. The principal concern for those 
involved with predictive testing has been the possibility of 
serious emotional and psychological effects in people whose 
results indicate a high risk of having the disease gene, 
particularly as these results may be available many years 
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before the onset of symptoms. The persons who receive a 
positive result may have great difficulty in sustaining goals 
and maintaining optimism in the face of this knowledge. The 
test results may have a similar impact on the spouse and may 
impose strain on the marital relationship. Many of these 
issues have been addressed in the context of Huntington 
disease (Huggins et al., 1990, 1992; Bloch et al., 1992; 
Chapman, 1992). While there have been no catastrophic 
responses to positive test results in any of the published 
reports, these predictive tests were all performed in a 
clinical context that provided pre-test psychiatric and 
psychological assessment, adhered fully to the principles of 
informed consent, offered both pre-test and post-test 
counselling, and included psychological support and follow-up 
(Chapman, 1992). A study of the consequences of predictive 
testing for Huntington disease showed potential benefits for 
the psychological health of persons who receive results that 
indicate either an increased or decreased risk of inheriting 
the gene for the disease (Wiggins et al., 1992). 
Notwithstanding these findings, there is agreement that there 
are many problems associated with predictive testing and this 
test should be approached by all parties with the utmost 
caution, and should not be undertaken without safeguards 
(Hayes, 1992). A number of centres in the United Kingdom and 
the United States of America offer predictive testing and 
different approaches to predictive testing have arisen (Fahy 
et al., 1989) 
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The World Federation of Neurology has issued an ethical p
olicy 
statement for Huntington disease molecular genetic predict
ive 
testing. The United Kingdom Huntington Prediction Consort
ium 
has also issued a protocol for predictive testing for 
Huntington disease. These realistic guidelines and 
recommendations concerning the use of molecular technology
 for 
predictive testing in Huntington disease are readily 
applicable to the late onset ataxias. Both disorders are 
inherited as autosomal dominant traits, manifest in adulth
ood, 
and have a similar course and prognosis. A similar geneti
c 
mechanism (ie. an unstable expanded trinucleotide repeat) 
is 
responsible for both disorders. Recently Shrimpton et al.
 
(1993) reported their experience of presymptomatic testing
 for 
autosomal dominant ataxia (SCAl) in the United Kingdom. 
The psychological survey in this project has identified 
several issues which will be addressed prior to the 
introduction of a predictive testing service for the fami
lial 
ataxias in the Western Cape region. Affected persons and 
their families, particularly in the rural areas require m
ore 
effective counselling, particularly with respect to 
misconceptions of risk status and improved understanding o
f 
the nature of the disorder. In the future it will be 
necessary to make optimal use of existing social services.
 
Often financial constraints and lack of transportation for
 
patients and persons at risk have made certain services ba
sed 
in the metropolitan areas inaccessible to some families. 
This 
accounts for many of the misconceptions held by members of
 the 
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The World Federation of Neurology has issued an ethical policy 
statement for Huntington disease molecular genetic predictive 
testing. The United Kingdom Huntington Prediction Consortium 
has also issued a protocol for predictive testing for 
Huntington disease. These realistic guidelines and 
recommendations concerning the use of molecular technology for 
predictive testing in Huntington disease are readily 
applicable to the late onset ataxias. Both disorders are 
inherited as autosomal dominant traits, manifest in adulthood, 
and have a similar course and prognosis. A similar genetic 
mechanism (ie. an unstable expanded trinucleotide repeat) is 
responsible for both disorders. Recently Shrimpton et al. 
(1993) reported their experience of presymptomatic testing for 
autosomal dominant ataxia (SCAl) in the United Kingdom 
(Shrimpton et al., 1993). 
The psychological survey in this project has identified 
several issues which will be addressed prior to the 
introduction of a predictive testing service for the familial 
ataxias in the Western Cape region. Affected persons and 
their families, particularly in the rural areas require more 
effective counselling, particularly with respect to 
misconceptions of risk status and improved understanding of 
the nature of the disorder. In the future it will be 
necessary to make optimal use of existing social services. 
Often financial constraints and lack of transportation for 
patients and persons at risk have made certain services based 
in the metropolitan areas inaccessible to some families. This 
accounts for many of the misconceptions held by members of the 
226 
affected families in the rural area. The relevant community 
social worker and nursing sisters require education regarding 
all aspects of the condition so that they are more able to 
assist in identifying and managing problems facing affected 
persons and their families. The primary health care worker is 
often faced with the task of assisting family members to cope 
with problems of caring for the ataxic patient, informin~ them 
of existing services and helping individuals at risk to come 
to terms with their own status. By educating the family 
members about the disorder, individuals at risk would be more 
able to make informed, voluntary decisions about their lives. 
Within the Groote Schuur Hospital complex, a multidisciplinary 
team is being assembled (neurologists, genetic counsellor, 
psychologist and social worker) to formulate and implement a 
protocol for the support service necessary for predictive 
testing for familial ataxia (based on WFN recommendations for 
Huntington disease). The author has attended the Canadian 
National Predictive Testing meeting in Vancouver in September 
1993 and is aware and informed of the cost, pitfalls and 
resources required to implement and maintain such a service. 
The Department of National Health and Population Development, 
Genetic Service, has been approached for a financial and 
service commitment for DNA banking and predictive testing. 
Their support will be vital for the maintenance of an ongoing 
service. In South Africa the expansion of the practice of 
modern tertiary care medicine to the interest of individual 
patients, needs to be balanced by collective measures required 
at the level of preventative and primary health care in order 
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to improve the health of future generations. Questions will 
be raised about the allocation of funds to provide an 
expensive laboratory service in order to do predictive testing 
on a disorder which is relatively uncommon in the community 
when other diseases such as TB are endemic, particularly in 
the light of reduced state funding of teaching hospitals and 
the medical research council. Although the late onset ataxias 
are a relatively rare group of disorders, the extent of the 
problem will increase with each successive generation 
aggravating the financial burden of chronically disabled 
patients to the health system. Predictive testing is within 
the realms of preventative and primary health care as it 
provides a practical solution in the genetic management of the 
disorder and I believe that it merits funding. It will 
probably not be feasible to establish facilities for 
predictive testing at more than one genetic laboratory in the 
country because of the cost in maintaining such a service 
(considering the number of samples that each lab would be 
likely to process). A practical solution would be to 
centralize such a facility to a single laboratory to cater for 
the needs of the whole country. In certain centres in the 
United States of America where predictive testing is offered 
(for Huntington disease), the uptake of the test has been low, 
even when those who are at risk are systematically informed of 
its availability (Quaid et al., 1987; Craufurd et al., 1989). 
Those currently being tested are therefore a self-selected 
group and those who decline to be tested might be less able to 
handle the severe stresses entailed (Harper et al., 1990). 
Predictive testing is, however, enhancing the quality of life 
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of many at risk individuals. As stated by Chapman (1992), in 
this way they are freed from the burdens of the unknown, 
provided with more certainty in their lives, and given a 
greater sense of control over decisions involving their 
educational and career choices, marriage and family planning. 
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